NF-kappaB	B-protein
functions	O
as	O
both	O
a	O
proapoptotic	B-protein
and	I-protein
antiapoptotic	I-protein
regulatory	I-protein
factor	I-protein
within	O
a	O
single	O
cell	O
type	O
.	O

Recently	O
NF-kappaB	B-protein
has	O
been	O
shown	O
to	O
have	O
both	O
proapoptotic	O
and	O
antiapoptotic	O
functions	O
.	O

In	O
T	B-cell_line
cell	I-cell_line
hybridomas	I-cell_line
,	O
both	O
T	O
cell	O
activators	O
and	O
glucocorticoids	O
induce	O
apoptosis	O
.	O

Here	O
we	O
show	O
that	O
blockade	O
of	O
NF-kappaB	B-protein
activity	O
,	O
using	O
a	O
dominant	B-protein
negative	I-protein
IkappaBalpha	I-protein
,	O
has	O
opposite	O
effects	O
on	O
these	O
two	O
apoptotic	O
signals	O
.	O

Treatment	O
with	O
PMA	O
plus	O
ionomycin	O
(	O
P/I	O
)	O
results	O
in	O
the	O
upregulation	O
of	O
Fas	B-protein
Ligand	I-protein
(	O
FasL	B-protein
)	O
and	O
induction	O
of	O
apoptosis	O
.	O

Inhibition	O
of	O
NF-kappaB	B-protein
activity	O
inhibits	O
the	O
P/I	O
mediated	O
induction	O
of	O
FasL	B-RNA
mRNA	I-RNA
and	O
decreases	O
the	O
level	O
of	O
apoptosis	O
in	O
these	O
cultures	O
,	O
thus	O
establishing	O
NF-kappaB	B-protein
as	O
a	O
proapoptotic	B-protein
factor	I-protein
in	O
this	O
context	O
.	O

Conversely	O
,	O
inhibition	O
of	O
NF-kappaB	B-protein
confers	O
a	O
tenfold	O
increase	O
in	O
glucocorticoid	O
mediated	O
apoptosis	O
,	O
establishing	O
that	O
NF-kappaB	B-protein
also	O
functions	O
as	O
an	O
antiapoptotic	O
factor	O
.	O

We	O
conclude	O
that	O
NF-kappaB	B-protein
is	O
a	O
context-dependent	O
apoptosis	O
regulator	O
.	O

Our	O
data	O
suggests	O
that	O
NF-kappaB	B-protein
may	O
function	O
as	O
an	O
antiapoptotic	O
factor	O
in	O
thymocytes	B-cell_type
while	O
functioning	O
as	O
a	O
proapoptotic	O
factor	O
in	O
mature	B-cell_type
peripheral	I-cell_type
T	I-cell_type
cells	I-cell_type
.	O

Cell	NULL
Death	NULL
and	NULL
Differentiation	NULL
(	NULL
1999	NULL
)	NULL
6	NULL
,	NULL
570-582	NULL
©	NULL
1999	NULL
Stockton	NULL
Press	NULL
All	NULL
rights	NULL
reserved	NULL
13509047/99	NULL
$	NULL
12.00	NULL
http	NULL
:	NULL
//www	NULL
.	NULL

NF-	NULL
<	NULL
xB	NULL
functions	NULL
as	NULL
both	NULL
a	NULL
proapoptotic	NULL
and	NULL
antiapoptotic	NULL
regulatory	NULL
factor	NULL
within	NULL
a	NULL
single	NULL
cell	NULL
type	NULL
Binhan	NULL
Lin	NULL
'	NULL
,	NULL
Cheryl	NULL
!	NULL

Williams-Skipp*	NULL
,	NULL
Yunxia	NULL
Tao	NULL
,	NULL
Mary	NULL
S.	NULL
Schleicher®	NULL
,	NULL
Labertta	NULL
L.	NULL
Cano	NULL
'	NULL
,	NULL
Richard	NULL
C.	NULL
Duke**	NULL
and	NULL
Robert	NULL
I.	NULL
Scheinman*	NULL
``	NULL
>	NULL
*	NULL
``	NULL
'	NULL
Program	NULL
in	NULL
Toxicology	NULL
,	NULL
Denver	NULL
,	NULL
Colorado	NULL
80262	NULL
,	NULL
USA	NULL
>	NULL
Department	NULL
of	NULL
Pharmaceutical	NULL
Sciences	NULL
,	NULL
School	NULL
of	NULL
Pharmacy	NULL
,	NULL
Denver	NULL
,	NULL
Colorado	NULL
80262	NULL
,	NULL
USA	NULL
°	NULL
University	NULL
of	NULL
Colorado	NULL
Cancer	NULL
Center	NULL
,	NULL
Denver	NULL
,	NULL
Colorado	NULL
80262	NULL
,	NULL
USA	NULL
*	NULL
Department	NULL
of	NULL
Medicine	NULL
and	NULL
Immunology	NULL
,	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
University	NULL
of	NULL
Colorado	NULL
Health	NULL
Sciences	NULL
Center	NULL
,	NULL
Denver	NULL
,	NULL
Colorado	NULL
80262	NULL
,	NULL
USA	NULL
5	NULL
Department	NULL
of	NULL
Pharmacology	NULL
,	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
University	NULL
of	NULL
Colorado	NULL
Health	NULL
Sciences	NULL
Center	NULL
,	NULL
Denver	NULL
,	NULL
Colorado	NULL
80262	NULL
,	NULL
USA	NULL
*	NULL
correspondence	NULL
author	NULL
:	NULL
Robert	NULL
|	NULL
.	NULL

Scheinman	NULL
,	NULL
Program	NULL
in	NULL
Toxicology	NULL
,	NULL
University	NULL
of	NULL
Colorado	NULL
Cancer	NULL
Center	NULL
,	NULL
Denver	NULL
,	NULL
Colorado	NULL
80262	NULL
,	NULL
USA	NULL
.	NULL

tel	NULL
:	NULL
(	NULL
303	NULL
)	NULL
315-6194	NULL
fax	NULL
:	NULL
(	NULL
303	NULL
)	NULL
315-0274	NULL
e-mail	NULL
:	NULL
robert.scheinman	NULL
@	NULL
uchsc.edu	NULL
Received	NULL
3.11.98	NULL
;	NULL
revised	NULL
:	NULL
5.2.99	NULL
;	NULL
accepted	NULL
:	NULL
31.3.99	NULL
Edited	NULL
by	NULL
B.	NULL
Osborne	NULL
Abstract	NULL
Recently	NULL
NF-	NULL
«	NULL
B	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
have	NULL
both	NULL
proapoptotic	NULL
and	NULL
antiapoptotic	NULL
functions	NULL
.	NULL

In	NULL
T	NULL
cell	NULL
hybridomas	NULL
,	NULL
both	NULL
T	NULL
cell	NULL
activators	NULL
and	NULL
glucocorticoids	NULL
induce	NULL
apoptosis	NULL
.	NULL

Here	NULL
we	NULL
show	NULL
that	NULL
blockade	NULL
of	NULL
NF-xB	NULL
activity	NULL
,	NULL
using	NULL
a	NULL
dominant	NULL
negative	NULL
IxBs	NULL
,	NULL
has	NULL
opposite	NULL
effects	NULL
on	NULL
these	NULL
two	NULL
apoptotic	NULL
signals	NULL
.	NULL

Treatment	NULL
with	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
(	NULL
P/	NULL
)	NULL
results	NULL
in	NULL
the	NULL
upregulation	NULL
of	NULL
Fas	NULL
Ligand	NULL
(	NULL
FasL	NULL
)	NULL
and	NULL
induction	NULL
of	NULL
apoptosis	NULL
.	NULL

Inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
inhibits	NULL
the	NULL
P/I	NULL
mediated	NULL
induction	NULL
of	NULL
FasL	NULL
mRNA	NULL
and	NULL
decreases	NULL
the	NULL
level	NULL
of	NULL
apoptosis	NULL
in	NULL
these	NULL
cultures	NULL
,	NULL
thus	NULL
establishing	NULL
NF-xB	NULL
as	NULL
a	NULL
proapoptotic	NULL
factor	NULL
in	NULL
this	NULL
context	NULL
.	NULL

Conversely	NULL
,	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
confers	NULL
a	NULL
tenfold	NULL
increase	NULL
in	NULL
glucocorticoid	NULL
mediated	NULL
apoptosis	NULL
,	NULL
establishing	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
also	NULL
functions	NULL
as	NULL
an	NULL
antiapoptotic	NULL
factor	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
NF-	NULL
«	NULL
xB	NULL
is	NULL
a	NULL
context-dependent	NULL
apoptosis	NULL
regulator	NULL
.	NULL

Our	NULL
data	NULL
suggests	NULL
that	NULL
NF-	NULL
«	NULL
xB	NULL
may	NULL
function	NULL
as	NULL
an	NULL
antiapoptotic	NULL
factor	NULL
in	NULL
thymocytes	NULL
while	NULL
functioning	NULL
as	NULL
a	NULL
proapoptotic	NULL
factor	NULL
in	NULL
mature	NULL
peripheral	NULL
T	NULL
cells	NULL
.	NULL

Keywords	NULL
:	NULL
NF-	NULL
«	NULL
B	NULL
;	NULL
glucocorticoid	NULL
;	NULL
Fas	NULL
Ligand	NULL
;	NULL
apoptosis	NULL
;	NULL
T	NULL
cell	NULL
;	NULL
AICD	NULL
;	NULL
thymic	NULL
selection	NULL
Abbreviations	NULL
:	NULL
TCR	NULL
,	NULL
T	NULL
cell	NULL
receptor	NULL
;	NULL
FasL	NULL
,	NULL
Fas	NULL
Ligand	NULL
;	NULL
AICD	NULL
,	NULL
activation	NULL
induced	NULL
cell	NULL
death	NULL
;	NULL
DEX	NULL
,	NULL
dexamethasone	NULL
;	NULL
mixBa	NULL
«	NULL
,	NULL
IxBaS	NULL
$	NULL
32/36A	NULL
mutant	NULL
;	NULL
neo	NULL
,	NULL
neomycin	NULL
resistance	NULL
gene	NULL
;	NULL
P/	NULL
,	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
Introduction	NULL
In	NULL
order	NULL
to	NULL
ensure	NULL
an	NULL
appropriately	NULL
functioning	NULL
immune	NULL
system	NULL
which	NULL
can	NULL
distinguish	NULL
between	NULL
self	NULL
and	NULL
non-self	NULL
,	NULL
a	NULL
number	NULL
of	NULL
different	NULL
signals	NULL
have	NULL
evolved	NULL
to	NULL
induce	NULL
lymphocyte	NULL
apoptosis	NULL
.	NULL

Endogenous	NULL
glucocorticoids	NULL
are	NULL
thought	NULL
to	NULL
mediate	NULL
apoptosis	NULL
of	NULL
thymocytes	NULL
with	NULL
non-functional	NULL
T	NULL
cell	NULL
receptors	NULL
(	NULL
TCR	NULL
)	NULL
during	NULL
positive	NULL
selection	NULL
.	NULL
``	NULL

In	NULL
turn	NULL
,	NULL
apoptosis	NULL
,	NULL
initiated	NULL
by	NULL
activation	NULL
of	NULL
the	NULL
TCR	NULL
,	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
negative	NULL
selection	NULL
of	NULL
thymocytes	NULL
as	NULL
well	NULL
as	NULL
deletion	NULL
of	NULL
peripheral	NULL
T	NULL
cells	NULL
.	NULL
``	NULL

Understanding	NULL
the	NULL
molecular	NULL
basis	NULL
for	NULL
T	NULL
cell	NULL
apoptosis	NULL
has	NULL
been	NULL
greatly	NULL
aided	NULL
by	NULL
the	NULL
development	NULL
of	NULL
cell	NULL
culture	NULL
systems	NULL
,	NULL
such	NULL
as	NULL
T	NULL
cell	NULL
hybridomas	NULL
,	NULL
amenable	NULL
to	NULL
biochemical	NULL
and	NULL
genetic	NULL
manipula-tions	NULL
.	NULL

Ashwell	NULL
and	NULL
colleagues	NULL
were	NULL
the	NULL
first	NULL
to	NULL
demonstrate	NULL
activation	NULL
induced	NULL
cell	NULL
cycle	NULL
arrest	NULL
followed	NULL
by	NULL
cell	NULL
death	NULL
.	NULL

>	NULL
*	NULL
This	NULL
activation	NULL
induced	NULL
cell	NULL
death	NULL
(	NULL
AICD	NULL
)	NULL
was	NULL
subsequently	NULL
characterized	NULL
as	NULL
apoptosis	NULL
.	NULL

``	NULL
~	NULL
``	NULL
Interestingly	NULL
,	NULL
simultaneous	NULL
exposure	NULL
of	NULL
T	NULL
cell	NULL
hybridomas	NULL
to	NULL
glucocorticoids	NULL
and	NULL
to	NULL
activation	NULL
results	NULL
in	NULL
the	NULL
mutual	NULL
inhibition	NULL
of	NULL
these	NULL
two	NULL
apoptotic	NULL
pathways	NULL
.	NULL
``	NULL

Indeed	NULL
this	NULL
observation	NULL
led	NULL
to	NULL
the	NULL
discovery	NULL
that	NULL
glucocorticoids	NULL
are	NULL
produced	NULL
in	NULL
the	NULL
fetal	NULL
thymus	NULL
and	NULL
function	NULL
to	NULL
induce	NULL
thymocyte	NULL
apoptosis	NULL
during	NULL
selection	NULL
.	NULL

'*	NULL
``	NULL
In	NULL
addition	NULL
this	NULL
work	NULL
led	NULL
to	NULL
the	NULL
observation	NULL
that	NULL
glucocorticoids	NULL
inhibit	NULL
anti-CD3	NULL
mediated	NULL
induction	NULL
of	NULL
Fas	NULL
Ligand	NULL
(	NULL
FasL	NULL
)	NULL
expression	NULL
.	NULL

``	NULL
?	NULL

While	NULL
glucocorticoid	NULL
mediated	NULL
thymocyte	NULL
apoptosis	NULL
remains	NULL
largely	NULL
undefined	NULL
,	NULL
AICD	NULL
in	NULL
peripheral	NULL
T	NULL
cells	NULL
has	NULL
been	NULL
intensively	NULL
studied	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
Ipr	NULL
and	NULL
gld	NULL
mutations	NULL
,	NULL
both	NULL
resulting	NULL
in	NULL
a	NULL
lymphoproliferative	NULL
disorder	NULL
primarily	NULL
inhibiting	NULL
peripheral	NULL
T	NULL
cell	NULL
deletion	NULL
,	NULL
'*	NULL
``	NULL
*	NULL
has	NULL
resulted	NULL
in	NULL
the	NULL
association	NULL
of	NULL
this	NULL
phenotype	NULL
with	NULL
the	NULL
dysfunction	NULL
of	NULL
the	NULL
Fas	NULL
receptor	NULL
(	NULL
Fas	NULL
)	NULL
and	NULL
the	NULL
FasL	NULL
respectively	NULL
.	NULL
``	NULL

Analysis	NULL
of	NULL
AICD	NULL
in	NULL
several	NULL
culture	NULL
models	NULL
including	NULL
T	NULL
cell	NULL
hybridomas	NULL
subsequently	NULL
identified	NULL
Fas/	NULL
FasL	NULL
interactions	NULL
as	NULL
important	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
apoptosis	NULL
.	NULL
'	NULL

''	NULL
~	NULL
'	NULL
``	NULL
Fas	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
TNF	NULL
receptor	NULL
family	NULL
which	NULL
includes	NULL
TNFR1	NULL
,	NULL
TNFR2	NULL
,	NULL
as	NULL
well	NULL
as	NULL
receptors	NULL
for	NULL
lymphotoxin-f	NULL
,	NULL
CD27	NULL
,	NULL
CD30	NULL
,	NULL
CD40	NULL
and	NULL
others	NULL
.	NULL
``	NULL

''	NULL
A	NULL
subgroup	NULL
within	NULL
this	NULL
family	NULL
which	NULL
includes	NULL
Fas	NULL
and	NULL
TNFR1	NULL
have	NULL
a	NULL
conserved	NULL
cytoplasmic	NULL
domain	NULL
,	NULL
referred	NULL
to	NULL
as	NULL
the	NULL
death	NULL
domain	NULL
,	NULL
which	NULL
is	NULL
necessary	NULL
for	NULL
initiation	NULL
of	NULL
apoptosis	NULL
.	NULL

A	NULL
growing	NULL
number	NULL
of	NULL
proteins	NULL
have	NULL
been	NULL
identified	NULL
which	NULL
interact	NULL
with	NULL
the	NULL
Fas	NULL
and	NULL
TNFR1	NULL
death	NULL
domains	NULL
.	NULL
'	NULL

''	NULL
~	NULL
``	NULL
``	NULL
Upon	NULL
engagement	NULL
of	NULL
the	NULL
FasL	NULL
,	NULL
Fas	NULL
associates	NULL
with	NULL
FADD	NULL
(	NULL
MORT1	NULL
)	NULL
which	NULL
itself	NULL
contains	NULL
a	NULL
C-terminal	NULL
death	NULL
domain	NULL
.	NULL

?	NULL
``	NULL

The	NULL
N-terminus	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
death	NULL
effector	NULL
domain	NULL
(	NULL
DED	NULL
)	NULL
interacts	NULL
with	NULL
pro-caspase	NULL
8	NULL
(	NULL
MACH	NULL
,	NULL
FLICE	NULL
)	NULL
,	NULL
ultimately	NULL
resulting	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
a	NULL
caspase	NULL
cascade	NULL
which	NULL
mediates	NULL
apoptosis	NULL
.	NULL
``	NULL

The	NULL
death	NULL
domain	NULL
of	NULL
TNFR1	NULL
associates	NULL
with	NULL
TRADD	NULL
and	NULL
with	NULL
RIP	NULL
.	NULL

``	NULL
®	NULL
``	NULL
``	NULL
TRADD	NULL
,	NULL
in	NULL
turn	NULL
,	NULL
interacts	NULL
with	NULL
FADD	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
apoptotic	NULL
signals	NULL
initiated	NULL
by	NULL
FasL	NULL
and	NULL
TNFz	NULL
ultimately	NULL
converge	NULL
.	NULL
``	NULL

''	NULL
TRADD	NULL
also	NULL
induces	NULL
the	NULL
transcription	NULL
factor	NULL
NF-xB	NULL
by	NULL
interacting	NULL
with	NULL
TRAF	NULL
proteins	NULL
.	NULL

``	NULL
°	NULL
NF-xB	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
responses	NULL
to	NULL
immune	NULL
challenge	NULL
,	NULL
inflammation	NULL
,	NULL
and	NULL
cellular	NULL
stress	NULL
.	NULL
``	NULL

''	NULL
``	NULL
``	NULL
In	NULL
addition	NULL
,	NULL
NF-xB	NULL
has	NULL
recently	NULL
been	NULL
shown	NULL
to	NULL
play	NULL
an	NULL
important	NULL
and	NULL
varied	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
apoptosis	NULL
.	NULL

NF-xB	NULL
is	NULL
comprised	NULL
of	NULL
a	NULL
heterodimeric	NULL
complex	NULL
of	NULL
a	NULL
50-kDal	NULL
subunit	NULL
(	NULL
p50	NULL
,	NULL
NF-xB1	NULL
)	NULL
and	NULL
a	NULL
65-kDal	NULL
subunit	NULL
(	NULL
p65	NULL
,	NULL
RelA	NULL
)	NULL
which	NULL
is	NULL
complexed	NULL
in	NULL
the	NULL
cytoplasm	NULL
with	NULL
a	NULL
family	NULL
of	NULL
inhibitors	NULL
termed	NULL
IxBs	NULL
.	NULL

``	NULL
**	NULL
``	NULL
The	NULL
NF-	NULL
«	NULL
xB	NULL
p50	NULL
and	NULL
RelA	NULL
subunits	NULL
,	NULL
along	NULL
with	NULL
p52	NULL
(	NULL
NF-xB2	NULL
,	NULL
lyt-10	NULL
)	NULL
and	NULL
RelB	NULL
,	NULL
share	NULL
homology	NULL
with	NULL
the	NULL
products	NULL
of	NULL
the	NULL
c-rel	NULL
oncogene	NULL
and	NULL
Drosophila	NULL
maternal	NULL
effects	NULL
gene	NULL
,	NULL
Dorsal	NULL
,	NULL
thus	NULL
forming	NULL
the	NULL
Rel/NF-xB	NULL
gene	NULL
family	NULL
.	NULL
``	NULL

''	NULL
The	NULL
N-terminal	NULL
region	NULL
of	NULL
homology	NULL
,	NULL
termed	NULL
the	NULL
Rel	NULL
homology	NULL
domain	NULL
,	NULL
mediates	NULL
dimerization	NULL
,	NULL
DNA	NULL
binding	NULL
,	NULL
nuclear	NULL
localization	NULL
,	NULL
and	NULL
interaction	NULL
with	NULL
IxB	NULL
through	NULL
IxB	NULL
's	NULL
ankyrin	NULL
repeat	NULL
domain	NULL
.	NULL

These	NULL
NF-kB	NULL
genes	NULL
are	NULL
able	NULL
to	NULL
homo-dimerize	NULL
and	NULL
heterodimerize	NULL
to	NULL
form	NULL
a	NULL
large	NULL
number	NULL
of	NULL
NF-xB-like	NULL
activities	NULL
which	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
have	NULL
differing	NULL
affinities	NULL
for	NULL
various	NULL
NF-xB	NULL
response	NULL
elements	NULL
.	NULL

``	NULL
?	NULL

Numerous	NULL
stimuli	NULL
including	NULL
mitogens	NULL
,	NULL
cytokines	NULL
,	NULL
reactive	NULL
oxygen	NULL
intermediates	NULL
,	NULL
LPS	NULL
,	NULL
and	NULL
viral	NULL
infection	NULL
result	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

In	NULL
many	NULL
instances	NULL
this	NULL
is	NULL
thought	NULL
to	NULL
involve	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
IxB	NULL
kinase	NULL
(	NULL
IKK	NULL
)	NULL
complex	NULL
which	NULL
then	NULL
phosphorylates	NULL
IxB	NULL
,	NULL
resulting	NULL
in	NULL
its	NULL
ubiquitination	NULL
and	NULL
degradation	NULL
by	NULL
the	NULL
proteosome	NULL
.	NULL

``	NULL
°~	NULL
``	NULL
Dissociation	NULL
of	NULL
IxB	NULL
from	NULL
NF-xB	NULL
allows	NULL
NF-	NULL
«	NULL
B	NULL
to	NULL
translocate	NULL
to	NULL
the	NULL
nucleus	NULL
.	NULL

Thus	NULL
NF-	NULL
«	NULL
xB-like	NULL
activities	NULL
comprise	NULL
a	NULL
complex	NULL
web	NULL
of	NULL
interrelated	NULL
factors	NULL
which	NULL
can	NULL
regulate	NULL
subsets	NULL
of	NULL
a	NULL
large	NULL
number	NULL
of	NULL
genes	NULL
in	NULL
response	NULL
to	NULL
specific	NULL
stimuli	NULL
.	NULL

In	NULL
a	NULL
number	NULL
of	NULL
systems	NULL
,	NULL
NF-xB	NULL
has	NULL
been	NULL
demonstrated	NULL
to	NULL
have	NULL
an	NULL
antiapoptotic	NULL
function	NULL
.	NULL

Knockout	NULL
of	NULL
relA	NULL
results	NULL
in	NULL
an	NULL
embryonic	NULL
lethal	NULL
phenotype	NULL
which	NULL
was	NULL
found	NULL
to	NULL
be	NULL
caused	NULL
by	NULL
TNFa	NULL
induced	NULL
apoptosis	NULL
within	NULL
the	NULL
fetal	NULL
liver	NULL
.	NULL
``	NULL

Subsequently	NULL
,	NULL
it	NULL
was	NULL
demonstrated	NULL
that	NULL
reintroduction	NULL
of	NULL
relA	NULL
to	NULL
immortalized	NULL
hepatocytes	NULL
derived	NULL
from	NULL
these	NULL
animals	NULL
protected	NULL
these	NULL
cells	NULL
from	NULL
TNFx	NULL
induced	NULL
apopto-sis	NULL
.	NULL
``	NULL

''	NULL
NF-xB	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
inhibit	NULL
TNFa	NULL
mediated	NULL
apoptosis	NULL
in	NULL
primary	NULL
rat	NULL
and	NULL
human	NULL
fibroblasts	NULL
as	NULL
well	NULL
as	NULL
Jurkat	NULL
T	NULL
cells	NULL
and	NULL
the	NULL
T24	NULL
human	NULL
bladder	NULL
carcinoma	NULL
line*®	NULL
and	NULL
in	NULL
MCF7	NULL
breast	NULL
cancer	NULL
cells	NULL
.	NULL
``	NULL

In	NULL
addition	NULL
,	NULL
NF-xB	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
play	NULL
a	NULL
role	NULL
in	NULL
apoptosis	NULL
mediated	NULL
by	NULL
engagement	NULL
of	NULL
PPAR	NULL
«	NULL
and	NULL
PPARy	NULL
in	NULL
both	NULL
TNF	NULL
«	NULL
stimulated	NULL
and	NULL
in	NULL
unstimulated	NULL
differentiated	NULL
macrophages	NULL
.	NULL
``	NULL

''	NULL
has	NULL
also	NULL
been	NULL
found	NULL
to	NULL
protect	NULL
ras	NULL
transformed	NULL
tumor	NULL
cells	NULL
from	NULL
apoptosis	NULL
induced	NULL
by	NULL
chemotherapy	NULL
.	NULL

*	NULL
``	NULL
*2	NULL
Several	NULL
NF-xB	NULL
responsive	NULL
antiapoptotic	NULL
genes	NULL
which	NULL
may	NULL
play	NULL
a	NULL
role	NULL
in	NULL
this	NULL
process	NULL
have	NULL
subsequently	NULL
been	NULL
identified	NULL
and	NULL
include	NULL
clAaP1	NULL
,	NULL
clAP2	NULL
,	NULL
TRAF1	NULL
and	NULL
TRAF2	NULL
.	NULL

*°	NULL
In	NULL
addition	NULL
IEXL-1	NULL
has	NULL
been	NULL
identified	NULL
as	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
responsive	NULL
antiapoptotic	NULL
gene**	NULL
however	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
this	NULL
protein	NULL
blocks	NULL
apoptosis	NULL
is	NULL
unclear	NULL
.	NULL

Regulation	NULL
of	NULL
NF-	NULL
«	NULL
xB	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
play	NULL
a	NULL
role	NULL
in	NULL
both	NULL
TGF8	NULL
mediated	NULL
induction	NULL
of	NULL
B	NULL
cell	NULL
apoptosis	NULL
through	NULL
induction	NULL
of	NULL
IxBa	NULL
«	NULL
expression	NULL
``	NULL
``	NULL
as	NULL
well	NULL
as	NULL
in	NULL
CD4O0L	NULL
rescue	NULL
from	NULL
apoptosis	NULL
through	NULL
decreased	NULL
IxBx	NULL
expression	NULL
.	NULL
``	NULL

''	NULL
Here	NULL
NF-kB	NULL
functions	NULL
to	NULL
stimulate	NULL
expression	NULL
of	NULL
c-myc	NULL
,	NULL
a	NULL
factor	NULL
necessary	NULL
for	NULL
B	NULL
cell	NULL
survival	NULL
.	NULL

Thus	NULL
NF-xB	NULL
plays	NULL
an	NULL
antiapoptotic	NULL
role	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
systems	NULL
and	NULL
activates	NULL
different	NULL
subsets	NULL
of	NULL
antiapoptotic	NULL
genes	NULL
within	NULL
these	NULL
systems	NULL
.	NULL

Evidence	NULL
has	NULL
also	NULL
accumulated	NULL
implicating	NULL
NF-xB	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
apoptosis	NULL
.	NULL

Studies	NULL
have	NULL
correlated	NULL
induction	NULL
of	NULL
apoptosis	NULL
with	NULL
activation	NULL
of	NULL
NF-xB	NULL
in	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
systems	NULL
including	NULL
avian	NULL
embryonic	NULL
development	NULL
,	NULL
``	NULL
``	NULL
cera-mide	NULL
activated	NULL
osteoblasts*®	NULL
and	NULL
dopaminergic	NULL
neurons	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
A	NULL
contextual	NULL
regulator	NULL
of	NULL
apoptosis	NULL
B	NULL
Lin	NULL
et	NULL
al	NULL
derived	NULL
from	NULL
Parkinson	NULL
disease	NULL
patients	NULL
.	NULL
``	NULL

''	NULL
With	NULL
the	NULL
development	NULL
of	NULL
inhibitors	NULL
of	NULL
NF-xB	NULL
function	NULL
,	NULL
more	NULL
definitive	NULL
evidence	NULL
has	NULL
since	NULL
been	NULL
generated	NULL
.	NULL

Alphavirus	NULL
induction	NULL
of	NULL
apoptosis	NULL
in	NULL
a	NULL
prostate	NULL
carcinoma	NULL
line	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
inhibited	NULL
by	NULL
inhibiting	NULL
NF-xB	NULL
activity	NULL
using	NULL
binding	NULL
site	NULL
decoys	NULL
.	NULL

``	NULL
``	NULL
°	NULL
Interestingly	NULL
,	NULL
viral	NULL
induction	NULL
of	NULL
apoptosis	NULL
in	NULL
a	NULL
neuroblastoma	NULL
line	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
inhibition	NULL
of	NULL
NF-xB	NULL
,	NULL
underscoring	NULL
the	NULL
cell	NULL
specificity	NULL
of	NULL
NF-xB	NULL
mediated	NULL
regulation	NULL
of	NULL
apoptosis	NULL
.	NULL

Similarly	NULL
,	NULL
Denge	NULL
virus	NULL
induction	NULL
of	NULL
apoptosis	NULL
in	NULL
hepatocytes	NULL
could	NULL
be	NULL
blocked	NULL
using	NULL
NF-	NULL
«	NULL
B	NULL
decoys	NULL
.	NULL
``	NULL

Within	NULL
the	NULL
CNS	NULL
,	NULL
pathological	NULL
activation	NULL
of	NULL
glutamate	NULL
receptors	NULL
and	NULL
the	NULL
subsequent	NULL
generation	NULL
of	NULL
oxygen	NULL
radicals	NULL
may	NULL
be	NULL
a	NULL
pathway	NULL
leading	NULL
to	NULL
an	NULL
apoptosis-like	NULL
process	NULL
of	NULL
neurodegeneration	NULL
common	NULL
to	NULL
several	NULL
disease	NULL
states	NULL
.	NULL
``	NULL

''	NULL
Evidence	NULL
for	NULL
NF-xB	NULL
involvement	NULL
came	NULL
from	NULL
the	NULL
observation	NULL
that	NULL
aspirin	NULL
both	NULL
acts	NULL
as	NULL
a	NULL
neuroprotective	NULL
agent	NULL
and	NULL
functions	NULL
to	NULL
inhibit	NULL
glutamate	NULL
receptor	NULL
mediated	NULL
activation	NULL
of	NULL
NF-xB	NULL
.	NULL

``	NULL
°	NULL
More	NULL
recent	NULL
studies	NULL
then	NULL
confirmed	NULL
the	NULL
role	NULL
of	NULL
NF-xB	NULL
by	NULL
showing	NULL
that	NULL
a	NULL
cell	NULL
permeable	NULL
NF-	NULL
«	NULL
xB	NULL
blocking	NULL
peptide	NULL
inhibited	NULL
quinolinic	NULL
acid-induced	NULL
striatal	NULL
cell	NULL
death	NULL
.	NULL
``	NULL

''	NULL
Thus	NULL
the	NULL
role	NULL
of	NULL
NF-xB	NULL
as	NULL
a	NULL
regulator	NULL
of	NULL
apoptosis	NULL
is	NULL
complex	NULL
and	NULL
tissue	NULL
specific	NULL
.	NULL

NF-	NULL
«	NULL
xB	NULL
activity	NULL
has	NULL
been	NULL
detected	NULL
in	NULL
both	NULL
thymocytes	NULL
and	NULL
mature	NULL
T	NULL
cells	NULL
.	NULL
``	NULL

''	NULL
``	NULL
``	NULL
Studies	NULL
of	NULL
specific	NULL
NF-xB	NULL
subunits	NULL
expressed	NULL
during	NULL
thymocyte	NULL
positive	NULL
selection	NULL
have	NULL
identified	NULL
a	NULL
strong	NULL
upregulation	NULL
of	NULL
c-Rel	NULL
mRNA	NULL
and	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
constitutive	NULL
activity	NULL
of	NULL
several	NULL
forms	NULL
of	NULL
NF-xB	NULL
.	NULL
``	NULL

In	NULL
mature	NULL
peripheral	NULL
T	NULL
cells	NULL
representing	NULL
murine	NULL
Th1	NULL
and	NULL
Th2	NULL
populations	NULL
,	NULL
NF-xB	NULL
activity	NULL
was	NULL
found	NULL
to	NULL
be	NULL
much	NULL
decreased	NULL
in	NULL
the	NULL
Th2	NULL
population	NULL
as	NULL
compared	NULL
to	NULL
Th1	NULL
and	NULL
ThO	NULL
populations	NULL
.	NULL

Thus	NULL
NF-xB	NULL
changes	NULL
both	NULL
in	NULL
subunit	NULL
composition	NULL
and	NULL
activity	NULL
level	NULL
during	NULL
T	NULL
cell	NULL
development	NULL
.	NULL

Nuclear	NULL
translocation	NULL
of	NULL
NF-xB	NULL
in	NULL
mature	NULL
peripheral	NULL
T	NULL
cells	NULL
requires	NULL
both	NULL
engagement	NULL
of	NULL
the	NULL
TCR	NULL
as	NULL
well	NULL
as	NULL
a	NULL
co-stimulatory	NULL
signal	NULL
.	NULL

In	NULL
turn	NULL
,	NULL
T	NULL
cell	NULL
activation	NULL
requires	NULL
the	NULL
de	NULL
novo	NULL
transcription	NULL
of	NULL
IL-2	NULL
,	NULL
which	NULL
is	NULL
regulated	NULL
by	NULL
NF-xB	NULL
,	NULL
NFAT	NULL
,	NULL
and	NULL
AP-1	NULL
activities	NULL
.	NULL
``	NULL

''	NULL
Knockout	NULL
of	NULL
specific	NULL
NF-xB	NULL
genes	NULL
results	NULL
in	NULL
reduced	NULL
peripheral	NULL
T	NULL
cell	NULL
activation	NULL
and	NULL
proliferation	NULL
,	NULL
but	NULL
little	NULL
change	NULL
in	NULL
thymic	NULL
selection	NULL
.	NULL
``	NULL

''	NULL
Recently	NULL
,	NULL
through	NULL
the	NULL
study	NULL
of	NULL
NF-xB	NULL
activation	NULL
via	NULL
IxBa	NULL
phosphorylation	NULL
,	NULL
serines	NULL
at	NULL
positions	NULL
32	NULL
and	NULL
36	NULL
were	NULL
identified	NULL
as	NULL
critical	NULL
targets	NULL
for	NULL
IKK	NULL
mediated	NULL
activa-tion	NULL
.	NULL

``	NULL
*®°	NULL
An	NULL
IxBa	NULL
mutant	NULL
was	NULL
then	NULL
developed	NULL
replacing	NULL
serines	NULL
32	NULL
and	NULL
36	NULL
with	NULL
alanines	NULL
.	NULL

This	NULL
mutant	NULL
binds	NULL
to	NULL
NF-xB	NULL
but	NULL
can	NULL
not	NULL
release	NULL
it	NULL
in	NULL
response	NULL
to	NULL
stimulation	NULL
and	NULL
thus	NULL
effectively	NULL
inhibits	NULL
all	NULL
inducible	NULL
forms	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
knockout	NULL
experiments	NULL
,	NULL
direction	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
this	NULL
mutant	NULL
(	NULL
mlkBa	NULL
)	NULL
to	NULL
thymocytes	NULL
of	NULL
transgenic	NULL
mice	NULL
,	NULL
results	NULL
in	NULL
a	NULL
significant	NULL
loss	NULL
of	NULL
T	NULL
cells	NULL
which	NULL
survive	NULL
thymic	NULL
selection	NULL
as	NULL
well	NULL
as	NULL
a	NULL
relative	NULL
increase	NULL
in	NULL
the	NULL
ratio	NULL
of	NULL
CD4	NULL
to	NULL
CD8	NULL
single	NULL
positive	NULL
T	NULL
cells	NULL
,	NULL
``	NULL
``	NULL
suggesting	NULL
that	NULL
NF-	NULL
«	NULL
xB	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
selection	NULL
process	NULL
and	NULL
that	NULL
different	NULL
forms	NULL
of	NULL
NF-xB	NULL
may	NULL
be	NULL
able	NULL
to	NULL
substitute	NULL
for	NULL
each	NULL
other	NULL
.	NULL

Hence	NULL
NF-xB	NULL
plays	NULL
a	NULL
role	NULL
both	NULL
in	NULL
the	NULL
processes	NULL
of	NULL
thymic	NULL
selection	NULL
as	NULL
well	NULL
as	NULL
peripheral	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Recently	NULL
,	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
glucocorticoids	NULL
can	NULL
inhibit	NULL
NF-xB	NULL
activity	NULL
through	NULL
direct	NULL
association	NULL
of	NULL
GR	NULL
with	NULL
NF-xB	NULL
subunits	NULL
,	NULL
°	NULL
``	NULL
~-	NULL
through	NULL
induction	NULL
of	NULL
IxBx	NULL
expres-sion	NULL
,	NULL
°°°	NULL
and	NULL
through	NULL
competition	NULL
for	NULL
the	NULL
co-activator	NULL
571	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
A	NULL
contextual	NULL
regulator	NULL
of	NULL
apoptosis	NULL
B	NULL
Lin	NULL
et	NULL
al	NULL
572	NULL
protein	NULL
,	NULL
CBP/p300.°	NULL
``	NULL
This	NULL
interaction	NULL
between	NULL
two	NULL
transcription	NULL
factors	NULL
,	NULL
both	NULL
of	NULL
which	NULL
function	NULL
to	NULL
regulate	NULL
apoptosis	NULL
,	NULL
has	NULL
led	NULL
us	NULL
to	NULL
hypothesize	NULL
that	NULL
NF-kB	NULL
may	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
modulating	NULL
glucocorticoid	NULL
mediated	NULL
apoptosis	NULL
as	NULL
well	NULL
as	NULL
AICD	NULL
.	NULL

Here	NULL
we	NULL
demonstrate	NULL
that	NULL
inhibition	NULL
of	NULL
NF-xB	NULL
leads	NULL
to	NULL
loss	NULL
of	NULL
the	NULL
induction	NULL
of	NULL
FasL	NULL
expression	NULL
and	NULL
reduced	NULL
apoptosis	NULL
while	NULL
simultaneously	NULL
increasing	NULL
the	NULL
sensitivity	NULL
of	NULL
these	NULL
cells	NULL
to	NULL
DEX	NULL
mediated	NULL
apoptosis	NULL
.	NULL

Thus	NULL
NF-xB	NULL
has	NULL
both	NULL
proapoptotic	NULL
and	NULL
antiapoptotic	NULL
functions	NULL
within	NULL
a	NULL
single	NULL
cell	NULL
type	NULL
.	NULL

Results	NULL
Inhibition	NULL
of	NULL
NF-xB	NULL
in	NULL
T	NULL
cell	NULL
hybridomas	NULL
As	NULL
mentioned	NULL
above	NULL
,	NULL
IxBa	NULL
«	NULL
phosphorylation	NULL
is	NULL
essential	NULL
for	NULL
NF-xB	NULL
activation	NULL
.	NULL

An	NULL
IxBa	NULL
mutant	NULL
in	NULL
which	NULL
serines	NULL
in	NULL
positions	NULL
32	NULL
and	NULL
36	NULL
have	NULL
been	NULL
substituted	NULL
for	NULL
alanines	NULL
(	NULL
mixBa	NULL
)	NULL
has	NULL
been	NULL
developed	NULL
by	NULL
several	NULL
laboratories	NULL
to	NULL
function	NULL
as	NULL
a	NULL
strong	NULL
dominant	NULL
negative	NULL
inhibitor	NULL
of	NULL
NF-xB	NULL
.	NULL

``	NULL
*°	NULL
We	NULL
introduced	NULL
this	NULL
IxB	NULL
«	NULL
mutant	NULL
into	NULL
the	NULL
T	NULL
cell	NULL
hybridoma	NULL
lines	NULL
,	NULL
DO11.10	NULL
and	NULL
2B4.11	NULL
by	NULL
electroporation	NULL
of	NULL
either	NULL
pCMV4-IxBa	NULL
«	NULL
S32/36A	NULL
or	NULL
pCMV4-FLAG-IxB	NULL
«	NULL
S32/36A	NULL
(	NULL
gifts	NULL
of	NULL
D.	NULL
Ballard	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
neomycin	NULL
resistance	NULL
gene	NULL
and	NULL
established	NULL
a	NULL
number	NULL
of	NULL
independent	NULL
stable	NULL
mixBa	NULL
expressing	NULL
lines	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
neomycin	NULL
resistance	NULL
gene	NULL
(	NULL
neo	NULL
)	NULL
was	NULL
also	NULL
transfected	NULL
alone	NULL
to	NULL
create	NULL
several	NULL
control	NULL
lines	NULL
.	NULL

Presence	NULL
of	NULL
the	NULL
FLAG	NULL
epitope	NULL
has	NULL
no	NULL
effect	NULL
on	NULL
mixkB	NULL
&	NULL
function	NULL
(	NULL
D.	NULL
Ballard	NULL
,	NULL
personal	NULL
communication	NULL
)	NULL
but	NULL
allows	NULL
for	NULL
the	NULL
measurement	NULL
of	NULL
transgene	NULL
detection	NULL
apart	NULL
from	NULL
endogenous	NULL
IxBa	NULL
«	NULL
expression	NULL
.	NULL

Figure	NULL
1	NULL
shows	NULL
a	NULL
representative	NULL
Western	NULL
blot	NULL
analyzing	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
FLAG	NULL
epitope	NULL
tagged	NULL
transgene	NULL
in	NULL
several	NULL
2B4.11	NULL
lines	NULL
.	NULL

The	NULL
transgene	NULL
migrates	NULL
just	NULL
below	NULL
the	NULL
41.8	NULL
kDal	NULL
molecular	NULL
weight	NULL
marker	NULL
as	NULL
expected	NULL
(	NULL
Figure	NULL
1	NULL
)	NULL
.	NULL

Lines	NULL
2P	NULL
,	NULL
4P	NULL
,	NULL
and	NULL
5P	NULL
are	NULL
representative	NULL
of	NULL
high	NULL
FLAG	NULL
epitope	NULL
expression	NULL
while	NULL
lines	NULL
3P	NULL
and	NULL
5M	NULL
are	NULL
representative	NULL
of	NULL
intermediate	NULL
FLAG	NULL
epitope	NULL
expression	NULL
(	NULL
Figure	NULL
1	NULL
)	NULL
.	NULL

Lines	NULL
3M	NULL
and	NULL
4M	NULL
have	NULL
very	NULL
low	NULL
,	NULL
but	NULL
detectable	NULL
,	NULL
transgene	NULL
expression	NULL
while	NULL
parental	NULL
2B4.11	NULL
cells	NULL
did	NULL
not	NULL
contain	NULL
the	NULL
FLAG	NULL
epitope	NULL
(	NULL
Figure	NULL
1	NULL
)	NULL
.	NULL

Neo	NULL
expressors	NULL
generated	NULL
a	NULL
pattern	NULL
identical	NULL
to	NULL
parental	NULL
lines	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
then	NULL
wanted	NULL
to	NULL
characterize	NULL
NF-	NULL
«	NULL
kB	NULL
expression	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

2B4.11	NULL
cultures	NULL
were	NULL
treated	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
(	NULL
P/	NULL
)	NULL
and	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

EMSA	NULL
analysis	NULL
was	NULL
then	NULL
performed	NULL
using	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
,	NULL
found	NULL
on	NULL
the	NULL
FasL	NULL
Par	NULL
.	NULL

-	NULL
2P	NULL
5P	NULL
5M	NULL
4P	NULL
4M	NULL
3P	NULL
3M	NULL
va	NULL
;	NULL
wts	NULL
``	NULL
:	NULL
43	NULL
ces	NULL
»	NULL
M	NULL
T	NULL
-	NULL
~	NULL
A	NULL
?	NULL

,	NULL
<	NULL
=	NULL
FLAG	NULL
com	NULL
GG	NULL
|	NULL
conn	NULL
+	NULL
*	NULL
NS	NULL
Figure	NULL
1	NULL
-	NULL
2B4.11	NULL
T	NULL
cell	NULL
lines	NULL
expressing	NULL
various	NULL
levels	NULL
of	NULL
FLAG-tagged	NULL
mixB	NULL
.	NULL

Cytosolic	NULL
extracts	NULL
of	NULL
the	NULL
parental	NULL
2B4.11	NULL
line	NULL
and	NULL
various	NULL
2B4.11	NULL
lines	NULL
expressing	NULL
a	NULL
FLAG-tagged	NULL
mixBa	NULL
transgene	NULL
were	NULL
examined	NULL
by	NULL
FLAG	NULL
antibody	NULL
Western	NULL
and	NULL
visualized	NULL
by	NULL
ECL	NULL
.	NULL

NS	NULL
:	NULL
non-specific	NULL
binding	NULL
.	NULL

Lines	NULL
2P	NULL
,	NULL
3P	NULL
,	NULL
4P	NULL
,	NULL
and	NULL
5P	NULL
were	NULL
isolated	NULL
from	NULL
one	NULL
transfection	NULL
experiment	NULL
.	NULL

Similarly	NULL
,	NULL
lines	NULL
3M	NULL
,	NULL
4M	NULL
,	NULL
and	NULL
5M	NULL
were	NULL
isolated	NULL
from	NULL
a	NULL
separate	NULL
transfection	NULL
experiment	NULL
promoter	NULL
,	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
2A	NULL
,	NULL
treatment	NULL
of	NULL
parental	NULL
2B4.11	NULL
cells	NULL
with	NULL
P/I	NULL
resulted	NULL
in	NULL
the	NULL
up	NULL
regulation	NULL
of	NULL
a	NULL
protein/DNA	NULL
complex	NULL
which	NULL
was	NULL
present	NULL
in	NULL
minor	NULL
amounts	NULL
in	NULL
non-activated	NULL
cells	NULL
.	NULL

This	NULL
complex	NULL
was	NULL
effectively	NULL
blocked	NULL
by	NULL
a	NULL
20-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
DNA	NULL
corresponding	NULL
to	NULL
an	NULL
NF-xB	NULL
site	NULL
derived	NULL
from	NULL
the	NULL
murine	NULL
H2-K°	NULL
MHC	NULL
class	NULL
|	NULL
promoter	NULL
(	NULL
xB	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
a	NULL
20-fold	NULL
excess	NULL
of	NULL
a	NULL
double	NULL
point	NULL
mutant	NULL
of	NULL
the	NULL
H2-K®°	NULL
NF-xB	NULL
site	NULL
(	NULL
mB	NULL
)	NULL
was	NULL
unable	NULL
to	NULL
effectively	NULL
block	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
complex	NULL
.	NULL

The	NULL
FasL	NULL
NF-xB	NULL
site	NULL
(	NULL
FL	NULL
)	NULL
also	NULL
competed	NULL
against	NULL
self	NULL
,	NULL
as	NULL
expected	NULL
.	NULL

To	NULL
further	NULL
confirm	NULL
the	NULL
identity	NULL
of	NULL
this	NULL
DNA	NULL
binding	NULL
protein	NULL
,	NULL
we	NULL
performed	NULL
a	NULL
supershift	NULL
experiment	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
2B	NULL
,	NULL
pretreatment	NULL
with	NULL
antisera	NULL
specific	NULL
for	NULL
relA	NULL
(	NULL
p65	NULL
)	NULL
partially	NULL
supershifted	NULL
the	NULL
complex	NULL
while	NULL
an	NULL
antisera	NULL
specific	NULL
for	NULL
p50	NULL
blocked	NULL
DNA	NULL
binding	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
complex	NULL
contains	NULL
of	NULL
heterodimers	NULL
of	NULL
relA	NULL
and	NULL
p50	NULL
.	NULL

While	NULL
the	NULL
presence	NULL
of	NULL
other	NULL
NF-xB	NULL
subunits	NULL
in	NULL
this	NULL
complex	NULL
has	NULL
yet	NULL
to	NULL
be	NULL
determined	NULL
,	NULL
it	NULL
is	NULL
clear	NULL
from	NULL
the	NULL
data	NULL
presented	NULL
that	NULL
this	NULL
complex	NULL
corresponds	NULL
to	NULL
NF-xB	NULL
.	NULL

We	NULL
then	NULL
tested	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
mixBa	NULL
transgene	NULL
to	NULL
block	NULL
the	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-xB	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
2C	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
DNA	NULL
binding	NULL
is	NULL
induced	NULL
upon	NULL
treatment	NULL
of	NULL
a	NULL
Neo	NULL
P/I	NULL
expressing	NULL
line	NULL
.	NULL

Induction	NULL
of	NULL
NF-xB	NULL
binding	NULL
in	NULL
the	NULL
2B4.11	NULL
4P	NULL
line	NULL
is	NULL
greatly	NULL
decreased	NULL
however	NULL
by	NULL
overexpression	NULL
of	NULL
the	NULL
transgene	NULL
(	NULL
compare	NULL
Figure	NULL
1	NULL
and	NULL
Figure	NULL
2C	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
a	NULL
low	NULL
mixBa	NULL
expressing	NULL
line	NULL
,	NULL
3M	NULL
,	NULL
was	NULL
able	NULL
to	NULL
translocate	NULL
NF-xB	NULL
after	NULL
P/I	NULL
treatment	NULL
indicating	NULL
that	NULL
the	NULL
decrease	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
translocation	NULL
requires	NULL
expression	NULL
of	NULL
the	NULL
transgene	NULL
and	NULL
is	NULL
not	NULL
just	NULL
caused	NULL
by	NULL
the	NULL
selection	NULL
process	NULL
.	NULL

FasL	NULL
expression	NULL
is	NULL
dependent	NULL
on	NULL
NF-	NULL
«	NULL
xB	NULL
translocation	NULL
The	NULL
study	NULL
of	NULL
Yang	NULL
and	NULL
colleagues	NULL
'	NULL
``	NULL
suggested	NULL
to	NULL
us	NULL
that	NULL
glucocorticoid	NULL
mediated	NULL
inhibition	NULL
of	NULL
FasL	NULL
may	NULL
involve	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
xB	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
cloning	NULL
of	NULL
FasL	NULL
upstream	NULL
sequence	NULL
uncovered	NULL
a	NULL
putative	NULL
NF-xB	NULL
site	NULL
.	NULL
``	NULL

''	NULL
To	NULL
determine	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
inhibition	NULL
of	NULL
NF-xB	NULL
translocation	NULL
on	NULL
FasL	NULL
expression	NULL
,	NULL
we	NULL
first	NULL
examined	NULL
DO11.10	NULL
cultures	NULL
transfected	NULL
with	NULL
pCMV4-IxB	NULL
«	NULL
S	NULL
$	NULL
32/36A	NULL
using	NULL
RT-PCR	NULL
.	NULL

Since	NULL
this	NULL
construct	NULL
lacks	NULL
an	NULL
epitope	NULL
tag	NULL
,	NULL
we	NULL
were	NULL
unable	NULL
to	NULL
follow	NULL
transgene	NULL
expression	NULL
by	NULL
Western	NULL
blot	NULL
.	NULL

Figure	NULL
3A	NULL
(	NULL
lanes	NULL
1-7	NULL
)	NULL
displays	NULL
a	NULL
representative	NULL
experiment	NULL
.	NULL

Cells	NULL
were	NULL
untreated	NULL
or	NULL
treated	NULL
with	NULL
P/	NULL
for	NULL
2	NULL
h	NULL
and	NULL
RNA	NULL
prepared	NULL
by	NULL
the	NULL
acidified	NULL
phenol	NULL
method	NULL
.	NULL
``	NULL

''	NULL
RT-PCR	NULL
was	NULL
then	NULL
performed	NULL
using	NULL
primers	NULL
specific	NULL
for	NULL
FasL	NULL
mRNA	NULL
(	NULL
Figure	NULL
3A	NULL
,	NULL
top	NULL
)	NULL
and	NULL
for	NULL
$	NULL
-actin	NULL
mRNA	NULL
(	NULL
Figure	NULL
3A	NULL
,	NULL
bottom	NULL
)	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
3A	NULL
,	NULL
lane	NULL
2	NULL
,	NULL
untreated	NULL
DO11.10	NULL
cultures	NULL
did	NULL
not	NULL
express	NULL
detectable	NULL
FasL	NULL
transcripts	NULL
.	NULL

After	NULL
P/l	NULL
treatment	NULL
however	NULL
,	NULL
a	NULL
robust	NULL
band	NULL
was	NULL
detected	NULL
corresponding	NULL
exactly	NULL
to	NULL
the	NULL
size	NULL
expected	NULL
for	NULL
FasL	NULL
(	NULL
compare	NULL
Figure	NULL
3A	NULL
,	NULL
lane	NULL
3	NULL
with	NULL
Figure	NULL
3B	NULL
,	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

We	NULL
obtained	NULL
several	NULL
pCMV4-IxBaS	NULL
$	NULL
32/36A	NULL
transfected	NULL
DO11.10	NULL
lines	NULL
in	NULL
which	NULL
FasL	NULL
expression	NULL
could	NULL
no	NULL
longer	NULL
be	NULL
induced	NULL
by	NULL
P/I	NULL
treatment	NULL
(	NULL
compare	NULL
Figure	NULL
3A	NULL
,	NULL
lane	NULL
3	NULL
with	NULL
lanes	NULL
6	NULL
and	NULL
7	NULL
)	NULL
.	NULL

In	NULL
comparison	NULL
,	NULL
expression	NULL
of	NULL
the	NULL
neomycin	NULL
resistance	NULL
gene	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
FasL	NULL
expression	NULL
(	NULL
compare	NULL
lane	NULL
3	NULL
with	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

In	NULL
a	NULL
separate	NULL
experiment	NULL
(	NULL
Figure	NULL
3A	NULL
,	NULL
lanes	NULL
8-12	NULL
)	NULL
,	NULL
another	NULL
pCMV4-IxBa	NULL
«	NULL
S32/36A	NULL
transfected	NULL
DO11.10	NULL
line	NULL
,	NULL
IxB2	NULL
,	NULL
was	NULL
found	NULL
to	NULL
express	NULL
low	NULL
levels	NULL
of	NULL
FasL	NULL
in	NULL
response	NULL
to	NULL
P/	NULL
treatment	NULL
as	NULL
compared	NULL
to	NULL
parental	NULL
and	NULL
Neo	NULL
expressors	NULL
(	NULL
compare	NULL
Figure	NULL
3A	NULL
lanes	NULL
9-11	NULL
)	NULL
.	NULL

Once	NULL
again	NULL
,	NULL
the	NULL
IxB4	NULL
line	NULL
was	NULL
unable	NULL
to	NULL
express	NULL
FasL	NULL
mRNA	NULL
(	NULL
Figure	NULL
3A	NULL
,	NULL
lane	NULL
12	NULL
)	NULL
.	NULL

All	NULL
cellular	NULL
derived	NULL
cDNAs	NULL
amplified	NULL
roughly	NULL
equivalent	NULL
amounts	NULL
of	NULL
the	NULL
300	NULL
bp	NULL
fragment	NULL
indicating	NULL
that	NULL
lack	NULL
of	NULL
amplified	NULL
FasL	NULL
is	NULL
not	NULL
due	NULL
to	NULL
RNA	NULL
degradation	NULL
(	NULL
Figure	NULL
3A	NULL
and	NULL
B	NULL
,	NULL
bottom	NULL
panels	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
several	NULL
weeks	NULL
later	NULL
,	NULL
several	NULL
of	NULL
these	NULL
pCMV4-IxB	NULL
«	NULL
S32/36A	NULL
transfected	NULL
DO11.10	NULL
lines	NULL
regained	NULL
their	NULL
ability	NULL
to	NULL
generate	NULL
FasL	NULL
mRNA	NULL
in	NULL
response	NULL
to	NULL
P/	NULL
treatment	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
suggesting	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
transgene	NULL
was	NULL
no	NULL
longer	NULL
expressing	NULL
properly	NULL
.	NULL

This	NULL
prompted	NULL
us	NULL
to	NULL
generate	NULL
new	NULL
lines	NULL
containing	NULL
the	NULL
mutant	NULL
IxBa	NULL
«	NULL
tagged	NULL
with	NULL
the	NULL
FLAG	NULL
epitope	NULL
as	NULL
described	NULL
above	NULL
and	NULL
as	NULL
shown	NULL
in	NULL
Figure	NULL
1	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
3B	NULL
,	NULL
expression	NULL
of	NULL
the	NULL
FLAG	NULL
tagged	NULL
transgene	NULL
in	NULL
2B4.11	NULL
T	NULL
cell	NULL
hybridomas	NULL
(	NULL
line	NULL
4P	NULL
)	NULL
resulted	NULL
once	NULL
again	NULL
in	NULL
the	NULL
loss	NULL
of	NULL
FasL	NULL
mRNA	NULL
expression	NULL
while	NULL
expression	NULL
of	NULL
the	NULL
neomycin	NULL
resistance	NULL
gene	NULL
had	NULL
no	NULL
effect	NULL
(	NULL
Figure	NULL
3B	NULL
,	NULL
compare	NULL
lane	NULL
3	NULL
with	NULL
lanes	NULL
5	NULL
and	NULL
7	NULL
)	NULL
.	NULL

Because	NULL
of	NULL
the	NULL
genetic	NULL
instability	NULL
of	NULL
these	NULL
T	NULL
cell	NULL
hybridoma	NULL
cultures	NULL
,	NULL
these	NULL
lines	NULL
were	NULL
screened	NULL
regularly	NULL
by	NULL
Western	NULL
blot	NULL
(	NULL
Figure	NULL
1	NULL
)	NULL
.	NULL

Transgene	NULL
expression	NULL
was	NULL
often	NULL
lost	NULL
within	NULL
1-3	NULL
months	NULL
of	NULL
culture	NULL
.	NULL

In	NULL
order	NULL
to	NULL
control	NULL
for	NULL
potential	NULL
changes	NULL
in	NULL
the	NULL
expression	NULL
level	NULL
of	NULL
the	NULL
transgene	NULL
,	NULL
each	NULL
treatment	NULL
group	NULL
was	NULL
divided	NULL
into	NULL
equal	NULL
aliquots	NULL
and	NULL
examined	NULL
at	NULL
several	NULL
levels	NULL
.	NULL

Expression	NULL
of	NULL
FasL	NULL
mRNA	NULL
abundance	NULL
was	NULL
determined	NULL
by	NULL
RT-PCR	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Loss	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
mixBa	NULL
«	NULL
transgene	NULL
invariably	NULL
resulted	NULL
in	NULL
reappearance	NULL
of	NULL
the	NULL
FasL	NULL
mRNA	NULL
upon	NULL
P/	NULL
treatment	NULL
further	NULL
suggesting	NULL
that	NULL
FasL	NULL
expression	NULL
is	NULL
specifically	NULL
inhibited	NULL
by	NULL
the	NULL
functional	NULL
inhibition	NULL
of	NULL
NF-xB	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
}	NULL
.	NULL

A	NULL
B	NULL
Competitor	NULL
-	NULL
-	NULL
«	NULL
B	NULL
m	NULL
«	NULL
B	NULL
FL	NULL
Ab	NULL
=	NULL
PMA	NULL
,	NULL
lono	NULL
-	NULL
+	NULL
+	NULL
++	NULL
Free	NULL
-L	NULL
Probe	NULL
p65	NULL
p50	NULL
Line	NULL
Neo	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
A	NULL
contextual	NULL
regulator	NULL
of	NULL
apoptosis	NULL
B	NULL
Lin	NULL
et	NULL
al	NULL
The	NULL
second	NULL
matched	NULL
aliquot	NULL
of	NULL
cells	NULL
was	NULL
analyzed	NULL
for	NULL
functional	NULL
FasL	NULL
protein	NULL
.	NULL

To	NULL
this	NULL
end	NULL
,	NULL
our	NULL
variously	NULL
treated	NULL
2B4.11	NULL
cultures	NULL
(	NULL
effector	NULL
cells	NULL
)	NULL
were	NULL
mixed	NULL
with	NULL
``	NULL
'Cr	NULL
loaded	NULL
L1210-Fas	NULL
cells	NULL
,	NULL
which	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
Fas	NULL
(	NULL
target	NULL
cells	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
functional	NULL
FasL	NULL
protein	NULL
on	NULL
the	NULL
effector	NULL
cell	NULL
surface	NULL
will	NULL
cause	NULL
target	NULL
cell	NULL
lysis	NULL
and	NULL
release	NULL
of	NULL
``	NULL
'Cr	NULL
into	NULL
the	NULL
culture	NULL
medium	NULL
.	NULL

All	NULL
untreated	NULL
2B4.11	NULL
lines	NULL
induced	NULL
target	NULL
cell	NULL
lysis	NULL
indistinguishable	NULL
from	NULL
the	NULL
spontaneous	NULL
lysis	NULL
rates	NULL
(	NULL
Figure	NULL
3C	NULL
)	NULL
.	NULL

Parental	NULL
and	NULL
neo	NULL
over-expressors	NULL
,	NULL
when	NULL
treated	NULL
with	NULL
P/l	NULL
and	NULL
co-cultured	NULL
with	NULL
the	NULL
target	NULL
cells	NULL
,	NULL
induced	NULL
significantly	NULL
higher	NULL
rates	NULL
of	NULL
lysis	NULL
(	NULL
averages	NULL
of	NULL
56	NULL
and	NULL
70	NULL
%	NULL
respectively	NULL
in	NULL
the	NULL
illustrated	NULL
experiment	NULL
)	NULL
.	NULL

Lines	NULL
expressing	NULL
high	NULL
levels	NULL
of	NULL
mixBa	NULL
«	NULL
however	NULL
,	NULL
upon	NULL
treatment	NULL
with	NULL
P/	NULL
,	NULL
showed	NULL
no	NULL
significant	NULL
increase	NULL
in	NULL
target	NULL
cell	NULL
lysis	NULL
,	NULL
indicating	NULL
a	NULL
lack	NULL
of	NULL
expression	NULL
of	NULL
functional	NULL
FasL	NULL
(	NULL
Figure	NULL
3C	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
PCR	NULL
data	NULL
above	NULL
,	NULL
low	NULL
mlxBa	NULL
«	NULL
expressing	NULL
lines	NULL
showed	NULL
intermediate	NULL
lysis	NULL
of	NULL
targets	NULL
upon	NULL
P/	NULL
treatment	NULL
,	NULL
while	NULL
loss	NULL
of	NULL
transgene	NULL
expression	NULL
correlated	NULL
with	NULL
significant	NULL
levels	NULL
of	NULL
target	NULL
cell	NULL
lysis	NULL
upon	NULL
P/	NULL
treatment	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
conclude	NULL
from	NULL
these	NULL
experiments	NULL
that	NULL
these	NULL
cells	NULL
express	NULL
functional	NULL
FasL	NULL
upon	NULL
activation	NULL
and	NULL
that	NULL
this	NULL
expression	NULL
requires	NULL
the	NULL
activation	NULL
of	NULL
NF-xB	NULL
.	NULL

While	NULL
this	NULL
work	NULL
was	NULL
in	NULL
progress	NULL
,	NULL
a	NULL
report	NULL
was	NULL
published	NULL
demonstrating	NULL
that	NULL
cell	NULL
damaging	NULL
agents	NULL
such	NULL
as	NULL
tenipo-side	NULL
and	NULL
etoposide	NULL
induce	NULL
expression	NULL
of	NULL
FasL	NULL
in	NULL
Jurkat	NULL
T	NULL
cell	NULL
cultures	NULL
through	NULL
induction	NULL
of	NULL
NF-xB	NULL
.	NULL
``	NULL

''	NULL
They	NULL
cloned	NULL
the	NULL
FasL	NULL
promoter	NULL
and	NULL
identified	NULL
an	NULL
NF-xB	NULL
site	NULL
approximately	NULL
1100	NULL
bp	NULL
upstream	NULL
from	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

Mutation	NULL
of	NULL
this	NULL
site	NULL
blocked	NULL
the	NULL
ability	NULL
of	NULL
DNA	NULL
damaging	NULL
agents	NULL
from	NULL
inducing	NULL
the	NULL
promoter	NULL
.	NULL

This	NULL
work	NULL
demonstrated	NULL
that	NULL
C	NULL
mixB4P	NULL
-	NULL
mlkB3M	NULL
P/	NULL
=	NULL
l	NULL
+	NULL
-o	NULL
+	NULL
NF-xB	NULL
mag	NULL
»	NULL
O	NULL
.	NULL

n	NULL
'	NULL
l	NULL
‘	NULL
.	NULL

!	NULL

4	NULL
%	NULL
ﬂ	NULL
ll	NULL
mun	NULL
...	NULL
Probe	NULL
Figure	NULL
2	NULL
Analysis	NULL
of	NULL
NF-xB	NULL
DNA	NULL
binding	NULL
in	NULL
2B4.11	NULL
parental	NULL
and	NULL
transfected	NULL
lines	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Nuclear	NULL
extracts	NULL
from	NULL
control	NULL
and	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
(	NULL
PMA/iono	NULL
)	NULL
activated	NULL
2B4.11	NULL
parental	NULL
cultures	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
probe	NULL
encoding	NULL
the	NULL
FasL	NULL
promoter	NULL
NF-kB	NULL
site	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
various	NULL
unlabeled	NULL
DNA	NULL
competitors	NULL
.	NULL

Results	NULL
were	NULL
examined	NULL
by	NULL
EMSA	NULL
and	NULL
visualized	NULL
by	NULL
Phosphor	NULL
Imager	NULL
.	NULL

xB	NULL
:	NULL
NF-xB	NULL
site	NULL
from	NULL
the	NULL
H2-K°MHC	NULL
class	NULL
|	NULL
promoter	NULL
,	NULL
xm	NULL
:	NULL
mutated	NULL
xB	NULL
sequence	NULL
,	NULL
FL	NULL
:	NULL
FasL	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
.	NULL

The	NULL
arrow	NULL
marks	NULL
the	NULL
location	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Nuclear	NULL
extract	NULL
from	NULL
a	NULL
PMA/ionomycin	NULL
activated	NULL
2B4.11	NULL
culture	NULL
was	NULL
preincubated	NULL
with	NULL
antibodies	NULL
specific	NULL
for	NULL
NF-xB	NULL
relA	NULL
(	NULL
p65	NULL
)	NULL
or	NULL
p50	NULL
subunits	NULL
and	NULL
analyzed	NULL
as	NULL
in	NULL
(	NULL
A	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
A	NULL
2B4.11	NULL
neo	NULL
expressor	NULL
,	NULL
line	NULL
4P	NULL
,	NULL
and	NULL
line	NULL
3M	NULL
were	NULL
either	NULL
untreated	NULL
or	NULL
activated	NULL
with	NULL
PMA/ionomycin	NULL
(	NULL
P/1	NULL
)	NULL
and	NULL
nuclear	NULL
extracts	NULL
analyzed	NULL
as	NULL
in	NULL
(	NULL
A	NULL
)	NULL
573	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
A	NULL
contextual	NULL
regulator	NULL
of	NULL
apoptosis	NULL
B	NULL
Lin	NULL
et	NULL
al	NULL
574	NULL
A	NULL
MW	NULL
Parental	NULL
Neo1	NULL
Neo2	NULL
IxB4	NULL
ixB9	NULL
MW	NULL
-	NULL
Par	NULL
.	NULL

Neo	NULL
IxB2	NULL
IxB4	NULL
PMA	NULL
lonomycin	NULL
=	NULL
+o	NULL
+	NULL
+o	NULL
+	NULL
#	NULL
004	NULL
04	NULL
+	NULL
<	NULL
PD	NULL
B_actin	NULL
«	NULL
aam	NULL
cae	NULL
*	NULL
[	NULL
R	NULL
f-actin	NULL
<	NULL
=	NULL
PD	NULL
Lane	NULL
000	NULL
g	NULL
_	NULL
2003	NULL
0	NULL
400	NULL
500	NULL
600	NULL
700	NULL
800	NULL
90	NULL
400	NULL
110	NULL
12	NULL
B	NULL
MW	NULL
-	NULL
Parental	NULL
Neo	NULL
mikB__	NULL
_	NULL
Control	NULL
PMA/	NULL
=o	NULL
0	NULL
4000	NULL
-	NULL
0	NULL
#	NULL
00-0	NULL
+	NULL
#	NULL
lonomycin	NULL
FasL	NULL
«	NULL
<	NULL
4	NULL
»	NULL
FasL	NULL
«	NULL
#	NULL
»	NULL
PD	NULL
Lane	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
C	NULL
100	NULL
a	NULL
80	NULL
-	NULL
OA	NULL
Control	NULL
c	NULL
__	NULL
]	NULL
HPMA	NULL
/	NULL
>	NULL
-	NULL
60	NULL
-	NULL
lonomycin	NULL
'	NULL
O	NULL
©	NULL
a	NULL
.	NULL

&	NULL
2	NULL
-	NULL
40	NULL
7	NULL
0	NULL
2	NULL
0	NULL
a	NULL
.	NULL

20	NULL
{	NULL
0	NULL
Ti	NULL
Parental	NULL
Neo	NULL
mikB	NULL
Figure	NULL
3	NULL
-	NULL
Analysis	NULL
of	NULL
FasL	NULL
expression	NULL
.	NULL

(	NULL
A	NULL
)	NULL
DO11.10	NULL
parental	NULL
,	NULL
pCl-neo	NULL
transfected	NULL
lines	NULL
(	NULL
Neo1	NULL
,	NULL
Neo2	NULL
)	NULL
,	NULL
and	NULL
transfected	NULL
lines	NULL
IxB2	NULL
,	NULL
IxB4	NULL
,	NULL
and	NULL
IxB9	NULL
were	NULL
untreated	NULL
or	NULL
treated	NULL
for	NULL
2h	NULL
with	NULL
PMA/ionomycin	NULL
.	NULL

RNA	NULL
was	NULL
prepared	NULL
and	NULL
analyzed	NULL
by	NULL
RT-PCR	NULL
for	NULL
FasL	NULL
(	NULL
top	NULL
panel	NULL
)	NULL
and	NULL
B-actin	NULL
(	NULL
bottom	NULL
panel	NULL
)	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

MW	NULL
:	NULL
1	NULL
kb	NULL
ladder	NULL
(	NULL
Gibco	NULL
)	NULL
.	NULL

PD	NULL
:	NULL
primer	NULL
dimer	NULL
.	NULL

(	NULL
B	NULL
)	NULL
2B4.11	NULL
parental	NULL
,	NULL
Neo1	NULL
(	NULL
Neo	NULL
)	NULL
,	NULL
and	NULL
4P	NULL
(	NULL
mlxB	NULL
)	NULL
lines	NULL
were	NULL
treated	NULL
and	NULL
mRNA	NULL
prepared	NULL
and	NULL
analyzed	NULL
as	NULL
in	NULL
(	NULL
A	NULL
)	NULL
Control	NULL
:	NULL
RT-PCR	NULL
from	NULL
a	NULL
FasL	NULL
cDNA	NULL
plasmid	NULL
,	NULL
PD	NULL
:	NULL
Primer	NULL
dimers	NULL
.	NULL

(	NULL
C	NULL
)	NULL
PMA/lonomycin	NULL
treated	NULL
and	NULL
untreated	NULL
2B4.11	NULL
parental	NULL
,	NULL
Neo-1	NULL
,	NULL
and	NULL
4P	NULL
(	NULL
mixB	NULL
)	NULL
lines	NULL
were	NULL
co-cultured	NULL
with	NULL
L1210	NULL
Fas	NULL
expressing	NULL
target	NULL
cells	NULL
pre-loaded	NULL
with	NULL
°'Cr	NULL
.	NULL

Specific	NULL
lysis	NULL
was	NULL
calculated	NULL
as	NULL
per	NULL
methods	NULL
and	NULL
materials	NULL
.	NULL

Open	NULL
bars	NULL
:	NULL
Untreated	NULL
control	NULL
,	NULL
Filled	NULL
bars	NULL
:	NULL
PMA/ionomycin	NULL
treated	NULL
.	NULL

Data	NULL
represents	NULL
three	NULL
independent	NULL
determinations	NULL
.	NULL

Error	NULL
bars	NULL
denote	NULL
standard	NULL
deviation	NULL
NF-	NULL
«	NULL
xB	NULL
acts	NULL
directly	NULL
to	NULL
induce	NULL
transcription	NULL
of	NULL
FasL	NULL
when	NULL
activated	NULL
by	NULL
DNA	NULL
damaging	NULL
agents	NULL
.	NULL

Our	NULL
work	NULL
confirms	NULL
this	NULL
observation	NULL
and	NULL
demonstrates	NULL
that	NULL
T	NULL
cell	NULL
activator	NULL
mediated	NULL
induction	NULL
of	NULL
FasL	NULL
is	NULL
also	NULL
dependent	NULL
on	NULL
the	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-xB	NULL
.	NULL

Inhibition	NULL
of	NULL
NF-	NULL
<	NULL
B	NULL
in	NULL
T	NULL
cell	NULL
hybridomas	NULL
has	NULL
both	NULL
proapoptotic	NULL
and	NULL
antiapoptotic	NULL
effects	NULL
depending	NULL
on	NULL
cellular	NULL
context	NULL
Engagement	NULL
of	NULL
Fas	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
play	NULL
a	NULL
major	NULL
role	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
AICD	NULL
.	NULL

'®~'°	NULL
To	NULL
determine	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
inhibition	NULL
of	NULL
NF-xB	NULL
activation	NULL
and	NULL
FasL	NULL
expression	NULL
on	NULL
AICD	NULL
,	NULL
2B4.11	NULL
cultures	NULL
were	NULL
treated	NULL
with	NULL
either	NULL
P/I	NULL
or	NULL
with	NULL
anti-CD3	NULL
for	NULL
24	NULL
h	NULL
and	NULL
viability	NULL
determined	NULL
by	NULL
trypan	NULL
blue	NULL
exclusion	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
4A	NULL
,	NULL
we	NULL
observed	NULL
87	NULL
%	NULL
(	NULL
+1	NULL
%	NULL
)	NULL
killing	NULL
of	NULL
the	NULL
OA	NULL
Control	NULL
100	NULL
mpP/	NULL
C	NULL
0	NULL
i	NULL
Percent	NULL
Viability	NULL
4a	NULL
&	NULL
O	NULL
O	NULL
ho	NULL
O	NULL
i	NULL
Parental	NULL
mIikB	NULL
120	NULL
~	NULL
C	NULL
Control	NULL
W	NULL
anti-CD3	NULL
110	NULL
100	NULL
90	NULL
80	NULL
Percent	NULL
Viability	NULL
70	NULL
4	NULL
60	NULL
50	NULL
Parental	NULL
Neo	NULL
Figure	NULL
4	NULL
Effect	NULL
of	NULL
NF-kB	NULL
inhibition	NULL
on	NULL
cell	NULL
viability	NULL
after	NULL
activation	NULL
.	NULL

(	NULL
A	NULL
)	NULL
2B4.11	NULL
parental	NULL
and	NULL
4P	NULL
(	NULL
mikB	NULL
)	NULL
lines	NULL
were	NULL
untreated	NULL
or	NULL
treated	NULL
for	NULL
24h	NULL
with	NULL
PMA/ionomycin	NULL
.	NULL

Cell	NULL
viability	NULL
was	NULL
assayed	NULL
by	NULL
trypan	NULL
blue	NULL
exclusion	NULL
.	NULL

Data	NULL
is	NULL
representative	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

Error	NULL
bars	NULL
denote	NULL
standard	NULL
deviation	NULL
.	NULL

(	NULL
B	NULL
)	NULL
2B4.11	NULL
parental	NULL
,	NULL
Neo-1	NULL
(	NULL
Neo	NULL
)	NULL
,	NULL
or	NULL
4P	NULL
(	NULL
mlkB	NULL
)	NULL
lines	NULL
were	NULL
treated	NULL
with	NULL
anti-CD3	NULL
for	NULL
24	NULL
h	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
and	NULL
cell	NULL
viability	NULL
measured	NULL
by	NULL
trypan	NULL
blue	NULL
exclusion	NULL
.	NULL

Data	NULL
is	NULL
representative	NULL
of	NULL
four	NULL
independent	NULL
experiments	NULL
.	NULL

Error	NULL
bars	NULL
denote	NULL
standard	NULL
deviation	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
A	NULL
contextual	NULL
regulator	NULL
of	NULL
apoptosis	NULL
B	NULL
Lin	NULL
et	NULL
al	NULL
parental	NULL
2B4.11	NULL
cultures	NULL
after	NULL
24	NULL
h	NULL
treatment	NULL
with	NULL
P/I	NULL
as	NULL
compared	NULL
to	NULL
matched	NULL
untreated	NULL
cultures	NULL
.	NULL

In	NULL
comparison	NULL
,	NULL
the	NULL
2B4.11	NULL
4P	NULL
line	NULL
showed	NULL
49	NULL
%	NULL
(	NULL
+3	NULL
%	NULL
)	NULL
killing	NULL
upon	NULL
similar	NULL
treatment	NULL
.	NULL

Thus	NULL
the	NULL
mixBa	NULL
«	NULL
transgene	NULL
seems	NULL
to	NULL
function	NULL
to	NULL
inhibit	NULL
cell	NULL
death	NULL
,	NULL
suggesting	NULL
that	NULL
NF-xB	NULL
activity	NULL
is	NULL
necessary	NULL
for	NULL
efficient	NULL
killing	NULL
to	NULL
occur	NULL
.	NULL

P/	NULL
treatment	NULL
is	NULL
a	NULL
powerful	NULL
T	NULL
cell	NULL
activator	NULL
which	NULL
functions	NULL
downstream	NULL
from	NULL
the	NULL
TCR	NULL
.	NULL

In	NULL
order	NULL
to	NULL
determine	NULL
the	NULL
effect	NULL
of	NULL
cell	NULL
death	NULL
mediated	NULL
solely	NULL
by	NULL
activation	NULL
of	NULL
the	NULL
TCR	NULL
,	NULL
2B4.11	NULL
cultures	NULL
were	NULL
treated	NULL
with	NULL
anti-CD3	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
4B	NULL
,	NULL
treatment	NULL
of	NULL
parental	NULL
cultures	NULL
resulted	NULL
in	NULL
a	NULL
32	NULL
%	NULL
(	NULL
+4	NULL
%	NULL
)	NULL
loss	NULL
in	NULL
viability	NULL
after	NULL
24	NULL
h	NULL
while	NULL
similarly	NULL
treated	NULL
Neo	NULL
expressors	NULL
experiences	NULL
a	NULL
29	NULL
%	NULL
(	NULL
+6	NULL
%	NULL
)	NULL
loss	NULL
in	NULL
viability	NULL
.	NULL

In	NULL
comparison	NULL
,	NULL
the	NULL
2B4.11	NULL
4P	NULL
line	NULL
experienced	NULL
a	NULL
13	NULL
%	NULL
(	NULL
+5	NULL
%	NULL
)	NULL
increase	NULL
in	NULL
viability	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
loss	NULL
of	NULL
viability	NULL
,	NULL
when	NULL
mediated	NULL
specifically	NULL
through	NULL
activation	NULL
of	NULL
the	NULL
TCR	NULL
,	NULL
is	NULL
completely	NULL
blocked	NULL
by	NULL
overexpression	NULL
of	NULL
the	NULL
mixBs	NULL
«	NULL
transgene	NULL
.	NULL

Our	NULL
viability	NULL
assay	NULL
can	NULL
not	NULL
distinguish	NULL
between	NULL
increased	NULL
cell	NULL
death	NULL
versus	NULL
decreased	NULL
proliferation	NULL
.	NULL

In	NULL
order	NULL
to	NULL
determine	NULL
if	NULL
this	NULL
increase	NULL
in	NULL
cell	NULL
survival	NULL
was	NULL
due	NULL
to	NULL
a	NULL
partial	NULL
or	NULL
complete	NULL
inhibition	NULL
of	NULL
apoptosis	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
either	NULL
PMA	NULL
,	NULL
ionomycin	NULL
,	NULL
or	NULL
P/I	NULL
for	NULL
24	NULL
h	NULL
as	NULL
above	NULL
and	NULL
then	NULL
assayed	NULL
for	NULL
cell	NULL
death	NULL
visually	NULL
by	NULL
the	NULL
ethidium	NULL
bromide/acridine	NULL
orange	NULL
technique	NULL
as	NULL
described	NULL
in	NULL
Methods	NULL
and	NULL
Materials	NULL
.	NULL
``	NULL

''	NULL
As	NULL
shown	NULL
in	NULL
Figure	NULL
5A	NULL
,	NULL
neither	NULL
PMA	NULL
or	NULL
ionomycin	NULL
alone	NULL
induced	NULL
appreciable	NULL
levels	NULL
of	NULL
apoptosis	NULL
in	NULL
parental	NULL
2B4.11	NULL
cells	NULL
.	NULL

Treatment	NULL
of	NULL
parental	NULL
2B4.11	NULL
cells	NULL
with	NULL
P/	NULL
however	NULL
resulted	NULL
in	NULL
approximately	NULL
25	NULL
%	NULL
of	NULL
the	NULL
population	NULL
clearly	NULL
showing	NULL
an	NULL
apoptotic	NULL
morphology	NULL
while	NULL
in	NULL
the	NULL
2B4.11	NULL
4P	NULL
line	NULL
,	NULL
apoptosis	NULL
was	NULL
indistinguishable	NULL
from	NULL
background	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
inhibition	NULL
of	NULL
NF-xB	NULL
has	NULL
a	NULL
profound	NULL
effect	NULL
on	NULL
the	NULL
ability	NULL
of	NULL
T	NULL
cell	NULL
hybridomas	NULL
to	NULL
undergo	NULL
apoptosis	NULL
in	NULL
response	NULL
to	NULL
direct	NULL
activation	NULL
of	NULL
the	NULL
TCR	NULL
or	NULL
to	NULL
activation	NULL
of	NULL
downstream	NULL
TCR	NULL
signaling	NULL
components	NULL
.	NULL

If	NULL
expression	NULL
of	NULL
NF-kB	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
induction	NULL
of	NULL
apoptosis	NULL
mediated	NULL
by	NULL
P/I	NULL
treatment	NULL
then	NULL
we	NULL
would	NULL
expect	NULL
a	NULL
rough	NULL
correlation	NULL
between	NULL
expression	NULL
of	NULL
the	NULL
mixB	NULL
«	NULL
transgene	NULL
and	NULL
protection	NULL
from	NULL
induction	NULL
of	NULL
P/	NULL
mediated	NULL
apoptosis	NULL
.	NULL

To	NULL
test	NULL
this	NULL
hypothesis	NULL
we	NULL
measured	NULL
apoptosis	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
DO11.10	NULL
and	NULL
2B4.11	NULL
lines	NULL
expressing	NULL
variable	NULL
amounts	NULL
of	NULL
the	NULL
mlxBa	NULL
«	NULL
transgene	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
5B	NULL
(	NULL
left	NULL
)	NULL
we	NULL
measured	NULL
the	NULL
induction	NULL
of	NULL
apoptosis	NULL
in	NULL
the	NULL
DO11.10	NULL
IxB2	NULL
line	NULL
as	NULL
compared	NULL
to	NULL
a	NULL
Neo	NULL
expressor	NULL
.	NULL

Since	NULL
this	NULL
line	NULL
was	NULL
created	NULL
with	NULL
pCMV4-IxBaS32/36A	NULL
,	NULL
we	NULL
were	NULL
unable	NULL
to	NULL
directly	NULL
measure	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
transgene	NULL
.	NULL

Nevertheless	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Figure	NULL
3A	NULL
,	NULL
lane	NULL
11	NULL
,	NULL
the	NULL
IxB2	NULL
expresses	NULL
significantly	NULL
less	NULL
FasL	NULL
mRNA	NULL
in	NULL
response	NULL
to	NULL
P/l	NULL
stimulation	NULL
than	NULL
the	NULL
parental	NULL
or	NULL
Neo	NULL
expressing	NULL
cells	NULL
.	NULL

We	NULL
found	NULL
that	NULL
this	NULL
loss	NULL
in	NULL
FasL	NULL
expression	NULL
correlated	NULL
with	NULL
a	NULL
partial	NULL
protection	NULL
from	NULL
P/	NULL
induced	NULL
apoptosis	NULL
as	NULL
compared	NULL
to	NULL
the	NULL
Neo	NULL
expressor	NULL
.	NULL

We	NULL
then	NULL
measured	NULL
the	NULL
induction	NULL
of	NULL
apoptosis	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
2B4.11	NULL
lines	NULL
expressing	NULL
varying	NULL
amounts	NULL
of	NULL
the	NULL
FLAG	NULL
epitope	NULL
tagged	NULL
mlxBa	NULL
transgene	NULL
as	NULL
shown	NULL
in	NULL
Figure	NULL
1	NULL
.	NULL

Line	NULL
3P	NULL
is	NULL
a	NULL
moderate	NULL
expressor	NULL
of	NULL
the	NULL
mixBa	NULL
«	NULL
transgene	NULL
and	NULL
as	NULL
shown	NULL
in	NULL
Figure	NULL
5	NULL
,	NULL
is	NULL
partially	NULL
protected	NULL
from	NULL
P/I	NULL
mediated	NULL
apoptosis	NULL
.	NULL

In	NULL
comparison	NULL
,	NULL
lines	NULL
3M	NULL
and	NULL
4M	NULL
have	NULL
barely	NULL
detectable	NULL
levels	NULL
of	NULL
transgene	NULL
expression	NULL
and	NULL
are	NULL
575	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
A	NULL
contextual	NULL
regulator	NULL
of	NULL
apoptosis	NULL
B	NULL
Lin	NULL
et	NULL
al	NULL
576	NULL
A	NULL
35	NULL
4	NULL
30	NULL
+	NULL
O	NULL
control	NULL
EPMA	NULL
g	NULL
25	NULL
+	NULL
lonomycin	NULL
8	NULL
P/	NULL
a.	NULL
o	NULL
a	NULL
.	NULL

<	NULL
I	NULL
st2	NULL
£	NULL
6	NULL
0	NULL
ks	NULL
®	NULL
a.	NULL
Parental	NULL
B	NULL
80	NULL
-	NULL
rea	NULL
e	NULL
|	NULL
OControl	NULL
MPA	NULL
|	NULL
70	NULL
+	NULL
60	NULL
+	NULL
A	NULL
Pa	NULL
8	NULL
50	NULL
+	NULL
a	NULL
2	NULL
.	NULL

«	NULL
<	NULL
40	NULL
+	NULL
b-g	NULL
30	NULL
+	NULL
@	NULL
A	NULL
.	NULL

20	NULL
+	NULL
10	NULL
+	NULL
0	NULL
-	NULL
+	NULL
t	NULL
t	NULL
i	NULL
:	NULL
:	NULL
Neo	NULL
_	NULL
IkB2	NULL
Neo	NULL
_	NULL
3P	NULL
3M	NULL
4M	NULL
Bo11.10	NULL
2B4.11	NULL
Figure	NULL
5	NULL
-	NULL
Effect	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
inhibition	NULL
on	NULL
apoptosis	NULL
after	NULL
activation	NULL
.	NULL

Apoptosis	NULL
was	NULL
morphologically	NULL
determined	NULL
using	NULL
the	NULL
ethidium	NULL
bromide/acridine	NULL
orange	NULL
technique	NULL
.	NULL
``	NULL

'	NULL
Per	NULL
cent	NULL
apoptosis	NULL
was	NULL
calculated	NULL
as	NULL
(	NULL
apoptotic	NULL
population	NULL
counted/total	NULL
population	NULL
counted	NULL
)	NULL
as	NULL
described	NULL
in	NULL
Methods	NULL
and	NULL
Materials	NULL
.	NULL

Error	NULL
bars	NULL
denote	NULL
standard	NULL
deviation	NULL
.	NULL

(	NULL
A	NULL
)	NULL
2B4.11	NULL
parental	NULL
and	NULL
4P	NULL
lines	NULL
were	NULL
either	NULL
left	NULL
untreated	NULL
or	NULL
treated	NULL
24	NULL
h	NULL
with	NULL
PMA	NULL
alone	NULL
,	NULL
ionomycin	NULL
alone	NULL
,	NULL
or	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
(	NULL
P/1	NULL
)	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Data	NULL
represents	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

Error	NULL
bars	NULL
denote	NULL
standard	NULL
deviation	NULL
.	NULL

(	NULL
B	NULL
)	NULL
lines	NULL
(	NULL
left	NULL
)	NULL
or	NULL
2B4.11	NULL
lines	NULL
(	NULL
right	NULL
)	NULL
,	NULL
transfected	NULL
with	NULL
either	NULL
pCl-Neo	NULL
(	NULL
Neo	NULL
)	NULL
,	NULL
pCl-Neo	NULL
plus	NULL
pCMV4-IxB	NULL
«	NULL
§32/36A	NULL
(	NULL
IxB2	NULL
)	NULL
,	NULL
or	NULL
pCl-Neo	NULL
plus	NULL
pCMV4-FLAG-IxB	NULL
«	NULL
$	NULL
32/36A	NULL
(	NULL
3P	NULL
,	NULL
3M	NULL
,	NULL
and	NULL
4M	NULL
)	NULL
were	NULL
treated	NULL
24h	NULL
with	NULL
P/I	NULL
and	NULL
apoptosis	NULL
determined	NULL
as	NULL
in	NULL
(	NULL
A	NULL
)	NULL
completely	NULL
unprotected	NULL
from	NULL
the	NULL
effects	NULL
of	NULL
P/I	NULL
treatment	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
protection	NULL
from	NULL
apoptosis	NULL
correlates	NULL
directly	NULL
with	NULL
varying	NULL
levels	NULL
of	NULL
FasL	NULL
expression	NULL
and	NULL
inversely	NULL
with	NULL
expression	NULL
of	NULL
the	NULL
mlxBa	NULL
«	NULL
transgene	NULL
.	NULL

Given	NULL
our	NULL
earlier	NULL
work	NULL
demonstrating	NULL
the	NULL
inhibition	NULL
of	NULL
NF-xB	NULL
by	NULL
glucocorticoids®®®	NULL
``	NULL
as	NULL
well	NULL
as	NULL
our	NULL
current	NULL
data	NULL
linking	NULL
NF-	NULL
«	NULL
B	NULL
to	NULL
FasL	NULL
expression	NULL
,	NULL
we	NULL
hypothesized	NULL
that	NULL
blockade	NULL
of	NULL
NF-xB	NULL
might	NULL
result	NULL
in	NULL
an	NULL
increased	NULL
sensitivity	NULL
A	NULL
70	NULL
--	NULL
E-	NULL
El	NULL
60	NULL
|	NULL
-4	NULL
--	NULL
Parental	NULL
a	NULL
K4	NULL
I3	NULL
,	NULL
50	NULL
aA	NULL
2	NULL
40	NULL
{	NULL
<	NULL
F4	NULL
5	NULL
30	NULL
-	NULL
*	NULL
o	NULL
,	NULL
``	NULL
&	NULL
-	NULL
20	NULL
-	NULL
-	NULL
'	NULL
10	NULL
A	NULL
.	NULL

é/	NULL
o	NULL
-	NULL
T	NULL
U	NULL
T	NULL
1	NULL
0	NULL
-9	NULL
-8	NULL
-7	NULL
-6	NULL
log	NULL
[	NULL
Dexamethasone	NULL
]	NULL
M	NULL
100	NULL
1	NULL
_s-mikB	NULL
-O	NULL
--	NULL
Neo	NULL
ama	NULL
=_	NULL
80	NULL
{	NULL
@	NULL
8	NULL
5	NULL
60	NULL
{	NULL
o	NULL
.	NULL

<	NULL
g	NULL
40	NULL
Fe	NULL
20	NULL
{	NULL
0	NULL
t	NULL
U	NULL
I	NULL
0	NULL
-8	NULL
-7	NULL
-6	NULL
log	NULL
[	NULL
Dexamethasone	NULL
]	NULL
M	NULL
Figure	NULL
6	NULL
Effect	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
inhibition	NULL
on	NULL
dexamethasone	NULL
induced	NULL
apoptosis	NULL
.	NULL

Apoptosis	NULL
was	NULL
determined	NULL
as	NULL
described	NULL
in	NULL
Figure	NULL
5	NULL
.	NULL

Data	NULL
represents	NULL
three	NULL
independent	NULL
determinations	NULL
.	NULL

Error	NULL
bars	NULL
denote	NULL
standard	NULL
deviation	NULL
.	NULL

(	NULL
A	NULL
)	NULL
DO11.10	NULL
parental	NULL
and	NULL
IxB9	NULL
(	NULL
mixB	NULL
)	NULL
lines	NULL
were	NULL
treated	NULL
24h	NULL
with	NULL
varying	NULL
concentrations	NULL
of	NULL
dexamethasone	NULL
as	NULL
shown	NULL
.	NULL

Filled	NULL
square/solid	NULL
line	NULL
:	NULL
Open	NULL
square/dashed	NULL
line	NULL
:	NULL
parental	NULL
DO11.10	NULL
line	NULL
.	NULL

(	NULL
B	NULL
)	NULL
2B4.11	NULL
Neo-1	NULL
(	NULL
Neo	NULL
)	NULL
and	NULL
4P	NULL
(	NULL
mixB	NULL
)	NULL
lines	NULL
were	NULL
treated	NULL
for	NULL
24	NULL
with	NULL
varying	NULL
concentrations	NULL
of	NULL
dexamethasone	NULL
as	NULL
shown	NULL
.	NULL

Filled	NULL
square/solid	NULL
line	NULL
:	NULL
2B4.11	NULL
4P	NULL
line	NULL
(	NULL
mikB	NULL
)	NULL
,	NULL
Open	NULL
square/dashed	NULL
line	NULL
:	NULL
2B4.11	NULL
Neo-1	NULL
line	NULL
(	NULL
Neo	NULL
)	NULL
to	NULL
glucocorticoid	NULL
mediated	NULL
apoptosis	NULL
.	NULL

In	NULL
order	NULL
to	NULL
test	NULL
this	NULL
possibility	NULL
,	NULL
we	NULL
incubated	NULL
either	NULL
the	NULL
parental	NULL
DO11.10	NULL
and	NULL
the	NULL
IxB9	NULL
lines	NULL
(	NULL
Figure	NULL
6A	NULL
)	NULL
or	NULL
the	NULL
2B4.11	NULL
Neo	NULL
expressors	NULL
and	NULL
the	NULL
2B4.11	NULL
4P	NULL
line	NULL
(	NULL
Figure	NULL
6B	NULL
)	NULL
with	NULL
varying	NULL
concentrations	NULL
of	NULL
dexamethasone	NULL
(	NULL
DEX	NULL
)	NULL
for	NULL
24	NULL
h.	NULL
Apoptosis	NULL
was	NULL
again	NULL
measured	NULL
by	NULL
the	NULL
acridine	NULL
orange/ethidium	NULL
bromide	NULL
technique	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
increasing	NULL
concentrations	NULL
of	NULL
DEX	NULL
resulted	NULL
in	NULL
increasing	NULL
levels	NULL
of	NULL
apoptosis	NULL
both	NULL
for	NULL
parental	NULL
DO11.10	NULL
and	NULL
for	NULL
2B4.11	NULL
Neo	NULL
expressing	NULL
cultures	NULL
in	NULL
a	NULL
similar	NULL
fashion	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
mixB	NULL
transgene	NULL
in	NULL
the	NULL
DO11.10	NULL
IxB9	NULL
line	NULL
resulted	NULL
in	NULL
approximately	NULL
a	NULL
tenfold	NULL
increase	NULL
in	NULL
sensitivity	NULL
to	NULL
DEX	NULL
mediated	NULL
apoptosis	NULL
(	NULL
Figure	NULL
6A	NULL
)	NULL
.	NULL

A	NULL
similar	NULL
increase	NULL
in	NULL
sensitivity	NULL
was	NULL
observed	NULL
in	NULL
our	NULL
2B4.11	NULL
4P	NULL
expressing	NULL
line	NULL
(	NULL
Figure	NULL
6B	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
while	NULL
expression	NULL
of	NULL
the	NULL
mlxBa	NULL
«	NULL
transgene	NULL
protects	NULL
T	NULL
cell	NULL
hybridomas	NULL
from	NULL
P/	NULL
mediated	NULL
apoptosis	NULL
,	NULL
in	NULL
the	NULL
context	NULL
of	NULL
glucocorticoid	NULL
treatment	NULL
,	NULL
inhibition	NULL
of	NULL
NF-xB	NULL
activity	NULL
results	NULL
in	NULL
a	NULL
significant	NULL
increase	NULL
in	NULL
apoptosis	NULL
in	NULL
two	NULL
different	NULL
T	NULL
cell	NULL
lines	NULL
.	NULL

NF-xB	NULL
is	NULL
not	NULL
required	NULL
for	NULL
the	NULL
mutual	NULL
inhibition	NULL
mediated	NULL
by	NULL
P/I	NULL
and	NULL
glucocorticoids	NULL
As	NULL
demonstrated	NULL
in	NULL
earlier	NULL
studies	NULL
,	NULL
exposure	NULL
to	NULL
T	NULL
cell	NULL
activators	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
glucocorticoids	NULL
induces	NULL
a	NULL
mutual	NULL
inhibition	NULL
of	NULL
the	NULL
two	NULL
apoptotic	NULL
signals	NULL
.	NULL
``	NULL

We	NULL
next	NULL
wanted	NULL
to	NULL
determine	NULL
if	NULL
inhibition	NULL
of	NULL
NF-xB	NULL
had	NULL
any	NULL
effect	NULL
on	NULL
this	NULL
phenomena	NULL
.	NULL

Parental	NULL
2B4.11	NULL
,	NULL
Neo-3	NULL
,	NULL
3P	NULL
,	NULL
and	NULL
5P	NULL
lines	NULL
were	NULL
incubated	NULL
with	NULL
varying	NULL
amounts	NULL
of	NULL
DEX	NULL
for	NULL
24	NULL
h	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
P/	NULL
.	NULL

Apoptosis	NULL
was	NULL
measured	NULL
by	NULL
the	NULL
acridine	NULL
orange/ethidium	NULL
bromide	NULL
technique	NULL
.	NULL

At	NULL
the	NULL
maximal	NULL
dose	NULL
of	NULL
glucocorticoid	NULL
,	NULL
we	NULL
counted	NULL
approximately	NULL
60	NULL
to	NULL
70	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
as	NULL
apoptotic	NULL
(	NULL
Figure	NULL
7	NULL
)	NULL
.	NULL

P/l	NULL
treatment	NULL
alone	NULL
in	NULL
this	NULL
experiment	NULL
produced	NULL
27	NULL
%	NULL
(	NULL
+5.7	NULL
%	NULL
)	NULL
apoptosis	NULL
in	NULL
our	NULL
neo-3	NULL
line	NULL
and	NULL
5	NULL
%	NULL
(	NULL
+1.4	NULL
%	NULL
)	NULL
in	NULL
our	NULL
3P	NULL
line	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

While	NULL
either	NULL
DEX	NULL
or	NULL
P/I	NULL
treatment	NULL
alone	NULL
induced	NULL
apoptosis	NULL
,	NULL
when	NULL
combined	NULL
,	NULL
apoptosis	NULL
levels	NULL
were	NULL
indistinguishable	NULL
from	NULL
background	NULL
(	NULL
Figure	NULL
7	NULL
)	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
observations	NULL
of	NULL
others	NULL
.	NULL
``	NULL

Inhibition	NULL
of	NULL
NF-xB	NULL
activity	NULL
had	NULL
a	NULL
small	NULL
effect	NULL
,	NULL
if	NULL
any	NULL
,	NULL
on	NULL
this	NULL
result	NULL
.	NULL

Thus	NULL
while	NULL
inhibition	NULL
of	NULL
NF-kB	NULL
has	NULL
opposite	NULL
effects	NULL
on	NULL
these	NULL
two	NULL
apoptosis	NULL
pathways	NULL
which	NULL
are	NULL
mutually	NULL
inhibitory	NULL
,	NULL
surprisingly	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
does	NULL
not	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
mutual	NULL
inhibition	NULL
that	NULL
occurs	NULL
between	NULL
these	NULL
two	NULL
pathways	NULL
.	NULL

Discussion	NULL
A	NULL
central	NULL
paradox	NULL
in	NULL
thymic	NULL
selection	NULL
is	NULL
that	NULL
one	NULL
signal	NULL
can	NULL
mediate	NULL
survival	NULL
or	NULL
the	NULL
induction	NULL
of	NULL
apoptosis	NULL
depending	NULL
on	NULL
70	NULL
-x-	NULL
Neo	NULL
-P/	NULL
-A-	NULL
Neo	NULL
+P/	NULL
a	NULL
-	NULL
59	NULL
-	NULL
#	NULL
-	NULL
FIkB	NULL
-PA	NULL
3	NULL
so	NULL
-o-	NULL
FIkB	NULL
+P/I	NULL
s	NULL
8	NULL
40	NULL
C	NULL
T	NULL
30	NULL
0	NULL
o	NULL
©	NULL
20	NULL
a	NULL
10	NULL
f	NULL
>	NULL
<	NULL
g74§	NULL
0	NULL
+	NULL
O	NULL
7	NULL
t	NULL
8	NULL
7	NULL
6	NULL
log	NULL
[	NULL
DEX	NULL
]	NULL
M	NULL
Figure	NULL
7	NULL
-	NULL
Effect	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
inhibition	NULL
on	NULL
the	NULL
mutual	NULL
inhibition	NULL
between	NULL
P/I	NULL
and	NULL
dexamethasone	NULL
induced	NULL
apoptosis	NULL
.	NULL

The	NULL
2B4.11	NULL
Neo-3	NULL
line	NULL
(	NULL
triangles	NULL
)	NULL
and	NULL
2B4.11	NULL
3P	NULL
line	NULL
(	NULL
squares	NULL
)	NULL
were	NULL
treated	NULL
with	NULL
varying	NULL
concentrations	NULL
of	NULL
DEX	NULL
as	NULL
shown	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
filled	NULL
symbols	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
open	NULL
symbols	NULL
)	NULL
of	NULL
PMA/	NULL
ionomycin	NULL
for	NULL
24h	NULL
.	NULL

Apoptosis	NULL
was	NULL
determined	NULL
as	NULL
described	NULL
in	NULL
Figure	NULL
5	NULL
.	NULL

Data	NULL
represent	NULL
three	NULL
separate	NULL
determinations	NULL
and	NULL
is	NULL
representative	NULL
of	NULL
experiments	NULL
with	NULL
other	NULL
mlxkBa	NULL
expressing	NULL
lines	NULL
.	NULL

Error	NULL
bars	NULL
denote	NULL
standard	NULL
deviation	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
A	NULL
contextual	NULL
regulator	NULL
of	NULL
apoptosis	NULL
B	NULL
Lin	NULL
et	NULL
al	NULL
the	NULL
strength	NULL
of	NULL
the	NULL
signal	NULL
and	NULL
the	NULL
differentiation	NULL
state	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
.	NULL

Our	NULL
interest	NULL
in	NULL
this	NULL
problem	NULL
arose	NULL
through	NULL
several	NULL
linked	NULL
observations	NULL
.	NULL

In	NULL
our	NULL
studies	NULL
of	NULL
NF-xB	NULL
,	NULL
we	NULL
discovered	NULL
an	NULL
interaction	NULL
between	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
and	NULL
NF-xB	NULL
resulting	NULL
in	NULL
the	NULL
mutual	NULL
inhibition	NULL
of	NULL
these	NULL
two	NULL
transcription	NULL
factors	NULL
which	NULL
functioned	NULL
at	NULL
several	NULL
levels	NULL
including	NULL
physical	NULL
interaction	NULL
and	NULL
induction	NULL
of	NULL
Others	NULL
have	NULL
more	NULL
recently	NULL
shown	NULL
that	NULL
NF-xB	NULL
and	NULL
GR	NULL
also	NULL
compete	NULL
for	NULL
the	NULL
co-activator	NULL
p300/CBP	NULL
.	NULL
``	NULL

''	NULL
During	NULL
this	NULL
time	NULL
,	NULL
several	NULL
reports	NULL
demonstrated	NULL
that	NULL
glucocorticoids	NULL
were	NULL
produced	NULL
in	NULL
the	NULL
thymic	NULL
epithelium	NULL
and	NULL
that	NULL
blockade	NULL
of	NULL
either	NULL
glucocorticoid	NULL
production	NULL
or	NULL
blockade	NULL
of	NULL
glucocorticoid	NULL
receptor	NULL
synthesis	NULL
resulted	NULL
in	NULL
increased	NULL
thymocyte	NULL
survival	NULL
during	NULL
positive	NULL
selection	NULL
.	NULL
``	NULL

''	NULL
A	NULL
previous	NULL
report	NULL
from	NULL
the	NULL
same	NULL
group	NULL
had	NULL
demonstrated	NULL
that	NULL
T	NULL
cell	NULL
activation	NULL
could	NULL
block	NULL
glucocorticoid	NULL
mediated	NULL
apoptosis	NULL
.	NULL
``	NULL

Interestingly	NULL
,	NULL
glucocorticoid	NULL
treatment	NULL
was	NULL
found	NULL
to	NULL
block	NULL
anti-CD3	NULL
mediated	NULL
induction	NULL
of	NULL
FasL	NULL
.	NULL
``	NULL

Given	NULL
the	NULL
recent	NULL
observations	NULL
that	NULL
NF-xB	NULL
can	NULL
play	NULL
a	NULL
role	NULL
as	NULL
either	NULL
antiapoptotic	NULL
or	NULL
proapoptotic	NULL
regulator	NULL
,	NULL
our	NULL
hypothesis	NULL
,	NULL
derived	NULL
from	NULL
these	NULL
observations	NULL
,	NULL
was	NULL
that	NULL
glucocorticoid	NULL
interactions	NULL
with	NULL
NF-xB	NULL
might	NULL
play	NULL
a	NULL
role	NULL
in	NULL
thymic	NULL
selection	NULL
.	NULL

We	NULL
chose	NULL
to	NULL
address	NULL
this	NULL
hypothesis	NULL
by	NULL
inhibiting	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
using	NULL
the	NULL
dominant	NULL
negative	NULL
mutant	NULL
IxB	NULL
«	NULL
.	NULL

The	NULL
detailed	NULL
apoptosis	NULL
studies	NULL
of	NULL
Ashwell	NULL
and	NULL
others	NULL
made	NULL
the	NULL
T	NULL
cell	NULL
hybridomas	NULL
2B4.11	NULL
and	NULL
DO11.10	NULL
attractive	NULL
model	NULL
systems	NULL
for	NULL
this	NULL
study	NULL
.	NULL

In	NULL
our	NULL
initial	NULL
experiments	NULL
we	NULL
chose	NULL
to	NULL
look	NULL
at	NULL
the	NULL
effects	NULL
of	NULL
inhibition	NULL
of	NULL
NF-xB	NULL
on	NULL
both	NULL
activation	NULL
induced	NULL
apoptosis	NULL
(	NULL
AICD	NULL
)	NULL
and	NULL
glucocorticoid	NULL
induced	NULL
apoptosis	NULL
.	NULL

Others	NULL
have	NULL
shown	NULL
in	NULL
this	NULL
hybridoma	NULL
model	NULL
that	NULL
AICD	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
upregulation	NULL
of	NULL
FasL	NULL
and	NULL
its	NULL
engagement	NULL
with	NULL
Fas	NULL
.	NULL
``	NULL

We	NULL
found	NULL
that	NULL
inhibition	NULL
of	NULL
NF-xB	NULL
results	NULL
in	NULL
a	NULL
loss	NULL
of	NULL
the	NULL
induction	NULL
of	NULL
FasL	NULL
mRNA	NULL
in	NULL
both	NULL
2B4.11	NULL
and	NULL
DO11.10	NULL
(	NULL
Figure	NULL
3	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
a	NULL
decrease	NULL
in	NULL
AICD	NULL
mediated	NULL
apoptosis	NULL
(	NULL
Figure	NULL
4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

Our	NULL
method	NULL
of	NULL
measuring	NULL
apoptosis	NULL
is	NULL
conservative	NULL
in	NULL
that	NULL
at	NULL
the	NULL
time	NULL
the	NULL
counts	NULL
were	NULL
performed	NULL
,	NULL
a	NULL
number	NULL
of	NULL
cells	NULL
may	NULL
have	NULL
already	NULL
been	NULL
eliminated	NULL
and	NULL
thus	NULL
would	NULL
not	NULL
be	NULL
counted	NULL
as	NULL
apoptotic	NULL
.	NULL

A	NULL
useful	NULL
experiment	NULL
would	NULL
be	NULL
to	NULL
reintroduce	NULL
FasL	NULL
expression	NULL
to	NULL
NF-	NULL
«	NULL
xB	NULL
inhibited	NULL
cells	NULL
and	NULL
show	NULL
that	NULL
protection	NULL
from	NULL
AICD	NULL
is	NULL
blocked	NULL
.	NULL

We	NULL
have	NULL
attempted	NULL
to	NULL
perform	NULL
this	NULL
experiment	NULL
through	NULL
transient	NULL
transfection	NULL
techniques	NULL
using	NULL
our	NULL
T	NULL
cell	NULL
hybridomas	NULL
but	NULL
low	NULL
transfection	NULL
efficiencies	NULL
have	NULL
stymied	NULL
this	NULL
attempt	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
while	NULL
AICD	NULL
was	NULL
significantly	NULL
decreased	NULL
by	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
it	NULL
was	NULL
never	NULL
totally	NULL
eradicated	NULL
(	NULL
Figure	NULL
5A	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
would	NULL
suggest	NULL
that	NULL
a	NULL
Fas-independent	NULL
apoptotic	NULL
pathway	NULL
may	NULL
also	NULL
be	NULL
activated	NULL
in	NULL
these	NULL
cells	NULL
however	NULL
further	NULL
work	NULL
will	NULL
be	NULL
necessary	NULL
to	NULL
define	NULL
these	NULL
points	NULL
.	NULL

While	NULL
our	NULL
studies	NULL
were	NULL
in	NULL
progress	NULL
several	NULL
reports	NULL
were	NULL
published	NULL
indicating	NULL
that	NULL
NF-kB	NULL
was	NULL
an	NULL
important	NULL
regulator	NULL
of	NULL
FasL	NULL
.	NULL

The	NULL
HTLV-1	NULL
Tax	NULL
protein	NULL
induces	NULL
the	NULL
expression	NULL
of	NULL
FasL	NULL
and	NULL
promotes	NULL
apoptosis	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL
``	NULL

Tax	NULL
is	NULL
known	NULL
to	NULL
activate	NULL
NF-xB	NULL
as	NULL
well	NULL
as	NULL
the	NULL
CREB/ATF	NULL
transcription	NULL
factor	NULL
family	NULL
through	NULL
different	NULL
domains	NULL
.	NULL

Interestingly	NULL
,	NULL
mutants	NULL
of	NULL
Tax	NULL
which	NULL
are	NULL
selectively	NULL
deficient	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
either	NULL
NF-xB	NULL
or	NULL
of	NULL
CREB/ATF	NULL
are	NULL
incapable	NULL
of	NULL
inducing	NULL
the	NULL
FasL	NULL
.	NULL

A	NULL
577	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
A	NULL
contextual	NULL
regulator	NULL
of	NULL
apoptosis	NULL
B	NULL
Lin	NULL
et	NULL
al	NULL
578	NULL
combination	NULL
of	NULL
these	NULL
mutants	NULL
however	NULL
restores	NULL
the	NULL
ability	NULL
to	NULL
induce	NULL
FasL	NULL
and	NULL
mediate	NULL
apoptosis	NULL
.	NULL

This	NULL
strongly	NULL
suggests	NULL
that	NULL
NF-xB	NULL
and	NULL
CREB/ATF	NULL
activities	NULL
are	NULL
necessary	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
FasL	NULL
.	NULL

Others	NULL
have	NULL
linked	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
with	NULL
the	NULL
induction	NULL
of	NULL
FasL	NULL
through	NULL
modulation	NULL
of	NULL
proteosome	NULL
function	NULL
using	NULL
the	NULL
bacterial	NULL
metabolite	NULL
,	NULL
They	NULL
found	NULL
that	NULL
agents	NULL
which	NULL
inhibited	NULL
NF-xB	NULL
activation	NULL
also	NULL
inhibited	NULL
induction	NULL
of	NULL
FasL	NULL
.	NULL

More	NULL
recently	NULL
,	NULL
a	NULL
study	NULL
of	NULL
the	NULL
DNA	NULL
damaging	NULL
agents	NULL
,	NULL
etoposide	NULL
and	NULL
teniposide	NULL
,	NULL
demonstrated	NULL
that	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
apoptosis	NULL
was	NULL
mediated	NULL
through	NULL
the	NULL
induction	NULL
of	NULL
FasL	NULL
and	NULL
that	NULL
NF-xB	NULL
and	NULL
AP-1	NULL
activities	NULL
were	NULL
essential	NULL
for	NULL
this	NULL
induction	NULL
.	NULL
``	NULL

The	NULL
authors	NULL
cloned	NULL
the	NULL
FasL	NULL
promoter	NULL
,	NULL
identified	NULL
an	NULL
NF-xB	NULL
site	NULL
between	NULL
0.9	NULL
and	NULL
1.2	NULL
kb	NULL
upstream	NULL
from	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
,	NULL
and	NULL
demonstrated	NULL
that	NULL
mutation	NULL
of	NULL
that	NULL
site	NULL
resulted	NULL
in	NULL
a	NULL
loss	NULL
of	NULL
etoposide	NULL
mediated	NULL
induction	NULL
.	NULL

This	NULL
report	NULL
thus	NULL
supplies	NULL
a	NULL
mechanistic	NULL
framework	NULL
for	NULL
our	NULL
results	NULL
,	NULL
indicating	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
directly	NULL
required	NULL
for	NULL
activation	NULL
of	NULL
FasL	NULL
transcription	NULL
.	NULL

Our	NULL
work	NULL
extends	NULL
the	NULL
results	NULL
of	NULL
Kasibhatla	NULL
et	NULL
al	NULL
.	NULL

by	NULL
demonstrating	NULL
that	NULL
T	NULL
cell	NULL
activation	NULL
signals	NULL
work	NULL
in	NULL
a	NULL
manner	NULL
similar	NULL
to	NULL
DNA	NULL
damaging	NULL
agents	NULL
in	NULL
respect	NULL
to	NULL
FasL	NULL
induction	NULL
.	NULL

This	NULL
is	NULL
interesting	NULL
in	NULL
that	NULL
an	NULL
NFAT	NULL
site	NULL
,	NULL
located	NULL
approximately	NULL
200	NULL
bp	NULL
upstream	NULL
from	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
,	NULL
was	NULL
also	NULL
identified	NULL
as	NULL
an	NULL
important	NULL
regulator	NULL
of	NULL
the	NULL
FasL	NULL
promoter	NULL
.	NULL

``	NULL
``	NULL
*	NULL
Unlike	NULL
etoposide	NULL
,	NULL
PMA/	NULL
ionomycin	NULL
treatment	NULL
activates	NULL
NFAT	NULL
.	NULL

Our	NULL
results	NULL
suggest	NULL
that	NULL
NFAT	NULL
activation	NULL
is	NULL
not	NULL
sufficient	NULL
to	NULL
activate	NULL
the	NULL
FasL	NULL
promoter	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
NF-xB	NULL
.	NULL

Interestingly	NULL
we	NULL
have	NULL
generated	NULL
preliminary	NULL
data	NULL
demonstrating	NULL
that	NULL
both	NULL
NF-xB	NULL
and	NULL
SP-1	NULL
are	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
the	NULL
putative	NULL
NFAT	NULL
site	NULL
in	NULL
EMSA	NULL
assays	NULL
(	NULL
Cano	NULL
and	NULL
Scheinman	NULL
,	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

The	NULL
function	NULL
of	NULL
the	NULL
NFAT	NULL
site	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
FasL	NULL
promoter	NULL
activity	NULL
may	NULL
be	NULL
more	NULL
complex	NULL
than	NULL
originally	NULL
suspected	NULL
.	NULL

A	NULL
second	NULL
level	NULL
of	NULL
complexity	NULL
comes	NULL
from	NULL
the	NULL
study	NULL
of	NULL
transgenic	NULL
mice	NULL
in	NULL
which	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
IxBx	NULL
mutant	NULL
has	NULL
been	NULL
directed	NULL
to	NULL
thymocytes	NULL
.	NULL

FasL	NULL
expression	NULL
was	NULL
detected	NULL
in	NULL
peripheral	NULL
T	NULL
cells	NULL
derived	NULL
from	NULL
these	NULL
animals	NULL
.	NULL
``	NULL

''	NULL
This	NULL
would	NULL
suggest	NULL
that	NULL
NF-xB	NULL
may	NULL
not	NULL
be	NULL
required	NULL
for	NULL
FasL	NULL
expression	NULL
in	NULL
all	NULL
T	NULL
cell	NULL
contexts	NULL
however	NULL
the	NULL
extent	NULL
to	NULL
which	NULL
the	NULL
mutant	NULL
IxBa	NULL
inhibits	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
mature	NULL
T	NULL
cells	NULL
in	NULL
this	NULL
transgenic	NULL
mouse	NULL
has	NULL
not	NULL
been	NULL
fully	NULL
explored	NULL
.	NULL

Constitutive	NULL
expression	NULL
of	NULL
FasL	NULL
,	NULL
as	NULL
seen	NULL
in	NULL
Sertoli	NULL
cells	NULL
,	NULL
would	NULL
not	NULL
be	NULL
predicted	NULL
to	NULL
require	NULL
NF-	NULL
«	NULL
xB	NULL
activation	NULL
.	NULL

It	NULL
is	NULL
clear	NULL
that	NULL
there	NULL
is	NULL
no	NULL
general	NULL
role	NULL
for	NULL
NF-xB	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
apoptosis	NULL
but	NULL
rather	NULL
,	NULL
NF-xB	NULL
functions	NULL
as	NULL
a	NULL
complex	NULL
and	NULL
cell	NULL
specific	NULL
regulator	NULL
of	NULL
apoptosis	NULL
.	NULL

In	NULL
a	NULL
study	NULL
of	NULL
Fas	NULL
resistant	NULL
T24	NULL
human	NULL
bladder	NULL
carcinoma	NULL
cells	NULL
,	NULL
it	NULL
was	NULL
observed	NULL
that	NULL
ligation	NULL
of	NULL
Fas	NULL
resulted	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
xB	NULL
while	NULL
no	NULL
such	NULL
activation	NULL
was	NULL
observed	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL
``	NULL

''	NULL
In	NULL
a	NULL
separate	NULL
study	NULL
,	NULL
ligation	NULL
of	NULL
Fas	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
was	NULL
shown	NULL
to	NULL
inhibit	NULL
NF-xB	NULL
activity	NULL
,	NULL
via	NULL
a	NULL
caspase-3-related	NULL
protease	NULL
mediated	NULL
cleavage	NULL
of	NULL
relA	NULL
and	NULL
p50	NULL
thus	NULL
inhibiting	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
early	NULL
in	NULL
the	NULL
apoptotic	NULL
process	NULL
.	NULL
``	NULL

''	NULL
Another	NULL
group	NULL
has	NULL
also	NULL
recently	NULL
reported	NULL
that	NULL
c-Rel	NULL
expression	NULL
prevents	NULL
both	NULL
TNFz	NULL
and	NULL
FasL	NULL
mediated	NULL
apoptosis	NULL
in	NULL
transformed	NULL
lymphoid	NULL
cells	NULL
.	NULL
``	NULL

''	NULL
It	NULL
is	NULL
important	NULL
to	NULL
note	NULL
in	NULL
each	NULL
of	NULL
these	NULL
cases	NULL
that	NULL
apoptosis	NULL
,	NULL
when	NULL
mediated	NULL
by	NULL
the	NULL
ligation	NULL
of	NULL
a	NULL
death	NULL
receptor	NULL
,	NULL
requires	NULL
the	NULL
interaction	NULL
of	NULL
an	NULL
effector	NULL
cell	NULL
with	NULL
a	NULL
target	NULL
cell	NULL
.	NULL

These	NULL
data	NULL
would	NULL
suggests	NULL
that	NULL
the	NULL
proapoptotic	NULL
function	NULL
of	NULL
NF-xB	NULL
is	NULL
limited	NULL
to	NULL
a	NULL
point	NULL
upstream	NULL
of	NULL
Fas	NULL
ligation	NULL
,	NULL
within	NULL
the	NULL
effector	NULL
cell	NULL
,	NULL
and	NULL
that	NULL
NF-xB	NULL
activity	NULL
may	NULL
interfere	NULL
with	NULL
later	NULL
stages	NULL
of	NULL
the	NULL
apoptotic	NULL
process	NULL
within	NULL
the	NULL
target	NULL
cell	NULL
,	NULL
perhaps	NULL
due	NULL
to	NULL
the	NULL
ability	NULL
of	NULL
NF-xB	NULL
to	NULL
induce	NULL
antiapoptotic	NULL
genes	NULL
such	NULL
as	NULL
clAP	NULL
and	NULL
TRAFs	NULL
.	NULL

*	NULL
In	NULL
this	NULL
regard	NULL
,	NULL
it	NULL
will	NULL
be	NULL
interesting	NULL
to	NULL
see	NULL
whether	NULL
NF-xB	NULL
functions	NULL
in	NULL
a	NULL
similar	NULL
fashion	NULL
as	NULL
a	NULL
proapoptotic	NULL
regulator	NULL
in	NULL
the	NULL
CNS	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
demonstrate	NULL
,	NULL
for	NULL
the	NULL
first	NULL
time	NULL
,	NULL
that	NULL
DEX	NULL
mediated	NULL
apoptosis	NULL
is	NULL
sensitive	NULL
to	NULL
the	NULL
state	NULL
of	NULL
NF-xB	NULL
activity	NULL
.	NULL

Inhibition	NULL
of	NULL
NF-xB	NULL
results	NULL
in	NULL
a	NULL
tenfold	NULL
increase	NULL
in	NULL
the	NULL
sensitivity	NULL
of	NULL
these	NULL
cells	NULL
to	NULL
DEX	NULL
(	NULL
Figure	NULL
6	NULL
and	NULL
7	NULL
)	NULL
.	NULL

Previously	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
GR	NULL
and	NULL
NF-xB	NULL
interact	NULL
to	NULL
mutually	NULL
inhibit	NULL
each	NULL
other	NULL
.	NULL

Thus	NULL
one	NULL
interpretation	NULL
of	NULL
this	NULL
result	NULL
in	NULL
that	NULL
by	NULL
inhibiting	NULL
NF-	NULL
«	NULL
B	NULL
we	NULL
have	NULL
removed	NULL
an	NULL
inhibitor	NULL
of	NULL
GR	NULL
function	NULL
,	NULL
allowing	NULL
more	NULL
GR	NULL
to	NULL
be	NULL
available	NULL
to	NULL
induce	NULL
apoptosis	NULL
.	NULL

We	NULL
do	NULL
not	NULL
favor	NULL
this	NULL
hypothesis	NULL
however	NULL
as	NULL
NF-xB	NULL
must	NULL
be	NULL
induced	NULL
to	NULL
function	NULL
,	NULL
suggesting	NULL
that	NULL
release	NULL
from	NULL
IxBa	NULL
is	NULL
a	NULL
prerequisite	NULL
for	NULL
interaction	NULL
with	NULL
GR	NULL
.	NULL

Indeed	NULL
,	NULL
we	NULL
can	NULL
only	NULL
detect	NULL
low	NULL
levels	NULL
of	NULL
NF-xB	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
nuclear	NULL
extracts	NULL
derived	NULL
from	NULL
uninduced	NULL
T	NULL
cell	NULL
hybridomas	NULL
(	NULL
Figure	NULL
2	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
have	NULL
found	NULL
that	NULL
an	NULL
excess	NULL
of	NULL
NF-xB	NULL
must	NULL
be	NULL
present	NULL
to	NULL
physically	NULL
inhibit	NULL
GR	NULL
.	NULL

A	NULL
second	NULL
interpretation	NULL
of	NULL
Figure	NULL
6	NULL
is	NULL
that	NULL
low	NULL
levels	NULL
of	NULL
NF-xB	NULL
activity	NULL
,	NULL
found	NULL
in	NULL
uninduced	NULL
T	NULL
cells	NULL
,	NULL
activate	NULL
the	NULL
expression	NULL
of	NULL
one	NULL
or	NULL
more	NULL
genes	NULL
which	NULL
function	NULL
to	NULL
inhibit	NULL
DEX	NULL
mediated	NULL
apoptosis	NULL
.	NULL

Indeed	NULL
as	NULL
mentioned	NULL
above	NULL
,	NULL
several	NULL
apoptosis	NULL
inhibitors	NULL
have	NULL
recently	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
under	NULL
NF-xB	NULL
control	NULL
and	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
protecting	NULL
from	NULL
TNF	NULL
induced	NULL
apoptosis	NULL
.	NULL
``	NULL

It	NULL
will	NULL
be	NULL
interesting	NULL
to	NULL
see	NULL
what	NULL
role	NULL
these	NULL
genes	NULL
might	NULL
play	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
glucocorticoid	NULL
mediated	NULL
apoptosis	NULL
.	NULL

These	NULL
results	NULL
supply	NULL
a	NULL
physiological	NULL
interpretation	NULL
to	NULL
our	NULL
previous	NULL
discovery	NULL
that	NULL
GR	NULL
and	NULL
NF-xB	NULL
are	NULL
mutually	NULL
inhibitory	NULL
and	NULL
demonstrates	NULL
a	NULL
potential	NULL
physiological	NULL
role	NULL
for	NULL
NF-kB	NULL
as	NULL
a	NULL
regulator	NULL
of	NULL
apoptosis	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

We	NULL
hypothesize	NULL
that	NULL
during	NULL
thymic	NULL
selection	NULL
,	NULL
NF-xB	NULL
protection	NULL
from	NULL
glucocorticoid	NULL
mediated	NULL
apoptosis	NULL
may	NULL
represent	NULL
a	NULL
mechanism	NULL
by	NULL
which	NULL
thymocytes	NULL
survive	NULL
positive	NULL
selection	NULL
.	NULL

In	NULL
order	NULL
to	NULL
induce	NULL
apoptosis	NULL
,	NULL
GR	NULL
must	NULL
induce	NULL
genes	NULL
(	NULL
such	NULL
as	NULL
IxBa	NULL
)	NULL
to	NULL
block	NULL
apoptosis	NULL
inhibitors	NULL
as	NULL
well	NULL
as	NULL
to	NULL
induce	NULL
genes	NULL
to	NULL
promote	NULL
apoptosis	NULL
itself	NULL
.	NULL

After	NULL
differentiation	NULL
is	NULL
completed	NULL
,	NULL
and	NULL
the	NULL
mature	NULL
T	NULL
cell	NULL
is	NULL
exported	NULL
to	NULL
the	NULL
periphery	NULL
,	NULL
the	NULL
role	NULL
of	NULL
NF-xB	NULL
then	NULL
changes	NULL
to	NULL
promote	NULL
the	NULL
linkage	NULL
of	NULL
T	NULL
cell	NULL
activation	NULL
with	NULL
eventual	NULL
deletion	NULL
through	NULL
induction	NULL
of	NULL
proapoptotic	NULL
molecules	NULL
such	NULL
as	NULL
FasL	NULL
.	NULL

Most	NULL
likely	NULL
,	NULL
other	NULL
proapoptotic	NULL
genes	NULL
will	NULL
be	NULL
identified	NULL
as	NULL
NF-xB	NULL
responsive	NULL
in	NULL
addition	NULL
to	NULL
FasL	NULL
.	NULL

Given	NULL
that	NULL
different	NULL
forms	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
are	NULL
expressed	NULL
at	NULL
different	NULL
points	NULL
in	NULL
T	NULL
cell	NULL
differentiation	NULL
,	NULL
it	NULL
is	NULL
intriguing	NULL
to	NULL
speculate	NULL
that	NULL
different	NULL
forms	NULL
of	NULL
NF-xB	NULL
may	NULL
responsible	NULL
for	NULL
antiapoptotic	NULL
and	NULL
proapoptotic	NULL
functions	NULL
.	NULL

As	NULL
the	NULL
mutant	NULL
IxBa	NULL
inhibits	NULL
all	NULL
forms	NULL
of	NULL
NF-xB	NULL
,	NULL
we	NULL
were	NULL
unable	NULL
to	NULL
address	NULL
this	NULL
issue	NULL
in	NULL
the	NULL
present	NULL
study	NULL
.	NULL

Further	NULL
experiments	NULL
will	NULL
need	NULL
to	NULL
be	NULL
performed	NULL
in	NULL
primary	NULL
T	NULL
cells	NULL
to	NULL
identify	NULL
which	NULL
forms	NULL
of	NULL
NF-xB	NULL
are	NULL
responsible	NULL
for	NULL
these	NULL
functions	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Cell	NULL
culture	NULL
DO11.10	NULL
and	NULL
2B4.11	NULL
T	NULL
cell	NULL
hybridoma	NULL
cultures	NULL
were	NULL
maintained	NULL
in	NULL
Dulbecco	NULL
's	NULL
Minimal	NULL
Essential	NULL
Media	NULL
(	NULL
DMEM	NULL
;	NULL
Gibco	NULL
BRL	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FBS	NULL
(	NULL
Gemini	NULL
Bio-Products	NULL
)	NULL
and	NULL
Penicillin-Streptomycin	NULL
(	NULL
50	NULL
units/ml	NULL
and	NULL
50	NULL
mg/m	NULL
!	NULL

respectively	NULL
;	NULL
Gibco	NULL
BRL	NULL
)	NULL
.	NULL

T	NULL
cell	NULL
hybridomas	NULL
were	NULL
kept	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
500000	NULL
cells/ml	NULL
or	NULL
less	NULL
.	NULL

Stably	NULL
transfected	NULL
cells	NULL
were	NULL
further	NULL
supplemented	NULL
with	NULL
450	NULL
ug/m	NULL
!	NULL

of	NULL
G418	NULL
Sulfate	NULL
(	NULL
Gemini	NULL
Bio-Products	NULL
)	NULL
to	NULL
select	NULL
for	NULL
transgene	NULL
expression	NULL
.	NULL

Cells	NULL
were	NULL
maintained	NULL
at	NULL
37°C	NULL
and	NULL
5	NULL
%	NULL
CO	NULL
»	NULL
.	NULL

Cells	NULL
were	NULL
activated	NULL
either	NULL
by	NULL
treatment	NULL
with	NULL
5	NULL
ng/ml	NULL
PMA	NULL
and	NULL
500	NULL
ng/m	NULL
!	NULL

lonomycin	NULL
(	NULL
Sigma	NULL
)	NULL
or	NULL
by	NULL
treatment	NULL
with	NULL
anti-CD3	NULL
for	NULL
varying	NULL
periods	NULL
of	NULL
time	NULL
.	NULL

For	NULL
anti-CD3	NULL
treatment	NULL
,	NULL
96-well	NULL
plates	NULL
were	NULL
coated	NULL
with	NULL
100	NULL
l	NULL
5	NULL
ug/ml	NULL
anti-CD3	NULL
(	NULL
in	NULL
PBS	NULL
pH	NULL
9.0	NULL
)	NULL
overnight	NULL
and	NULL
washed	NULL
with	NULL
PBS	NULL
(	NULL
pH	NULL
7.0	NULL
)	NULL
before	NULL
use	NULL
.	NULL

Transfection	NULL
of	NULL
cell	NULL
lines	NULL
DO11.10	NULL
and	NULL
2B4.11	NULL
T	NULL
cell	NULL
hybridomas	NULL
were	NULL
stably	NULL
transfected	NULL
by	NULL
electroporation	NULL
.	NULL

An	NULL
aliquot	NULL
of	NULL
2	NULL
x	NULL
10°	NULL
cells	NULL
were	NULL
suspended	NULL
in	NULL
500	NULL
ul	NULL
of	NULL
RPMI	NULL
1640	NULL
media	NULL
(	NULL
Gibco	NULL
BRL	NULL
)	NULL
supplemented	NULL
with	NULL
MEM	NULL
NonEssential	NULL
Amino	NULL
Acids	NULL
(	NULL
Gibco	NULL
BRL	NULL
)	NULL
and	NULL
1	NULL
mM	NULL
MEM	NULL
Sodium	NULL
Pyruvate	NULL
(	NULL
Gibco	NULL
BRL	NULL
)	NULL
.	NULL

Using	NULL
0.4	NULL
cm	NULL
electroporation	NULL
cuvettes	NULL
(	NULL
Invitrogen	NULL
)	NULL
samples	NULL
were	NULL
electroporated	NULL
at	NULL
a	NULL
capacitance	NULL
of	NULL
960	NULL
uF	NULL
and	NULL
250	NULL
volts	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
pCl-neo	NULL
(	NULL
Promega	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
either	NULL
20	NULL
ug	NULL
of	NULL
pCMV4-IxB	NULL
«	NULL
§32/36A	NULL
or	NULL
20	NULL
ug	NULL
of	NULL
pCMV4-FLAG-IxBaS32/36A	NULL
(	NULL
gifts	NULL
of	NULL
D.	NULL
Ballard	NULL
,	NULL
Vanderbilt	NULL
University	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
removed	NULL
and	NULL
placed	NULL
into	NULL
5	NULL
ml	NULL
of	NULL
supplemented	NULL
DMEM	NULL
(	NULL
as	NULL
above	NULL
)	NULL
for	NULL
72	NULL
h	NULL
then	NULL
fed	NULL
with	NULL
G418	NULL
supplemented	NULL
DMEM	NULL
(	NULL
as	NULL
above	NULL
)	NULL
for	NULL
further	NULL
culture	NULL
.	NULL

After	NULL
several	NULL
days	NULL
clones	NULL
were	NULL
isolated	NULL
by	NULL
dilution	NULL
of	NULL
the	NULL
cells	NULL
and	NULL
plating	NULL
into	NULL
96	NULL
well	NULL
plates	NULL
,	NULL
then	NULL
visually	NULL
scanning	NULL
for	NULL
wells	NULL
that	NULL
contained	NULL
single	NULL
cells	NULL
which	NULL
were	NULL
then	NULL
cultured	NULL
.	NULL

Individual	NULL
colonies	NULL
were	NULL
grown	NULL
and	NULL
frozen	NULL
in	NULL
aliquots	NULL
before	NULL
use	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSA	NULL
)	NULL
Extracts	NULL
for	NULL
EMSA	NULL
were	NULL
prepared	NULL
from	NULL
10	NULL
``	NULL
cells	NULL
.	NULL

T	NULL
cell	NULL
hybridomas	NULL
were	NULL
initially	NULL
lysed	NULL
by	NULL
dounce	NULL
homogenization	NULL
in	NULL
buffer	NULL
A	NULL
(	NULL
10	NULL
mM	NULL
Tris	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
,	NULL
0.75	NULL
mM	NULL
spermine	NULL
,	NULL
0.15	NULL
mM	NULL
spermidine	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
0.1	NULL
mM	NULL
EGTA	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
10	NULL
mM	NULL
KCI	NULL
)	NULL
and	NULL
protease	NULL
inhibitors	NULL
{	NULL
100	NULL
mg/ml	NULL
PMSF	NULL
,	NULL
100	NULL
uM	NULL
leupeptin	NULL
,	NULL
10	NULL
uM	NULL
pepstatin	NULL
A	NULL
)	NULL
.	NULL

The	NULL
lysed	NULL
cells	NULL
were	NULL
spun	NULL
down	NULL
(	NULL
12000	NULL
x	NULL
g	NULL
,	NULL
10	NULL
min	NULL
,	NULL
4°C	NULL
)	NULL
and	NULL
the	NULL
supernatant	NULL
removed	NULL
.	NULL

The	NULL
nuclear	NULL
pellet	NULL
was	NULL
quickly	NULL
washed	NULL
in	NULL
1	NULL
ml	NULL
buffer	NULL
A	NULL
to	NULL
remove	NULL
residual	NULL
cytoplasmic	NULL
extract	NULL
,	NULL
spun	NULL
3	NULL
min	NULL
as	NULL
above	NULL
,	NULL
and	NULL
then	NULL
resuspended	NULL
in	NULL
50	NULL
ul	NULL
buffer	NULL
C	NULL
(	NULL
20	NULL
mM	NULL
Tris	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
,	NULL
0.75	NULL
mM	NULL
spermine	NULL
,	NULL
0.15	NULL
mM	NULL
spermidine	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
2	NULL
mM	NULL
EGTA	NULL
,	NULL
2	NULL
mM	NULL
DTT	NULL
,	NULL
20	NULL
%	NULL
glycerol	NULL
)	NULL
plus	NULL
protease	NULL
inhibitors	NULL
.	NULL

The	NULL
volume	NULL
was	NULL
measured	NULL
and	NULL
NaC	NULL
!	NULL

added	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
0.4	NULL
M	NULL
while	NULL
mixing	NULL
.	NULL

The	NULL
nuclei	NULL
were	NULL
extracted	NULL
on	NULL
ice	NULL
for	NULL
15	NULL
min	NULL
with	NULL
occasional	NULL
mixing	NULL
.	NULL

The	NULL
nuclei	NULL
were	NULL
then	NULL
pelleted	NULL
(	NULL
13	NULL
000	NULL
x	NULL
g	NULL
,	NULL
10	NULL
min	NULL
,	NULL
4°C	NULL
)	NULL
and	NULL
the	NULL
supernatant	NULL
was	NULL
removed	NULL
as	NULL
nuclear	NULL
extract	NULL
.	NULL

Nuclear	NULL
and	NULL
cytoplasmic	NULL
extracts	NULL
were	NULL
aliquoted	NULL
and	NULL
quick	NULL
frozen	NULL
using	NULL
dry	NULL
ice/ethano	NULL
!	NULL

l	NULL
bath	NULL
.	NULL

Protein	NULL
concentrations	NULL
were	NULL
measured	NULL
by	NULL
method	NULL
of	NULL
Bradford	NULL
with	NULL
Bio-Rad	NULL
dye	NULL
reagent	NULL
used	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

``	NULL
>	NULL
DNA	NULL
binding	NULL
reactions	NULL
were	NULL
performed	NULL
incubating	NULL
2-5	NULL
ug	NULL
of	NULL
nuclear	NULL
extract	NULL
with	NULL
0.5	NULL
ug	NULL
poly	NULL
(	NULL
dl-dC	NULL
)	NULL
in	NULL
binding	NULL
buffer	NULL
(	NULL
5	NULL
mM	NULL
Tris	NULL
[	NULL
pH	NULL
7.01	NULL
,	NULL
50	NULL
%	NULL
glycerol	NULL
,	NULL
0.5	NULL
mM	NULL
DTT	NULL
,	NULL
0.25	NULL
mM	NULL
EDTA	NULL
)	NULL
for	NULL
10	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Approximately	NULL
10000	NULL
c.p.m	NULL
.	NULL

of	NULL
°°P-labeled	NULL
DNA	NULL
probe	NULL
was	NULL
then	NULL
added	NULL
and	NULL
allowed	NULL
to	NULL
bind	NULL
for	NULL
30	NULL
min	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
then	NULL
loaded	NULL
onto	NULL
a	NULL
5	NULL
%	NULL
native	NULL
acrylamide	NULL
TGE	NULL
(	NULL
25	NULL
mM	NULL
Tris	NULL
,	NULL
190	NULL
mM	NULL
glycine	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
)	NULL
gel	NULL
.	NULL

After	NULL
gel	NULL
electrophoresis	NULL
,	NULL
the	NULL
gels	NULL
were	NULL
dried	NULL
and	NULL
data	NULL
visualized	NULL
by	NULL
Phosphor	NULL
Imager	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
:	NULL
A	NULL
contextual	NULL
regulator	NULL
of	NULL
apoptosis	NULL
B	NULL
Lin	NULL
et	NULL
al	NULL
DNA	NULL
probes	NULL
and	NULL
unlabeled	NULL
competitors	NULL
were	NULL
prepared	NULL
by	NULL
annealing	NULL
oligonucleotides	NULL
and	NULL
performing	NULL
fill-in	NULL
reactions	NULL
with	NULL
the	NULL
Klenow	NULL
fragment	NULL
of	NULL
DNA	NULL
polymerase	NULL
|	NULL
(	NULL
GIBCO	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
and	NULL
as	NULL
described	NULL
.	NULL
``	NULL

''	NULL
Our	NULL
NF-xB	NULL
probe	NULL
derived	NULL
from	NULL
the	NULL
FasL	NULL
gene	NULL
including	NULL
the	NULL
putative	NULL
NF-xB	NULL
site	NULL
is	NULL
CAGAAAATTGTGGGCGGAAACTTCCAGGGGTTTCGTC	NULL
and	NULL
corresponds	NULL
to	NULL
the	NULL
region	NULL
spanning	NULL
from	NULL
-291	NULL
to	NULL
-259	NULL
relative	NULL
to	NULL
the	NULL
translation	NULL
start	NULL
site	NULL
.	NULL
``	NULL

''	NULL
The	NULL
NF-xB	NULL
binding	NULL
site	NULL
competitor	NULL
is	NULL
derived	NULL
from	NULL
the	NULL
region	NULL
|	NULL
enhancer	NULL
of	NULL
the	NULL
H-2K	NULL
``	NULL
gene	NULL
with	NULL
the	NULL
sequence	NULL
CAGGGCTGGGGATTCCCCATCTCCACAGTTTCACTTC	NULL
.	NULL

A	NULL
double	NULL
point	NULL
mutant	NULL
of	NULL
this	NULL
site	NULL
has	NULL
the	NULL
sequence	NULL
CAGGGCTGC-GGATTCCCG	NULL
@	NULL
ATCTCCACAGTTTCACTTC.S°	NULL
Mutated	NULL
bases	NULL
are	NULL
in	NULL
bold	NULL
and	NULL
underlined	NULL
.	NULL

Western	NULL
blots	NULL
Cytoplasmic	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
above	NULL
.	NULL

A	NULL
volume	NULL
of	NULL
extract	NULL
corresponding	NULL
to	NULL
20	NULL
ug	NULL
protein	NULL
was	NULL
size	NULL
separated	NULL
by	NULL
sodium	NULL
dodecy	NULL
!	NULL

sulfate-10	NULL
%	NULL
polyacrylamide	NULL
ge	NULL
!	NULL

electrophoresis	NULL
(	NULL
SDS-PAGE	NULL
)	NULL
and	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
by	NULL
electro-blotting	NULL
in	NULL
25	NULL
mM	NULL
Tris	NULL
base	NULL
,	NULL
0.2	NULL
M	NULL
glycine	NULL
,	NULL
20	NULL
%	NULL
methanol	NULL
at	NULL
100V	NULL
for	NULL
1	NULL
h	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
nitrocellulose	NULL
blot	NULL
was	NULL
blocked	NULL
for	NULL
1	NULL
to	NULL
2	NULL
h	NULL
in	NULL
TBST	NULL
(	NULL
10	NULL
mM	NULL
Tris	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
0.05	NULL
%	NULL
Tween	NULL
20	NULL
)	NULL
plus	NULL
10	NULL
%	NULL
dried	NULL
milk	NULL
.	NULL

FLAG-probe	NULL
(	NULL
D8	NULL
)	NULL
antibody	NULL
(	NULL
Santa	NULL
Cruz	NULL
)	NULL
was	NULL
diluted	NULL
1:2,000	NULL
in	NULL
TBST	NULL
plus	NULL
10	NULL
%	NULL
dried	NULL
milk	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
with	NULL
gentle	NULL
shaking	NULL
.	NULL

The	NULL
blot	NULL
was	NULL
washed	NULL
five	NULL
times	NULL
for	NULL
5	NULL
min	NULL
each	NULL
in	NULL
TBST	NULL
.	NULL

An	NULL
HRP	NULL
conjugated	NULL
anti-rabbit	NULL
IgG	NULL
antibody	NULL
(	NULL
Promega	NULL
)	NULL
was	NULL
diluted	NULL
1	NULL
:	NULL
10000	NULL
in	NULL
TBST	NULL
plus	NULL
10	NULL
%	NULL
dried	NULL
milk	NULL
and	NULL
the	NULL
blot	NULL
incubated	NULL
with	NULL
this	NULL
secondary	NULL
antibody	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
with	NULL
gentle	NULL
shaking	NULL
.	NULL

The	NULL
blot	NULL
was	NULL
washed	NULL
five	NULL
times	NULL
as	NULL
described	NULL
above	NULL
.	NULL

The	NULL
secondary	NULL
antibody	NULL
was	NULL
visualized	NULL
by	NULL
electrochemiluminescence	NULL
(	NULL
ECL	NULL
,	NULL
Amersham	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturers	NULL
instructions	NULL
and	NULL
recorded	NULL
on	NULL
Kodak	NULL
XARS	NULL
film	NULL
.	NULL

Extraction	NULL
and	NULL
purification	NULL
of	NULL
RNA	NULL
and	NULL
RT-PCR	NULL
Total	NULL
RNA	NULL
was	NULL
prepared	NULL
by	NULL
the	NULL
acidified	NULL
phenol	NULL
method	NULL
as	NULL
described	NULL
.	NULL
``	NULL

The	NULL
mRNA	NULL
was	NULL
converted	NULL
to	NULL
cDNA	NULL
utilizing	NULL
SuperScript	NULL
II	NULL
RT	NULL
(	NULL
Gibco	NULL
BRL	NULL
)	NULL
with	NULL
oligo	NULL
dT	NULL
(	NULL
Gibco	NULL
)	NULL
as	NULL
the	NULL
primer	NULL
as	NULL
directed	NULL
by	NULL
the	NULL
manufacturer	NULL
.	NULL

Two	NULL
ul	NULL
of	NULL
the	NULL
cDNA	NULL
was	NULL
used	NULL
as	NULL
template	NULL
for	NULL
PCR	NULL
using	NULL
primers	NULL
for	NULL
mouse	NULL
FasL	NULL
:	NULL
TTCTGGGTAGACAGCAGTGC-CACTTCATC	NULL
and	NULL
CAGTTTCGTTGATCACAAGGCCACCTTTC	NULL
or	NULL
$	NULL
-actin	NULL
:	NULL
5	NULL
GATGCATTGTTACAGGAAGT	NULL
and	NULL
3	NULL
'	NULL
TCATACATOCT-CAAGTTGGGGG	NULL
.	NULL

Reaction	NULL
conditions	NULL
for	NULL
FasL	NULL
amplification	NULL
were	NULL
35	NULL
cycles	NULL
of	NULL
,	NULL
melting	NULL
at	NULL
94°	NULL
for	NULL
30	NULL
s	NULL
,	NULL
annealing	NULL
at	NULL
65°	NULL
for	NULL
30	NULL
s	NULL
,	NULL
and	NULL
extension	NULL
at	NULL
72°	NULL
for	NULL
45	NULL
s.	NULL
Reaction	NULL
conditions	NULL
for	NULL
B-actin	NULL
amplification	NULL
were	NULL
12	NULL
cycles	NULL
of	NULL
melting	NULL
at	NULL
94°	NULL
for	NULL
30	NULL
s	NULL
,	NULL
annealing	NULL
at	NULL
48°	NULL
for	NULL
30	NULL
s	NULL
,	NULL
and	NULL
extension	NULL
at	NULL
72°	NULL
for	NULL
45	NULL
s.	NULL
PCR	NULL
products	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
1	NULL
%	NULL
agarose	NULL
gel	NULL
with	NULL
ethidium	NULL
bromide	NULL
and	NULL
visualized	NULL
with	NULL
UV	NULL
and	NULL
recorded	NULL
by	NULL
Polaroid	NULL
and	NULL
scanned	NULL
.	NULL

Apoptosis	NULL
and	NULL
cell	NULL
viability	NULL
assays	NULL
Apoptosis	NULL
was	NULL
assayed	NULL
using	NULL
the	NULL
acridine	NULL
orange/ethidium	NULL
bromide	NULL
double	NULL
dye	NULL
technique	NULL
.	NULL
``	NULL

'	NULL
Sample	NULL
cells	NULL
were	NULL
spun	NULL
down	NULL
(	NULL
900	NULL
x	NULL
g	NULL
,	NULL
5	NULL
min	NULL
)	NULL
and	NULL
washed	NULL
with	NULL
PBS	NULL
.	NULL

Two	NULL
ul	NULL
of	NULL
dye	NULL
mix	NULL
(	NULL
100	NULL
ug/im|	NULL
acridine	NULL
orange	NULL
(	NULL
Sigma	NULL
)	NULL
+100	NULL
ug/m|	NULL
ethidium	NULL
bromide	NULL
in	NULL
PBS	NULL
)	NULL
was	NULL
placed	NULL
in	NULL
the	NULL
bottom	NULL
of	NULL
a	NULL
12	NULL
x	NULL
75-mm	NULL
glass	NULL
tube	NULL
and	NULL
25	NULL
ul	NULL
of	NULL
cell	NULL
suspension	NULL
was	NULL
added	NULL
to	NULL
the	NULL
tube	NULL
and	NULL
mixed	NULL
by	NULL
hand	NULL
.	NULL

Ten	NULL
ul	NULL
of	NULL
this	NULL
mixture	NULL
was	NULL
placed	NULL
on	NULL
a	NULL
microscope	NULL
slide	NULL
and	NULL
covered	NULL
with	NULL
a	NULL
22-mm	NULL
``	NULL
cover	NULL
slip	NULL
.	NULL

Samples	NULL
were	NULL
examined	NULL
with	NULL
a	NULL
40x	NULL
dry	NULL
objective	NULL
using	NULL
epi-illumination	NULL
and	NULL
a	NULL
filter	NULL
combination	NULL
suitable	NULL
for	NULL
observing	NULL
579	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
A	NULL
contextual	NULL
regulator	NULL
of	NULL
apoptosis	NULL
B	NULL
Lin	NULL
et	NULL
al	NULL
580	NULL
fluorescein	NULL
.	NULL

One	NULL
hundred	NULL
cells	NULL
were	NULL
counted	NULL
per	NULL
sample	NULL
and	NULL
the	NULL
number	NULL
of	NULL
cells	NULL
in	NULL
each	NULL
of	NULL
the	NULL
following	NULL
four	NULL
states	NULL
was	NULL
recorded	NULL
:	NULL
VN	NULL
viable	NULL
normal	NULL
(	NULL
bright	NULL
green	NULL
chromatin	NULL
with	NULL
organized	NULL
structure	NULL
)	NULL
,	NULL
VA-viable	NULL
apoptotic	NULL
(	NULL
bright	NULL
green	NULL
chromatin	NULL
that	NULL
is	NULL
condensed	NULL
or	NULL
fragmented	NULL
)	NULL
,	NULL
NVN-non-viable	NULL
normal	NULL
cells	NULL
(	NULL
bright	NULL
orange	NULL
chromatin	NULL
with	NULL
organized	NULL
structure	NULL
)	NULL
,	NULL
NVA-non-viable	NULL
apoptotic	NULL
(	NULL
bright	NULL
orange	NULL
chromatin	NULL
that	NULL
is	NULL
condensed	NULL
or	NULL
fragmented	NULL
)	NULL
.	NULL

Per	NULL
cent	NULL
apoptosis	NULL
was	NULL
then	NULL
calculated	NULL
using	NULL
the	NULL
following	NULL
formula	NULL
:	NULL
VA+NVA/100=	NULL
%	NULL
apoptosis	NULL
.	NULL

Cell	NULL
viability	NULL
was	NULL
assayed	NULL
using	NULL
trypan	NULL
blue	NULL
exclusion	NULL
.	NULL

A	NULL
100	NULL
ul	NULL
aliquot	NULL
of	NULL
cells	NULL
was	NULL
taken	NULL
and	NULL
mixed	NULL
with	NULL
100	NULL
pl	NULL
of	NULL
trypan	NULL
blue	NULL
solution	NULL
(	NULL
0.1	NULL
%	NULL
in	NULL
PBS	NULL
)	NULL
.	NULL

A	NULL
10	NULL
ul	NULL
aliquot	NULL
was	NULL
placed	NULL
on	NULL
a	NULL
hemocytometer	NULL
and	NULL
number	NULL
of	NULL
viable	NULL
cells	NULL
(	NULL
clear	NULL
)	NULL
and	NULL
non-viable	NULL
cells	NULL
(	NULL
dark	NULL
blue	NULL
)	NULL
were	NULL
counted	NULL
.	NULL

Results	NULL
were	NULL
expressed	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
cells	NULL
counted	NULL
.	NULL

©	NULL
``	NULL
Chromium	NULL
labeling	NULL
and	NULL
release	NULL
assay	NULL
Fas	NULL
expressing	NULL
L1210-Fas	NULL
cells	NULL
to	NULL
be	NULL
used	NULL
as	NULL
targets	NULL
in	NULL
``	NULL
'Cr	NULL
release	NULL
assays	NULL
were	NULL
suspended	NULL
at	NULL
1-5	NULL
x	NULL
10°	NULL
in	NULL
100	NULL
ul	NULL
of	NULL
RPMI	NULL
1640	NULL
medium	NULL
with	NULL
5	NULL
%	NULL
heat	NULL
inactivated	NULL
FBS	NULL
(	NULL
R5	NULL
)	NULL
to	NULL
which	NULL
100	NULL
uCi	NULL
of	NULL
``	NULL
'Cr	NULL
in	NULL
R5	NULL
were	NULL
added	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
incubated	NULL
for	NULL
90	NULL
min	NULL
at	NULL
37°C	NULL
,	NULL
washed	NULL
twice	NULL
in	NULL
R5	NULL
,	NULL
resuspended	NULL
in	NULL
10	NULL
ml	NULL
of	NULL
R5	NULL
,	NULL
and	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
30	NULL
min	NULL
.	NULL

They	NULL
were	NULL
washed	NULL
once	NULL
more	NULL
,	NULL
resuspended	NULL
in	NULL
R5	NULL
,	NULL
and	NULL
counted	NULL
.	NULL

The	NULL
labeled	NULL
cells	NULL
(	NULL
10	NULL
%	NULL
in	NULL
100	NULL
p	NULL
!	NULL
)	NULL

were	NULL
placed	NULL
in	NULL
individual	NULL
wells	NULL
of	NULL
96-well	NULL
V-bottomed	NULL
microtiter	NULL
plates	NULL
that	NULL
contained	NULL
various	NULL
concentrations	NULL
of	NULL
effector	NULL
cells	NULL
in	NULL
triplicate	NULL
in	NULL
100	NULL
ul	NULL
of	NULL
R5	NULL
.	NULL

The	NULL
plates	NULL
were	NULL
centrifuged	NULL
(	NULL
50	NULL
x	NULL
g	NULL
;	NULL
5	NULL
min	NULL
)	NULL
to	NULL
establish	NULL
cell	NULL
contact	NULL
and	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
18	NULL
h	NULL
prior	NULL
to	NULL
harvest	NULL
.	NULL

At	NULL
the	NULL
end	NULL
of	NULL
the	NULL
incubation	NULL
period	NULL
,	NULL
the	NULL
plates	NULL
were	NULL
centrifuged	NULL
at	NULL
100	NULL
x	NULL
g	NULL
for	NULL
10	NULL
min	NULL
and	NULL
100	NULL
l	NULL
of	NULL
cell-free	NULL
supernatant	NULL
was	NULL
collected	NULL
from	NULL
each	NULL
well	NULL
.	NULL

Radioactivity	NULL
in	NULL
supernatants	NULL
were	NULL
measured	NULL
in	NULL
a	NULL
gamma	NULL
counter	NULL
.	NULL

Per	NULL
cent	NULL
specific	NULL
release	NULL
was	NULL
calculated	NULL
by	NULL
the	NULL
following	NULL
formula	NULL
:	NULL
C.P-M-.exp	NULL
-	NULL
C-P-M-spont	NULL
C.P-Mmax	NULL
-	NULL
S-P-M-spont	NULL
%	NULL
specific	NULL
release	NULL
=	NULL
x	NULL
100	NULL
Maximal	NULL
release	NULL
was	NULL
determined	NULL
from	NULL
supernatants	NULL
of	NULL
cells	NULL
that	NULL
were	NULL
subjected	NULL
to	NULL
1	NULL
%	NULL
Triton-X	NULL
.	NULL

Spontaneous	NULL
release	NULL
(	NULL
C.P-M-spon	NULL
;	NULL
)	NULL
Was	NULL
determined	NULL
from	NULL
target	NULL
cells	NULL
incubated	NULL
without	NULL
added	NULL
effector	NULL
cells	NULL
.	NULL
``	NULL

Acknowledgements	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
through	NULL
grants	NULL
to	NULL
RIS	NULL
from	NULL
the	NULL
Arthritis	NULL
Foundation	NULL
,	NULL
the	NULL
Cancer	NULL
League	NULL
of	NULL
Colorado	NULL
,	NULL
the	NULL
Burroughs	NULL
Wellcome	NULL
Fund	NULL
,	NULL
the	NULL
American	NULL
Association	NULL
of	NULL
Colleges	NULL
of	NULL
Pharmacy	NULL
,	NULL
the	NULL
Lupus	NULL
Foundation	NULL
of	NULL
America	NULL
,	NULL
and	NULL
the	NULL
Colorado	NULL
Advanced	NULL
Technology	NULL
Institute	NULL
.	NULL

RCD	NULL
is	NULL
supported	NULL
by	NULL
USPHS-NIH	NULL
grants	NULL
Al40394	NULL
,	NULL
Al40607	NULL
,	NULL
and	NULL
CA46934	NULL
.	NULL

References	NULL
1	NULL
.	NULL

SprentJ	NULL
,	NULL
Lo	NULL
D	NULL
,	NULL
Gao	NULL
EK	NULL
and	NULL
Ron	NULL
Y	NULL
(	NULL
1988	NULL
)	NULL
T	NULL
cell	NULL
selection	NULL
in	NULL
the	NULL
thymus	NULL
.	NULL

Immunol	NULL
.	NULL

Rev	NULL
.	NULL

101	NULL
:	NULL
172-190	NULL
.	NULL

2	NULL
.	NULL

Kabelitz	NULL
D	NULL
,	NULL
Pohl	NULL
T	NULL
and	NULL
Pechhold	NULL
K	NULL
(	NULL
1993	NULL
)	NULL
Activation-induced	NULL
cell	NULL
death	NULL
(	NULL
apoptosis	NULL
)	NULL
of	NULL
mature	NULL
peripheral	NULL
T	NULL
lymphocytes	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
14	NULL
:	NULL
338-339	NULL
.	NULL

3	NULL
.	NULL

Ashwell	NULL
JD	NULL
,	NULL
Longo	NULL
DL	NULL
and	NULL
Bridges	NULL
SH	NULL
(	NULL
1987	NULL
)	NULL
T-cell	NULL
tumor	NULL
elimination	NULL
as	NULL
a	NULL
result	NULL
of	NULL
T-cell	NULL
receptor-mediated	NULL
activation	NULL
.	NULL

Science	NULL
237	NULL
:	NULL
61-64	NULL
.	NULL

4	NULL
.	NULL

Mercep	NULL
M	NULL
,	NULL
Bluestone	NULL
JA	NULL
,	NULL
Noguchi	NULL
PD	NULL
and	NULL
Ashwell	NULL
JD	NULL
(	NULL
1988	NULL
)	NULL
Inhibition	NULL
of	NULL
transformed	NULL
T	NULL
cell	NULL
growth	NULL
in	NULL
Vitro	NULL
by	NULL
Monoclonal	NULL
Antibodies	NULL
Directed	NULL
against	NULL
Distinct	NULL
Activating	NULL
Molecules	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

140	NULL
:	NULL
324-335	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30.	NULL
.	NULL

Shi	NULL
Y	NULL
,	NULL
Sahai	NULL
BM	NULL
and	NULL
Green	NULL
DR	NULL
(	NULL
1989	NULL
)	NULL
Cyclosporin	NULL
A	NULL
inhibits	NULL
activation-induced	NULL
cell	NULL
death	NULL
in	NULL
T-cell	NULL
hybridomas	NULL
and	NULL
thymocytes	NULL
.	NULL

Nature	NULL
339	NULL
:	NULL
625-626.	NULL
.	NULL

Ucker	NULL
DS	NULL
,	NULL
Ashwel1	NULL
JD	NULL
and	NULL
Nickas	NULL
G	NULL
(	NULL
1989	NULL
)	NULL
Activation-induced	NULL
T	NULL
Cell	NULL
Death	NULL
I	NULL
.	NULL

Requirements	NULL
for	NULL
de	NULL
Novo	NULL
Transcription	NULL
and	NULL
Translation	NULL
and	NULL
Association	NULL
with	NULL
Genome	NULL
Fragmentation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

143	NULL
:	NULL
3461-3469.	NULL
.	NULL

Shi	NULL
YF	NULL
,	NULL
Szalay	NULL
MG	NULL
,	NULL
Paskar	NULL
L	NULL
,	NULL
Sahai	NULL
BM	NULL
,	NULL
Boyer	NULL
M	NULL
,	NULL
Singh	NULL
B	NULL
and	NULL
Green	NULL
DR	NULL
(	NULL
1990	NULL
)	NULL
Activation-Induced	NULL
Cell	NULL
Death	NULL
in	NULL
T	NULL
Cell	NULL
Hybridomas	NULL
is	NULL
Due	NULL
to	NULL
Apoptosis	NULL
.	NULL

Morphologic	NULL
aspects	NULL
and	NULL
DNA	NULL
fragmentation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

144	NULL
:	NULL
3326-3333.	NULL
.	NULL

Zacharchuk	NULL
CM	NULL
,	NULL
Mercep	NULL
M	NULL
and	NULL
Ashwell	NULL
JD	NULL
(	NULL
1990	NULL
)	NULL
Programmed	NULL
T	NULL
lymphocyte	NULL
death	NULL
:	NULL
cell	NULL
activation-	NULL
and	NULL
steroid-induced	NULL
pathways	NULL
are	NULL
mutually	NULL
antagonistic	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

145	NULL
:	NULL
4037-4045.	NULL
.	NULL

Iwata	NULL
M	NULL
,	NULL
Hanaoka	NULL
S	NULL
and	NULL
Sato	NULL
K	NULL
(	NULL
1991	NULL
)	NULL
Rescue	NULL
of	NULL
thymocytes	NULL
and	NULL
T	NULL
cell	NULL
hybridomas	NULL
from	NULL
glucocorticoid-induced	NULL
apoptosis	NULL
by	NULL
stimulation	NULL
via	NULL
the	NULL
T	NULL
cell	NULL
receptor/CD3	NULL
complex	NULL
:	NULL
a	NULL
possible	NULL
in	NULL
vitro	NULL
model	NULL
for	NULL
positive	NULL
selection	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
repertoire	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

21	NULL
:	NULL
643-648	NULL
.	NULL

Vacchio	NULL
MS	NULL
,	NULL
Papadopoulos	NULL
V	NULL
and	NULL
Ashwell	NULL
JD	NULL
(	NULL
1994	NULL
)	NULL
Steroid	NULL
production	NULL
in	NULL
the	NULL
thymus	NULL
:	NULL
implications	NULL
for	NULL
thymocyte	NULL
development	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

179	NULL
:	NULL
1835-1846	NULL
.	NULL

King	NULL
LB	NULL
,	NULL
Vacchio	NULL
MS	NULL
,	NULL
Hunziker	NULL
R	NULL
,	NULL
Margulies	NULL
DH	NULL
and	NULL
Ashwell	NULL
JD	NULL
(	NULL
1995	NULL
)	NULL
A	NULL
targeted	NULL
glucocorticoid	NULL
receptor	NULL
antisense	NULL
transgene	NULL
increases	NULL
thymocyte	NULL
apoptosis	NULL
and	NULL
alters	NULL
thymocyte	NULL
development	NULL
.	NULL

Immunity	NULL
5	NULL
:	NULL
647-656	NULL
.	NULL

Yang	NULL
Y	NULL
,	NULL
Mercep	NULL
M	NULL
,	NULL
Ware	NULL
CF	NULL
and	NULL
Ashwell	NULL
JD	NULL
(	NULL
1995	NULL
)	NULL
Fas	NULL
and	NULL
Activation-induced	NULL
Fas	NULL
Ligand	NULL
Mediate	NULL
Apoptosis	NULL
of	NULL
T	NULL
Cell	NULL
Hybridomas	NULL
:	NULL
Inhibition	NULL
of	NULL
Fas	NULL
Ligand	NULL
Expression	NULL
by	NULL
Retinoic	NULL
Acid	NULL
and	NULL
Glucocorticoids	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

181	NULL
:	NULL
1673-1682	NULL
.	NULL

Russell	NULL
JH	NULL
,	NULL
Rush	NULL
B	NULL
,	NULL
Weaver	NULL
C	NULL
and	NULL
Wang	NULL
R	NULL
(	NULL
1993	NULL
)	NULL
Mature	NULL
T	NULL
cells	NULL
of	NULL
autoimmune	NULL
Ipr/lpr	NULL
mice	NULL
have	NULL
a	NULL
defect	NULL
in	NULL
antigen-stimulated	NULL
suicide	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90	NULL
:	NULL
4409-4413	NULL
.	NULL

Russell	NULL
JH	NULL
and	NULL
Wang	NULL
R	NULL
(	NULL
1993	NULL
)	NULL
Autoimmune	NULL
gid	NULL
mutation	NULL
uncouples	NULL
suicide	NULL
and	NULL
cytokine/proliferation	NULL
pathways	NULL
in	NULL
activated	NULL
mature	NULL
T	NULL
cells	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

23	NULL
:	NULL
2379-2382	NULL
.	NULL

Nagata	NULL
S	NULL
and	NULL
Golstein	NULL
P	NULL
(	NULL
1995	NULL
)	NULL
The	NULL
Fas	NULL
death	NULL
factor	NULL
.	NULL

Science	NULL
267	NULL
:	NULL
1449-1456	NULL
.	NULL

Dhein	NULL
J	NULL
,	NULL
Walczak	NULL
H	NULL
,	NULL
Baumler	NULL
C	NULL
,	NULL
Debatin	NULL
KM	NULL
and	NULL
Krammer	NULL
PH	NULL
(	NULL
1995	NULL
)	NULL
Autocrine	NULL
T	NULL
cell	NULL
suicide	NULL
mediated	NULL
by	NULL
APO-1	NULL
(	NULL
Fas/CD95	NULL
)	NULL
.	NULL

Nature	NULL
373	NULL
:	NULL
438-441	NULL
.	NULL

Brunner	NULL
T	NULL
,	NULL
Mogil	NULL
RJ	NULL
,	NULL
LaFace	NULL
D	NULL
,	NULL
Yoo	NULL
NJ	NULL
,	NULL
Mahoubl	NULL
A	NULL
,	NULL
Echeverri	NULL
F	NULL
,	NULL
Martin	NULL
SJ	NULL
,	NULL
Force	NULL
WR	NULL
,	NULL
Lynch	NULL
DH	NULL
,	NULL
Ware	NULL
CF	NULL
and	NULL
Green	NULL
DR	NULL
(	NULL
1995	NULL
)	NULL
Cell-autonomous	NULL
Fas	NULL
(	NULL
CD95	NULL
)	NULL
/Fas-ligand	NULL
interaction	NULL
mediates	NULL
activation-induced	NULL
apoptosis	NULL
in	NULL
T-cell	NULL
hybridomas	NULL
.	NULL

Nature	NULL
373	NULL
:	NULL
441-444	NULL
.	NULL

Ju	NULL
S-T	NULL
,	NULL
Panka	NULL
DJ	NULL
,	NULL
Cul	NULL
H	NULL
,	NULL
Ettinger	NULL
R	NULL
,	NULL
El	NULL
Khatib	NULL
M	NULL
,	NULL
Sheh	NULL
DH	NULL
,	NULL
Stanger	NULL
BZ	NULL
and	NULL
Marshak-Rothstein	NULL
A	NULL
(	NULL
1995	NULL
)	NULL
Fas	NULL
(	NULL
CD95	NULL
)	NULL
/FasL	NULL
interactions	NULL
required	NULL
for	NULL
programmed	NULL
cell	NULL
death	NULL
after	NULL
T-cell	NULL
activation	NULL
.	NULL

Nature	NULL
373	NULL
:	NULL
444-448	NULL
.	NULL

Chinnaiyan	NULL
AM	NULL
and	NULL
Dixit	NULL
VM	NULL
(	NULL
1996	NULL
)	NULL
The	NULL
Cell-Death	NULL
Machine	NULL
.	NULL

Current	NULL
Biology	NULL
6	NULL
:	NULL
555-562	NULL
.	NULL

Peter	NULL
ME	NULL
,	NULL
Heufelder	NULL
AE	NULL
and	NULL
Hengartner	NULL
MO	NULL
(	NULL
1997	NULL
)	NULL
Advances	NULL
in	NULL
Apoptosis	NULL
Research	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94	NULL
;	NULL
12736-12737	NULL
.	NULL

Nagata	NULL
S	NULL
(	NULL
1997	NULL
)	NULL
Apoptosis	NULL
by	NULL
Death	NULL
Factor	NULL
.	NULL

Cell	NULL
88	NULL
:	NULL
355-365	NULL
.	NULL

Boldin	NULL
MP	NULL
,	NULL
Varfolomeev	NULL
EE	NULL
,	NULL
Pancer	NULL
Z	NULL
,	NULL
Mett	NULL
IL	NULL
,	NULL
Camonis	NULL
JH	NULL
and	NULL
Wallach	NULL
D	NULL
(	NULL
1995	NULL
)	NULL
A	NULL
novel	NULL
protein	NULL
that	NULL
interacts	NULL
with	NULL
the	NULL
death	NULL
domain	NULL
of	NULL
Fas/APO1	NULL
contains	NULL
a	NULL
sequence	NULL
motif	NULL
related	NULL
to	NULL
the	NULL
death	NULL
domain	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
:	NULL
7795-7798	NULL
.	NULL

Chinnaiyan	NULL
AM	NULL
,	NULL
O'Rourke	NULL
K	NULL
,	NULL
Tewari	NULL
M	NULL
and	NULL
Dixit	NULL
VM	NULL
(	NULL
1995	NULL
)	NULL
FADD	NULL
,	NULL
a	NULL
novel	NULL
death	NULL
domain-containing	NULL
protein	NULL
,	NULL
interacts	NULL
with	NULL
the	NULL
death	NULL
domain	NULL
of	NULL
Fas	NULL
and	NULL
initiates	NULL
apoptosis	NULL
.	NULL

Cell	NULL
.	NULL

81	NULL
:	NULL
505-512	NULL
.	NULL

Boldin	NULL
MP	NULL
,	NULL
Goncharov	NULL
TM	NULL
,	NULL
Goltsev	NULL
YV	NULL
,	NULL
Wallach	NULL
D	NULL
(	NULL
1996	NULL
)	NULL
Involvement	NULL
of	NULL
MACH	NULL
,	NULL
a	NULL
novel	NULL
MORTA1/FADD-interacting	NULL
protease	NULL
,	NULL
in	NULL
Fas/APO-1-	NULL
and	NULL
TNF	NULL
receptor-induced	NULL
cell	NULL
death	NULL
.	NULL

Cell	NULL
.	NULL

85	NULL
:	NULL
803-815	NULL
.	NULL

Muzio	NULL
M	NULL
,	NULL
Chinnaiyan	NULL
AM	NULL
,	NULL
Kischkel	NULL
FC	NULL
,	NULL
O'Rourke	NULL
K	NULL
,	NULL
Shevchenko	NULL
A	NULL
,	NULL
Ni	NULL
J	NULL
,	NULL
Scatffidi	NULL
C	NULL
,	NULL
Bretz	NULL
JD	NULL
,	NULL
Zhang	NULL
M	NULL
,	NULL
Gentz	NULL
R	NULL
,	NULL
Mann	NULL
M	NULL
,	NULL
Krammer	NULL
PH	NULL
,	NULL
Peter	NULL
ME	NULL
,	NULL
Dixit	NULL
VM	NULL
(	NULL
1996	NULL
)	NULL
FLICE	NULL
,	NULL
a	NULL
novel	NULL
FADD-homologous	NULL
ICE/CED-3-like	NULL
protease	NULL
,	NULL
is	NULL
recruited	NULL
to	NULL
the	NULL
CD95	NULL
(	NULL
Fas/APO-1	NULL
)	NULL
death-	NULL
inducing	NULL
signaling	NULL
complex	NULL
.	NULL

Cell	NULL
85	NULL
:	NULL
817-827	NULL
.	NULL

Hsu	NULL
H	NULL
,	NULL
Xiong	NULL
J	NULL
and	NULL
Goeddel	NULL
DV	NULL
(	NULL
1995	NULL
)	NULL
The	NULL
TNF	NULL
receptor	NULL
1-associated	NULL
protein	NULL
TRADD	NULL
signals	NULL
cell	NULL
death	NULL
and	NULL
NF-kappa	NULL
B	NULL
activation	NULL
.	NULL

Cell	NULL
81	NULL
:	NULL
495-504	NULL
.	NULL

Stanger	NULL
BZ	NULL
,	NULL
Leder	NULL
P	NULL
,	NULL
Lee	NULL
TH	NULL
,	NULL
Kim	NULL
E	NULL
and	NULL
Seed	NULL
B	NULL
(	NULL
1995	NULL
)	NULL
RIP	NULL
:	NULL
a	NULL
novel	NULL
protein	NULL
containing	NULL
a	NULL
death	NULL
domain	NULL
that	NULL
interacts	NULL
with	NULL
Fas/APO-1	NULL
(	NULL
CD95	NULL
)	NULL
in	NULL
yeast	NULL
and	NULL
causes	NULL
cell	NULL
death	NULL
.	NULL

Cell	NULL
.	NULL

81	NULL
:	NULL
513-523	NULL
.	NULL

Hsu	NULL
H	NULL
,	NULL
Shu	NULL
HB	NULL
,	NULL
Pan	NULL
MG	NULL
and	NULL
Goeddel	NULL
DV	NULL
(	NULL
1996	NULL
)	NULL
TRADD-TRAF2	NULL
and	NULL
TRADD-FADD	NULL
interactions	NULL
define	NULL
two	NULL
distinct	NULL
TNF	NULL
receptor	NULL
1	NULL
signal	NULL
transduction	NULL
pathways	NULL
.	NULL

Cell	NULL
84	NULL
:	NULL
299-308	NULL
.	NULL

Rothe	NULL
M	NULL
,	NULL
Wong	NULL
SC	NULL
,	NULL
Henzel	NULL
WJ	NULL
and	NULL
Goeddel	NULL
DV	NULL
(	NULL
1994	NULL
)	NULL
A	NULL
novel	NULL
family	NULL
of	NULL
putative	NULL
signal	NULL
transducers	NULL
associated	NULL
with	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
the	NULL
75	NULL
kDa	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor	NULL
.	NULL

Cell	NULL
78	NULL
:	NULL
681-692	NULL
.	NULL

Baeuerle	NULL
PA	NULL
and	NULL
Henkel	NULL
T	NULL
(	NULL
1994	NULL
)	NULL
Function	NULL
and	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12	NULL
:	NULL
141-179	NULL
.	NULL

31	NULL
.	NULL

Ca	NULL
32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

Baldwin	NULL
Jr	NULL
AS	NULL
(	NULL
1996	NULL
)	NULL
The	NULL
NF-kappa	NULL
B	NULL
and	NULL
|	NULL
kappa	NULL
B	NULL
proteins	NULL
:	NULL
new	NULL
discoveries	NULL
and	NULL
insights	NULL
.	NULL

Annual	NULL
Review	NULL
of	NULL
Immunology	NULL
.	NULL

14	NULL
:	NULL
649-683	NULL
.	NULL

Kunsch	NULL
C	NULL
,	NULL
Ruben	NULL
SM	NULL
,	NULL
Rosen	NULL
CA	NULL
(	NULL
1992	NULL
)	NULL
Selection	NULL
of	NULL
optimal	NULL
kappa	NULL
B/Re	NULL
!	NULL

DNA-binding	NULL
motifs	NULL
:	NULL
interaction	NULL
of	NULL
both	NULL
subunits	NULL
of	NULL
NF-kappaB	NULL
with	NULL
DNA	NULL
is	NULL
required	NULL
for	NULL
transcriptional	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
:	NULL
4412-4421	NULL
.	NULL

Mercurio	NULL
F	NULL
,	NULL
Zhu	NULL
H	NULL
,	NULL
Murray	NULL
BW	NULL
,	NULL
Shevchenko	NULL
A	NULL
,	NULL
Bennett	NULL
BL	NULL
,	NULL
Li	NULL
J	NULL
,	NULL
Young	NULL
DB	NULL
,	NULL
Barbosa	NULL
M	NULL
,	NULL
Mann	NULL
M	NULL
,	NULL
Manning	NULL
A	NULL
and	NULL
Rao	NULL
A	NULL
(	NULL
1997	NULL
)	NULL
IKK-1	NULL
and	NULL
IKK-2	NULL
:	NULL
cytokine-activated	NULL
IkappaB	NULL
kinases	NULL
essential	NULL
for	NULL
NF-kappaB	NULL
activation	NULL
.	NULL

Science	NULL
278	NULL
:	NULL
860-866	NULL
.	NULL

Woronicz	NULL
JD	NULL
,	NULL
Gao	NULL
X	NULL
,	NULL
Cao	NULL
Z	NULL
,	NULL
Rothe	NULL
M	NULL
and	NULL
Goeddel	NULL
DV	NULL
IkappaB	NULL
kinase-beta	NULL
:	NULL
NF-kB	NULL
activation	NULL
and	NULL
complex	NULL
formation	NULL
with	NULL
IkappaB	NULL
kinase-aipha	NULL
and	NULL
NIK	NULL
.	NULL

Science	NULL
278	NULL
:	NULL
866-869	NULL
.	NULL

ZandiE	NULL
,	NULL
Rothwarf	NULL
DM	NULL
,	NULL
Delhase	NULL
M	NULL
,	NULL
Hayakawa	NULL
Mand	NULL
Karin	NULL
M	NULL
(	NULL
1997	NULL
)	NULL
The	NULL
IkappaB	NULL
kinase	NULL
complex	NULL
(	NULL
IKK	NULL
)	NULL
contains	NULL
two	NULL
kinase	NULL
subunits	NULL
,	NULL
IKKalpha	NULL
and	NULL
IKKbeta	NULL
,	NULL
necessary	NULL
for	NULL
IkappaB	NULL
phosphorylation	NULL
and	NULL
NF-kappaB	NULL
activation	NULL
.	NULL

Cell	NULL
91	NULL
:	NULL
243-252	NULL
.	NULL

Beg	NULL
AA	NULL
,	NULL
Sha	NULL
WC	NULL
,	NULL
Bronson	NULL
RT	NULL
,	NULL
Ghosh	NULL
S	NULL
and	NULL
Baltimore	NULL
D	NULL
(	NULL
1995	NULL
)	NULL
Embryonic	NULL
lethality	NULL
and	NULL
liver	NULL
degeneration	NULL
in	NULL
mice	NULL
lacking	NULL
the	NULL
RelA	NULL
component	NULL
of	NULL
NF-xB	NULL
.	NULL

Nature	NULL
376	NULL
:	NULL
167-170	NULL
.	NULL

Beg	NULL
AA	NULL
and	NULL
Baltimore	NULL
D	NULL
(	NULL
1996	NULL
)	NULL
An	NULL
essential	NULL
role	NULL
for	NULL
NF-kappaB	NULL
in	NULL
preventing	NULL
TNF-alpha-induced	NULL
cell	NULL
death	NULL
.	NULL

Science	NULL
274	NULL
;	NULL
782-784	NULL
.	NULL

Van	NULL
Antwerp	NULL
DJ	NULL
,	NULL
Martin	NULL
SJ	NULL
,	NULL
Kafri	NULL
T	NULL
,	NULL
Green	NULL
DR	NULL
,	NULL
Verma	NULL
IM	NULL
(	NULL
1996	NULL
)	NULL
Suppression	NULL
of	NULL
TNF-alpha-induced	NULL
apoptosis	NULL
by	NULL
NF-kappaB	NULL
.	NULL

Science	NULL
274	NULL
:	NULL
787-789	NULL
.	NULL

Liu	NULL
ZG	NULL
,	NULL
Hsu	NULL
H	NULL
,	NULL
Goeddel	NULL
DV	NULL
and	NULL
Karin	NULL
M	NULL
(	NULL
1996	NULL
)	NULL
Dissection	NULL
of	NULL
TNF	NULL
receptor	NULL
1	NULL
effector	NULL
functions	NULL
:	NULL
JNK	NULL
activation	NULL
is	NULL
not	NULL
linked	NULL
to	NULL
apoptosis	NULL
while	NULL
NF-kappaB	NULL
activation	NULL
prevents	NULL
cell	NULL
death	NULL
.	NULL

Cell	NULL
87	NULL
:	NULL
565-576	NULL
.	NULL

Chinetti	NULL
G	NULL
,	NULL
Griglio	NULL
S	NULL
,	NULL
Antonucci	NULL
M	NULL
,	NULL
Torra	NULL
IP	NULL
,	NULL
Delerive	NULL
P	NULL
,	NULL
Majd	NULL
Z	NULL
,	NULL
Fruchart	NULL
JC	NULL
,	NULL
Chapman	NULL
J	NULL
,	NULL
Najib	NULL
J	NULL
and	NULL
Staels	NULL
B	NULL
(	NULL
1998	NULL
)	NULL
Activation	NULL
of	NULL
proliferator-activated	NULL
receptors	NULL
alpha	NULL
and	NULL
gamma	NULL
induces	NULL
apoptosis	NULL
of	NULL
human	NULL
monocyte-derived	NULL
macrophages	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273	NULL
:	NULL
25573-25580	NULL
.	NULL

Wang	NULL
CY	NULL
,	NULL
Mayo	NULL
MW	NULL
and	NULL
Baldwin	NULL
Jr	NULL
AS	NULL
(	NULL
1996	NULL
)	NULL
TNF-	NULL
and	NULL
cancer	NULL
therapy-induced	NULL
apoptosis	NULL
:	NULL
potentiation	NULL
by	NULL
inhibition	NULL
of	NULL
NF-kappaB	NULL
.	NULL

Science	NULL
274	NULL
:	NULL
784-787	NULL
.	NULL

Mayo	NULL
MW	NULL
,	NULL
Wang	NULL
CY	NULL
,	NULL
Cogswell	NULL
PC	NULL
,	NULL
Rogers-Graham	NULL
KS	NULL
,	NULL
Lowe	NULL
SW	NULL
,	NULL
Der	NULL
CJ	NULL
and	NULL
Baldwin	NULL
Jr	NULL
AS	NULL
(	NULL
1997	NULL
)	NULL
Requirement	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
to	NULL
suppress	NULL
p53-independent	NULL
apoptosis	NULL
induced	NULL
by	NULL
oncogenic	NULL
Ras	NULL
.	NULL

Science	NULL
278	NULL
:	NULL
1812-1815	NULL
.	NULL

Wang	NULL
CY	NULL
,	NULL
Mayo	NULL
MW	NULL
,	NULL
Komneluk	NULL
RG	NULL
,	NULL
Goeddel	NULL
DV	NULL
and	NULL
Baldwin	NULL
Jr	NULL
AS	NULL
(	NULL
1998	NULL
)	NULL
NF-kappaB	NULL
antiapoptosis	NULL
:	NULL
induction	NULL
of	NULL
TRAF1	NULL
and	NULL
TRAF2	NULL
and	NULL
c-IAP	NULL
1	NULL
and	NULL
c-lAP2	NULL
to	NULL
suppress	NULL
caspase-8	NULL
activation	NULL
.	NULL

Science	NULL
281	NULL
:	NULL
1680-1683	NULL
.	NULL

Wu	NULL
MX	NULL
,	NULL
AoZ	NULL
,	NULL
Prasad	NULL
KV	NULL
,	NULL
Wu	NULL
R	NULL
and	NULL
Schlossman	NULL
SF	NULL
(	NULL
1998	NULL
)	NULL
IEX-1L	NULL
.	NULL

,	NULL
an	NULL
apoptosis	NULL
inhibitor	NULL
involved	NULL
in	NULL
NF-kappaB-mediated	NULL
cell	NULL
survival	NULL
.	NULL

Science	NULL
281	NULL
:	NULL
998-1001	NULL
.	NULL

Arsura	NULL
M	NULL
,	NULL
Wu	NULL
M	NULL
and	NULL
Sonenshein	NULL
GE	NULL
(	NULL
1996	NULL
)	NULL
TGF§1	NULL
inhibits	NULL
activity	NULL
inducing	NULL
apoptosis	NULL
of	NULL
B	NULL
cells	NULL
:	NULL
Transcriptional	NULL
Activation	NULL
of	NULL
IxBa	NULL
.	NULL

Immunity	NULL
5	NULL
:	NULL
31	NULL
40	NULL
.	NULL

Schauer	NULL
SL	NULL
,	NULL
Bellas	NULL
RE	NULL
,	NULL
Sonenshein	NULL
GE	NULL
(	NULL
1998	NULL
)	NULL
Dominant	NULL
signals	NULL
leading	NULL
to	NULL
inhibitor	NULL
kappaB	NULL
protein	NULL
degradation	NULL
mediate	NULL
CD40	NULL
ligand	NULL
rescue	NULL
of	NULL
WEHI	NULL
231	NULL
immature	NULL
B	NULL
cells	NULL
from	NULL
receptor-mediated	NULL
apoptosis	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

160	NULL
:	NULL
4398-4405	NULL
.	NULL

Abbadie	NULL
C	NULL
,	NULL
Kabrun	NULL
N	NULL
,	NULL
Bouali	NULL
F	NULL
,	NULL
Smardova	NULL
J	NULL
,	NULL
Stehelin	NULL
D	NULL
,	NULL
Vandenbunder	NULL
B	NULL
and	NULL
Enrietto	NULL
PJ	NULL
(	NULL
1993	NULL
)	NULL
High	NULL
levels	NULL
of	NULL
c-re	NULL
!	NULL

expression	NULL
are	NULL
associated	NULL
with	NULL
programmed	NULL
cell	NULL
death	NULL
in	NULL
the	NULL
developing	NULL
avian	NULL
embryo	NULL
and	NULL
in	NULL
bone	NULL
marrow	NULL
cells	NULL
in	NULL
vitro	NULL
.	NULL

Cell	NULL
75	NULL
:	NULL
899-912	NULL
.	NULL

Kitajima	NULL
!	NULL

,	NULL
Soejima	NULL
Y	NULL
,	NULL
Takasaki	NULL
I	NULL
,	NULL
Beppu	NULL
H	NULL
,	NULL
Tokioka	NULL
T	NULL
and	NULL
Maruyama	NULL
|	NULL
(	NULL
1996	NULL
)	NULL
Ceramide-induced	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
a	NULL
potential	NULL
mediator	NULL
of	NULL
the	NULL
apoptotic	NULL
response	NULL
to	NULL
TNF	NULL
in	NULL
murine	NULL
clonal	NULL
osteoblasts	NULL
.	NULL

Bone	NULL
19	NULL
:	NULL
263-270	NULL
.	NULL

Hunot	NULL
S	NULL
,	NULL
Brugg	NULL
B	NULL
,	NULL
Ricard	NULL
D	NULL
,	NULL
Michel	NULL
PP	NULL
,	NULL
Muriel	NULL
MP	NULL
,	NULL
Ruberg	NULL
M	NULL
,	NULL
Faucheux	NULL
BA	NULL
,	NULL
Agid	NULL
Y	NULL
and	NULL
Hirsch	NULL
EC	NULL
(	NULL
1997	NULL
)	NULL
Nuclear	NULL
translocation	NULL
of	NULL
NF-xB	NULL
is	NULL
increased	NULL
in	NULL
dopaminergic	NULL
neurons	NULL
of	NULL
patients	NULL
with	NULL
parkinson	NULL
disease	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.S.A.	NULL
94	NULL
:	NULL
7531-7536	NULL
.	NULL

Lin	NULL
K-1	NULL
,	NULL
Lee	NULL
S-H	NULL
,	NULL
Narayanan	NULL
R	NULL
,	NULL
Baraban	NULL
JM	NULL
,	NULL
Hardwick	NULL
JM	NULL
and	NULL
Ratan	NULL
RR	NULL
(	NULL
1995	NULL
)	NULL
Thiol	NULL
agents	NULL
and	NULL
Bcl-2	NULL
identify	NULL
an	NULL
alphavirus-induced	NULL
apoptotic	NULL
pathway	NULL
that	NULL
requires	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NF-xB	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

131	NULL
:	NULL
1149-1161	NULL
.	NULL

Marianneau	NULL
P	NULL
,	NULL
Cardona	NULL
A	NULL
,	NULL
Edelman	NULL
L	NULL
,	NULL
Deubel	NULL
V	NULL
and	NULL
Despres	NULL
P	NULL
(	NULL
1997	NULL
)	NULL
Dengue	NULL
virus	NULL
replication	NULL
in	NULL
human	NULL
hepatoma	NULL
cells	NULL
activates	NULL
NF-xB	NULL
which	NULL
in	NULL
turn	NULL
induces	NULL
apoptotic	NULL
cell	NULL
death	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

71	NULL
:	NULL
3244	NULL
-	NULL
3249	NULL
.	NULL

Lipton	NULL
SA	NULL
and	NULL
Rosenberg	NULL
PA	NULL
(	NULL
1994	NULL
)	NULL
Mechanisms	NULL
of	NULL
disease	NULL
:	NULL
Excitatory	NULL
amino	NULL
acids	NULL
as	NULL
a	NULL
final	NULL
common	NULL
pathway	NULL
for	NULL
neurologic	NULL
disorders	NULL
.	NULL

N.	NULL
Eng	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

330	NULL
:	NULL
613-622	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
:	NULL
A	NULL
contextual	NULL
regulator	NULL
of	NULL
apoptosis	NULL
B	NULL
Lin	NULL
et	NULL
al	NULL
53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

69	NULL
.	NULL

70	NULL
.	NULL

71	NULL
.	NULL

72	NULL
.	NULL

Grilli	NULL
M	NULL
,	NULL
Pizzi	NULL
M	NULL
,	NULL
Memo	NULL
M	NULL
and	NULL
Spano	NULL
P	NULL
(	NULL
1996	NULL
)	NULL
Neuroprotection	NULL
by	NULL
aspirin	NULL
and	NULL
sodium	NULL
salicylate	NULL
through	NULL
blockade	NULL
of	NULL
NF-xB	NULL
activation	NULL
.	NULL

Science	NULL
274	NULL
:	NULL
1383-1385	NULL
.	NULL

Qin	NULL
ZH	NULL
,	NULL
Wang	NULL
Y	NULL
,	NULL
Nakai	NULL
M	NULL
and	NULL
Chase	NULL
TN	NULL
(	NULL
1998	NULL
)	NULL
Nuclear	NULL
factor-kappa	NULL
B	NULL
contributes	NULL
to	NULL
excitotoxin-induced	NULL
apoptosis	NULL
in	NULL
rat	NULL
striatum	NULL
.	NULL

Mol	NULL
.	NULL

Pharmacol	NULL
.	NULL

53	NULL
:	NULL
33-42	NULL
.	NULL

Moore	NULL
NC	NULL
,	NULL
Girdlestone	NULL
J	NULL
,	NULL
Anderson	NULL
G	NULL
,	NULL
Owen	NULL
JJ	NULL
and	NULL
Jenkinson	NULL
EJ	NULL
(	NULL
1995	NULL
)	NULL
Stimulation	NULL
of	NULL
thymocytes	NULL
before	NULL
and	NULL
after	NULL
positive	NULL
selection	NULL
results	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
different	NULL
NF-kappa	NULL
B/Re	NULL
!	NULL

protein	NULL
complexes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

155	NULL
:	NULL
4653-4660	NULL
.	NULL

Jain	NULL
J	NULL
,	NULL
Loh	NULL
C	NULL
and	NULL
Rao	NULL
A	NULL
(	NULL
1995	NULL
)	NULL
Transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

7	NULL
:	NULL
333-342	NULL
.	NULL

Maggirwar	NULL
SB	NULL
,	NULL
Harhaj	NULL
EW	NULL
and	NULL
Sun	NULL
SC	NULL
(	NULL
1997	NULL
)	NULL
Regulation	NULL
of	NULL
the	NULL
interleukin-2	NULL
CD28-responsive	NULL
element	NULL
by	NULL
NF-ATp	NULL
and	NULL
various	NULL
NF-kappaB/Rel	NULL
transcription	NULL
factors	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

17	NULL
:	NULL
2605-2614	NULL
.	NULL

Gerondakis	NULL
S	NULL
,	NULL
Grumont	NULL
R	NULL
,	NULL
Rourke	NULL
I	NULL
and	NULL
Grossmann	NULL
M	NULL
(	NULL
1998	NULL
)	NULL
The	NULL
regulation	NULL
and	NULL
roles	NULL
of	NULL
Rel/NF-kappa	NULL
B	NULL
transcription	NULL
factors	NULL
during	NULL
lymphocyte	NULL
activation	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

10	NULL
:	NULL
353-359	NULL
.	NULL

Brockman	NULL
JA	NULL
,	NULL
Scherer	NULL
DC	NULL
,	NULL
McKinsey	NULL
TA	NULL
,	NULL
Hall	NULL
SM	NULL
,	NULL
QiX	NULL
,	NULL
Lee	NULL
WY	NULL
and	NULL
Ballard	NULL
DW	NULL
(	NULL
1995	NULL
)	NULL
Coupling	NULL
of	NULL
a	NULL
signal	NULL
response	NULL
domain	NULL
in	NULL
IBa	NULL
to	NULL
multiple	NULL
pathways	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
:	NULL
2809-2818	NULL
.	NULL

Brown	NULL
K	NULL
,	NULL
Gerstberger	NULL
S	NULL
,	NULL
Carlson	NULL
L	NULL
,	NULL
Franzoso	NULL
G	NULL
and	NULL
Sigbenlist	NULL
U	NULL
(	NULL
1995	NULL
)	NULL
Control	NULL
of	NULL
|	NULL
kappa	NULL
B-alpha	NULL
proteolysis	NULL
by	NULL
site-specific	NULL
,	NULL
signal-induced	NULL
phosphorylation	NULL
.	NULL

Science	NULL
.	NULL

267	NULL
:	NULL
1485-1488	NULL
.	NULL

Boothby	NULL
MR	NULL
,	NULL
Mora	NULL
AL	NULL
,	NULL
Scherer	NULL
DC	NULL
,	NULL
Brockman	NULL
JA	NULL
and	NULL
Ballard	NULL
DW	NULL
(	NULL
1997	NULL
)	NULL
Perturbation	NULL
of	NULL
the	NULL
T	NULL
lymphocyte	NULL
lineage	NULL
in	NULL
transgenic	NULL
mice	NULL
expressing	NULL
a	NULL
constitutive	NULL
repressor	NULL
of	NULL
nuclear	NULL
factor	NULL
(	NULL
NF	NULL
)	NULL
-kappaB	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

185	NULL
:	NULL
1897	NULL
1907	NULL
.	NULL

Ray	NULL
A	NULL
and	NULL
Prefontaine	NULL
KE	NULL
(	NULL
1994	NULL
)	NULL
Physical	NULL
association	NULL
and	NULL
functional	NULL
antagonism	NULL
between	NULL
the	NULL
p65	NULL
subunit	NULL
of	NULL
transcription	NULL
factor	NULL
NF-kappa	NULL
B	NULL
and	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91	NULL
:	NULL
752-756	NULL
.	NULL

Scheinman	NULL
RI	NULL
,	NULL
Gualberto	NULL
A	NULL
,	NULL
Jewell	NULL
CM	NULL
,	NULL
Cidlowski	NULL
JA	NULL
and	NULL
Baldwin	NULL
Jr	NULL
AS	NULL
(	NULL
1995	NULL
)	NULL
Characterization	NULL
of	NULL
the	NULL
Mechanisms	NULL
Involved	NULL
in	NULL
the	NULL
Transrepression	NULL
of	NULL
NF-xB	NULL
by	NULL
Activated	NULL
Glucocorticoid	NULL
Receptors	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

15	NULL
:	NULL
943-953	NULL
.	NULL

Caldenhoven	NULL
E	NULL
,	NULL
Liden	NULL
J	NULL
,	NULL
Wissink	NULL
S	NULL
,	NULL
Van	NULL
de	NULL
Stolpe	NULL
A	NULL
,	NULL
Raaijimakers	NULL
J	NULL
,	NULL
Koenderman	NULL
L	NULL
,	NULL
Okret	NULL
S	NULL
,	NULL
Gustafsson	NULL
JA	NULL
and	NULL
Van	NULL
der	NULL
Saag	NULL
PT	NULL
(	NULL
1995	NULL
)	NULL
Negative	NULL
cross-talk	NULL
between	NULL
RelA	NULL
and	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
:	NULL
a	NULL
possible	NULL
mechanism	NULL
for	NULL
the	NULL
antiinflammatory	NULL
action	NULL
of	NULL
glucocorticoids	NULL
.	NULL

Molecular	NULL
Endocrinology	NULL
9	NULL
:	NULL
401-412	NULL
.	NULL

Scheinman	NULL
RI	NULL
,	NULL
Cogswell	NULL
PC	NULL
,	NULL
Lofquist	NULL
AK	NULL
and	NULL
Baldwin	NULL
Jr	NULL
AS	NULL
(	NULL
1995	NULL
)	NULL
Role	NULL
of	NULL
transcriptional	NULL
activation	NULL
of	NULL
IxBa	NULL
in	NULL
mediation	NULL
of	NULL
immunosuppression	NULL
by	NULL
glucocorticoids	NULL
.	NULL

Science	NULL
270	NULL
:	NULL
283-286	NULL
.	NULL

Auphan	NULL
N	NULL
,	NULL
DiDonato	NULL
JA	NULL
,	NULL
Rosette	NULL
C	NULL
,	NULL
Helmberg	NULL
A	NULL
and	NULL
Karin	NULL
M	NULL
(	NULL
1995	NULL
)	NULL
Immunosuppression	NULL
by	NULL
glucocorticoids	NULL
:	NULL
inhibition	NULL
of	NULL
NF-xB	NULL
activity	NULL
through	NULL
induction	NULL
of	NULL
IxB	NULL
synthesis	NULL
.	NULL

Science	NULL
270	NULL
:	NULL
232-233	NULL
.	NULL

De	NULL
Bosscher	NULL
K	NULL
,	NULL
Schmitz	NULL
ML	NULL
,	NULL
Vanden-Berghe	NULL
W	NULL
,	NULL
Plaisance	NULL
S	NULL
,	NULL
Fiers	NULL
W	NULL
and	NULL
Haegeman	NULL
G	NULL
(	NULL
1997	NULL
)	NULL
Glucocorticoid-mediated	NULL
repression	NULL
of	NULL
nuclear	NULL
factor-kappaB-dependent	NULL
transcription	NULL
involves	NULL
direct	NULL
interference	NULL
with	NULL
transactiva-tion	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94	NULL
:	NULL
13504-13509	NULL
.	NULL

Takahashi	NULL
T	NULL
,	NULL
Tanaka	NULL
M	NULL
,	NULL
Inazawa	NULL
J	NULL
,	NULL
Abe	NULL
T	NULL
,	NULL
Suda	NULL
T	NULL
and	NULL
Nagata	NULL
S	NULL
(	NULL
1994	NULL
)	NULL
Human	NULL
Fas	NULL
ligand	NULL
:	NULL
gene	NULL
structure	NULL
,	NULL
chromosomal	NULL
location	NULL
and	NULL
species	NULL
specificity	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

6	NULL
:	NULL
1567-1574	NULL
.	NULL

ChomezynskiP	NULL
and	NULL
Sacchi	NULL
N	NULL
(	NULL
1987	NULL
)	NULL
Single-step	NULL
method	NULL
of	NULL
RNA	NULL
isolation	NULL
by	NULL
acid	NULL
guanidinium	NULL
thiocyanate-phenol-chloroform	NULL
extraction	NULL
.	NULL

Analytical	NULL
Biochemistry	NULL
162	NULL
:	NULL
156-159	NULL
.	NULL

Kasibhatla	NULL
S	NULL
,	NULL
Brunner	NULL
T	NULL
,	NULL
Genestier	NULL
L	NULL
,	NULL
Echeverri	NULL
F	NULL
,	NULL
Mahboubi	NULL
A	NULL
and	NULL
Green	NULL
DR	NULL
(	NULL
1998	NULL
)	NULL
DNA	NULL
damaging	NULL
agents	NULL
induce	NULL
expression	NULL
of	NULL
Fas	NULL
ligand	NULL
and	NULL
subsequent	NULL
apoptosis	NULL
in	NULL
T	NULL
lymphocytes	NULL
via	NULL
the	NULL
activation	NULL
of	NULL
NF-kappa	NULL
B	NULL
and	NULL
AP-1	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
1	NULL
:	NULL
543-551	NULL
.	NULL

Duke	NULL
RC	NULL
and	NULL
Cohen	NULL
JJ	NULL
(	NULL
1991	NULL
)	NULL
Quantitation	NULL
of	NULL
apoptotic	NULL
index	NULL
and	NULL
cell	NULL
viability	NULL
using	NULL
fluorescent	NULL
dyes	NULL
.	NULL

In	NULL
Current	NULL
Protocols	NULL
in	NULL
Immunology	NULL
JE	NULL
Coligan	NULL
,	NULL
AM	NULL
Kruisbeck	NULL
,	NULL
DH	NULL
Marguiles	NULL
,	NULL
EM	NULL
Sevach	NULL
and	NULL
W	NULL
Strober	NULL
eds	NULL
.	NULL

New	NULL
York	NULL
:	NULL
Green	NULL
Publishing	NULL
and	NULL
Wiley-Interscience	NULL
pp3.17.1	NULL
-	NULL
3.17.3	NULL
.	NULL

Chen	NULL
X	NULL
,	NULL
Zachar	NULL
V	NULL
,	NULL
Zdravkovic	NULL
M	NULL
,	NULL
Guo	NULL
M	NULL
,	NULL
Ebbesen	NULL
P	NULL
and	NULL
Liu	NULL
X	NULL
(	NULL
1997	NULL
)	NULL
Role	NULL
of	NULL
the	NULL
Fas/Fas	NULL
ligand	NULL
pathway	NULL
in	NULL
apoptotic	NULL
cell	NULL
death	NULL
induced	NULL
by	NULL
the	NULL
human	NULL
T	NULL
cell	NULL
lymphotropic	NULL
virus	NULL
type	NULL
I	NULL
Tax	NULL
transactivator	NULL
.	NULL

J.	NULL
Gen.	NULL
Virol	NULL
.	NULL

78	NULL
:	NULL
3277-3285	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
:	NULL
A	NULL
contextual	NULL
regulator	NULL
of	NULL
apoptosis	NULL
B	NULL
Lin	NULL
et	NULL
al	NULL
582	NULL
73	NULL
.	NULL

74	NULL
.	NULL

75	NULL
.	NULL

76	NULL
.	NULL

77	NULL
.	NULL

Cui	NULL
H	NULL
,	NULL
Matsui	NULL
K	NULL
,	NULL
Omura	NULL
S	NULL
,	NULL
Schauer	NULL
SL	NULL
,	NULL
Matulka	NULL
RA	NULL
,	NULL
Sonenshein	NULL
GE	NULL
and	NULL
Ju	NULL
ST	NULL
(	NULL
1997	NULL
)	NULL
Proteasome	NULL
regulation	NULL
of	NULL
activation-induced	NULL
T	NULL
cell	NULL
death	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94	NULL
:	NULL
7515-7520	NULL
.	NULL

Latinis	NULL
KM	NULL
,	NULL
Norian	NULL
LA	NULL
,	NULL
Elision	NULL
SL	NULL
and	NULL
Koretzky	NULL
GA	NULL
(	NULL
1997	NULL
)	NULL
Two	NULL
NFAT	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
participate	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
CD95	NULL
(	NULL
Fas	NULL
)	NULL
ligand	NULL
expression	NULL
in	NULL
activated	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272	NULL
:	NULL
31427-31434	NULL
.	NULL

Ponton	NULL
A	NULL
,	NULL
Clement	NULL
MV	NULL
and	NULL
Stamenkovic	NULL
I	NULL
(	NULL
1996	NULL
)	NULL
The	NULL
CD95	NULL
(	NULL
APO-1/Fas	NULL
)	NULL
receptor	NULL
activates	NULL
NF-kappaB	NULL
independently	NULL
of	NULL
its	NULL
cytotoxic	NULL
function	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
:	NULL
8991-8995	NULL
.	NULL

Ravi	NULL
R	NULL
,	NULL
Bedi	NULL
A	NULL
,	NULL
Fuchs	NULL
EJ	NULL
and	NULL
Bedi	NULL
A	NULL
(	NULL
1998	NULL
)	NULL
CD95	NULL
(	NULL
Fas	NULL
)	NULL
-induced	NULL
caspase-mdiated	NULL
proteolysis	NULL
of	NULL
NF-xB	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

58	NULL
:	NULL
882-886	NULL
.	NULL

Zong	NULL
WX	NULL
,	NULL
Bash	NULL
J	NULL
and	NULL
Gelinas	NULL
C	NULL
(	NULL
1998	NULL
)	NULL
Rel	NULL
blocks	NULL
both	NULL
anti-Fas-	NULL
and	NULL
TNF	NULL
alpha-induced	NULL
apoptosis	NULL
and	NULL
an	NULL
intact	NULL
Rel	NULL
transactivation	NULL
domain	NULL
is	NULL
essential	NULL
for	NULL
this	NULL
effect	NULL
.	NULL

Cell	NULL
Death	NULL
Differ	NULL
.	NULL

5	NULL
:	NULL
963-972	NULL
.	NULL

78	NULL
.	NULL

79	NULL
.	NULL

80	NULL
.	NULL

81	NULL
.	NULL

Chu	NULL
ZL	NULL
,	NULL
McKinsey	NULL
TA	NULL
,	NULL
Liu	NULL
L	NULL
,	NULL
Gentry	NULL
JJ	NULL
,	NULL
Malim	NULL
MH	NULL
and	NULL
Ballard	NULL
DW	NULL
(	NULL
1997	NULL
)	NULL
Suppression	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor-induced	NULL
cell	NULL
death	NULL
by	NULL
inhibitor	NULL
of	NULL
apoptosis	NULL
c-lAP2	NULL
is	NULL
under	NULL
NF-kappaB	NULL
control	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94	NULL
:	NULL
10057	NULL
10062	NULL
.	NULL

Bradford	NULL
MM	NULL
(	NULL
1976	NULL
)	NULL
A	NULL
Rapid	NULL
and	NULL
Sensitive	NULL
Method	NULL
for	NULL
the	NULL
Quantitation	NULL
of	NULL
Microgram	NULL
Quantities	NULL
of	NULL
Protein	NULL
Utilizing	NULL
the	NULL
Principle	NULL
of	NULL
Protein-dye	NULL
binding	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

72	NULL
:	NULL
248-254	NULL
.	NULL

Scheinman	NULL
RI	NULL
,	NULL
Beg	NULL
AA	NULL
and	NULL
Baldwin	NULL
AS	NULL
(	NULL
1993	NULL
)	NULL
NF-	NULL
«	NULL
B	NULL
p100	NULL
(	NULL
lyt-10	NULL
)	NULL
is	NULL
a	NULL
Component	NULL
of	NULL
H2TF1	NULL
and	NULL
Can	NULL
Function	NULL
as	NULL
an	NULL
IxB-Like	NULL
Molecule	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13	NULL
:	NULL
6089-6101	NULL
.	NULL

Duke	NULL
RC	NULL
,	NULL
Chervenak	NULL
R	NULL
and	NULL
Cohen	NULL
JJ	NULL
(	NULL
1983	NULL
)	NULL
Endogenous	NULL
endonuclease-induced	NULL
DNA	NULL
fragmentation	NULL
:	NULL
an	NULL
early	NULL
event	NULL
in	NULL
cell-mediated	NULL
cytolysis	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
80	NULL
:	NULL
6361-6365	NULL
.	NULL

